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ABSTRACT

This disclosure concerns nucleic acid molecules and methods

of use thereof for control of hemipteran pests through RNA
interference-mediated inhibition of target coding and tran
scribed non-coding sequences in hemipteran pests. The dis
closure also concerns methods for making transgenic plants
that express nucleic acid molecules useful for the control of
hemipteran pests, and the plant cells and plants obtained
thereby.
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PARENTAL RNA SUPPRESSION OF
HUNCHBACKGENE TO CONTROL
HEMPTERAN PESTS
PRIORITY CLAIM

0001. This application claims the benefit of the filing date
of U.S. Provisional Patent Application Ser. No. 62/092,776,
filed Dec. 16, 2014, for “PARENTAL RNAISUPPRESSION
OF HUNCHBACK GENE TO CONTROL HEMIPTERAN

PESTS” which is incorporated herein in its entirety.
FIELD OF THE DISCLOSURE

0002 The present invention relates generally to genetic
control of plant damage caused by hemipteran pests. In par
ticular embodiments, the present disclosure relates to identi
fication of target coding and non-coding polynucleotides, and
the use of recombinant DNA technologies for post-transcrip
tionally repressing or inhibiting expression of target coding
and non-coding polynucleotides in the cells of a hemipteran
pest to provide a plant protective effect.
BACKGROUND

0003 Stink bugs and other hemipteran insects (het
eroptera) are an important agricultural pest complex. World
wide, over 50 closely related species of stink bugs are known
to cause crop damage. McPherson & McPherson (2000) Stink
bugs of economic importance in America north of Mexico,
CRC Press. Hemipteran insects are present in a large number
of important crops including maize, soybean, fruit, veg
etables, and cereals.

0004 Stink bugs go through multiple nymph stages before
reaching the adult stage. These insects develop from eggs to
adults in about 30-40 days. Both nymphs and adults feed on
sap from Soft tissues into which they also inject digestive
enzymes causing extra-oral tissue digestion and necrosis.
Digested plant material and nutrients are then ingested.
Depletion of water and nutrients from the plant vascular sys
tem results in plant tissue damage. Damage to developing
grain and seeds is the most significant as yield and germina
tion are significantly reduced. Multiple generations occur in
warm climates resulting in significant insect pressure. Cur
rent management of Stink bugs relies on insecticide treatment
on an individual field basis. Therefore, alternative manage
ment strategies are urgently needed to minimize ongoing crop
losses.

0005 RNA interference (RNAi) is a process utilizing
endogenous cellular pathways, whereby an interfering RNA
(iRNA) molecule (e.g., a double stranded RNA (dsRNA)
molecule) that is specific for all, or any portion of adequate
size, of a target gene results in the degradation of the mRNA
encoded thereby. In recent years, RNAi has been used to
perform gene "knockdown” in a number of species and
experimental systems; for example, Caenorhabditis elegans,
plants, insect embryos, and cells in tissue culture. See, e.g.,
Fire et al. (1998) Nature 391:806-11; Martinez et al. (2002)
Cell 110:563-74; McManus and Sharp (2002) Nature Rev.
Genetics 3: 737-47.

0006 RNAi accomplishes degradation of mRNA through
an endogenous pathway including the DICER protein com
plex. DICER cleaves long dsRNA molecules into short frag
ments of approximately 20 nucleotides, termed Small inter
fering RNA (siRNA). The siRNA is unwound into two single
Stranded RNAS: the passenger strand and the guide strand.
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The passenger Strand is degraded, and the guide Strand is
incorporated into the RNA-induced silencing complex
(RISC). Micro inhibitory ribonucleic acids (miRNAs) are
structurally very similar molecules that are cleaved from pre
cursor molecules containing a polynucleotide "loop' con
necting the hybridized passenger and guide Strands, and they
may be similarly incorporated into RISC. Post-transcrip
tional gene silencing occurs when the guide Strand binds
specifically to a complementary mRNA molecule and
induces cleavage by Argonaute, the catalytic component of
the RISC complex. This process is known to spread systemi
cally throughout some eukaryotic organisms despite initially
limited concentrations of siRNA and/or miRNA such as

plants, nematodes, and some insects.
0007 Only transcripts complementary to the siRNA and/
or miRNA are cleaved and degraded, and thus the knock
down of mRNA expression is sequence-specific. In plants,
several functional groups of DICER genes exist. The gene
silencing effect of RNAi persists for days and, under experi
mental conditions, can lead to a decline in abundance of the

targeted transcript of 90% or more, with consequent reduc
tion in levels of the corresponding protein. In insects, there
are at least two DICER genes, where DICER1 facilitates
miRNA-directed degradation by Argonaute 1. Lee et al.
(2004) Cell 117(1):69-81. DICER2 facilitates siRNA-di
rected degradation by Argonaute2.
0008. The overwhelming majority of sequences comple
mentary to insect DNAs (such as, for example, the 9,000+
sequences identified in U.S. Pat. No. 7,612,194 and U.S.

Patent Publication Nos. 2007/0050860, 2010/0192265, and

2011/0154545) do not provide a plant protective effect when
used as dsRNA or siRNA. For example, Baum et al. (2007)
Nature Biotechnology 25:1322-1326, describe the effects of
inhibiting several WCR gene targets by RNAi. These authors
reported that 8 of the 26 target genes they tested were notable
to provide experimentally significant coleopteran pest mor
tality at a very high iERNA (e.g., dsRNA) concentration of

more than 520 ng/cm.

0009. The authors of U.S. Pat. No. 7,612,194 and U.S.
Patent Publication No. 2007/0050860 made the first report of
in planta RNAi in corn plants targeting the western corn
rootworm. Baum et al. (2007) Nat. Biotechnol. 25(11): 1322
6. These authors describe a high-throughput in vivo dietary
RNAi system to screen potential target genes for developing
transgenic RNAi maize. Of an initial gene pool of 290 targets,
only 14 exhibited larval control potential. One of the most
effective double-stranded RNAs (dsRNA) targeted a gene
encoding vacuolar ATPase subunit A (V-ATPase), resulting in
a rapid Suppression of corresponding endogenous mRNA and
triggering a specific RNAi response with low concentrations
of dsRNA. Thus, these authors documented for the first time

the potential for in planta RNAi as a possible pest manage
ment tool, while simultaneously demonstrating that effective
targets could not be accurately identified a priori, even from a
relatively small set of candidate genes.
0010. Another potential application of RNAi for insect
control involves parental RNAi (pRNAi). First described in
Caenorhabditis elegans, pRNAi was identified by injection
of dsRNA into the body cavity (or application of dsRNA via
ingestion), causing gene inactivity in offspring embryos. Fire
et al. (1998), supra; Timmons and Fire (1998) Nature 395
(6705):854. A similar process was described in the model
coleopteran, Tribolium castaneum, whereby female pupae
injected with dsRNA corresponding to three unique genes
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that control segmentation during embryonic development
resulted in knock down of Zygotic genes in offspring
embryos. Bucher et al. (2002) Curr. Biol. 12(3):R85-6.
Nearly all of the offspring larvae in this study displayed
gene-specific phenotypes one week after injection. Although
injection of dsRNA for functional genomics studies has been
successful in a variety of insects, uptake of dsRNA from the
gut environment through oral exposure to dsRNA and Subse
quent down-regulation of essential genes is required in order
for RNAi to be effective as a pest management tool. Auer and
Frederick (2009) Trends Biotechnol. 27(11):644-51.
0.011 Parental RNAi has been used to describe the func
tion of embryonic genes in a number of insect species, includ
ing the springtail, Orchesella cincta (Konopova and Akam
(2014) Evodevo 5(1):2); the brown planthopper, Nilaparvata
higens; the sawfly, Athalia rosae (Yoshiyama et al. (2013) J.
Insect Physiol. 59(4):400-7); the German cockroach, Mat
tel/a germanica (Piulachs et al. (2010) Insect Biochem. Mol.
Biol. 40:468-75); and the pea aphid, Acyrthosiphon pisum
(Mao et al. (2013) Arch Insect Biochem Physiol 84(4): 209
21). The pRNAi response in all these instances was achieved
by injection of dsRNA into the hemocoel of the parental
female.
SUMMARY OF THE DISCLOSURE

0012 Disclosed herein are nucleic acid molecules (e.g.,
target genes, DNAs, dsRNAs, siRNAs, shRNAs, miRNAs,
and hpRNAs), and methods of use thereof, for the control of
hemipteran pests, including, for example, Euschistus heros
(Fabr) (Neotropical Brown Stink Bug, “BSB'); E. servus
(Say) (Brown Stink Bug); Nezara viridula (L.) (Southern
Green Stink Bug); Piezodorus guildinii (Westwood) (Red
banded Stink Bug); Halyomorpha halys (Stal) (Brown Mar
morated Stink Bug); Chinavia hilare (Say) (Green Stink
Bug); C marginiatum (Palisot de Beauvois); Dichelops mela
canthus (Dallas); D. furcatus (F.); Edessa meditabunda (F.);
Thyanta perditor (F) (Neotropical Red Shouldered Stink
Bug); Horcias nobilellus (Berg) (Cotton Bug); Taedia Stig
mosa (Berg); Dysdercus peruvianus (Guérin-Méneville):
NeOmegalotomus parvus (Westwood); Leptoglossus Zonatus
(Dallas); Niesthrea Sidae (F.); Lygus hesperus (Knight)
(Western Tarnished Plant Bug); and L. lineolaris (Palisot de
Beauvois). In particular examples, exemplary nucleic acid
molecules are disclosed that may be homologous to at least a
portion of one or more native nucleic acids in a hemipteran
pest. In some embodiments, hemipteran pests are controlled
by reducing the capacity of an existing generation of the pest
to produce a Subsequent generation of the pest. In certain
examples, delivery of the nucleic acid molecules to hemi
pteran pests does not result in significant mortality to the
pests, but reduces the number of viable progeny produced
therefrom.

0013. In these and further examples, the native nucleic
acid may be a target gene, the product of which may be, for
example and without limitation: involved in a metabolic pro
cess; involved in a reproductive process; and/or involved in
embryonic and/or nymph development. In some examples,
post-transcriptional inhibition of the expression of a target
gene by a nucleic acid molecule comprising a polynucleotide
homologous thereto may result in reduced growth and/or
reproduction of the hemipteran pest. In specific examples, a
hunchback gene is selected as a target gene for post-transcrip
tional silencing. In particular examples, a target gene useful
for post-transcriptional inhibition is the novel gene referred to
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hereinas BSB hunchback (SEQID NO:1), referred to herein
in some places as BSB hb. An isolated nucleic acid molecule
comprising the polynucleotide of SEQID NO:1; the comple
ment of SEQ ID NO:1; and/or fragments of either of the
foregoing (e.g., SEQ ID NO:2) is therefore also disclosed
herein.

0014. Also disclosed are nucleic acid molecules compris
ing a polynucleotide that encodes a polypeptide that is at least
about 85% identical to an amino acid sequence within a target
gene product (for example, the product of a hunchback gene).
For example, a nucleic acid molecule may comprise a poly
nucleotide encoding a polypeptide that is at least 85% iden
tical to SEQ ID NO:3 (BSB HUNCHBACK); and/or an
amino acid sequence within a product of BSB hb. Further
disclosed are nucleic acid molecules comprising a polynucle
otide that is the reverse complement of a polynucleotide that
encodes a polypeptide at least 85% identical to an amino acid
sequence within a target gene product.
0015. Further disclosed are cDNA polynucleotides that
may be used for the production of iRNA (e.g., dsRNA,
siRNA, shRNA, miRNA, and hpRNA) molecules that are
complementary to all or part of a hemipteran pest target gene,
for example, a hunchback gene. In particular embodiments,
dsRNAs, siRNAs, shRNAs, miRNAs, and/or hpRNAs may
be produced in vitro, or in vivo by a genetically-modified
organism, such as a plant or bacterium. In particular
examples, cDNA molecules are disclosed that may be used to
produce iRNA molecules that are complementary to all or
part of mRNA transcribed from BSB hb (SEQID NO:1).
0016. Additionally disclosed are means for inhibiting
expression of an essential gene in a hemipteran pest, and
means for protecting a plant from a hemipteran pest. A means
for inhibiting expression of an essential gene in a hemipteran
pest is a single- or double-stranded RNA molecule consisting
of a polynucleotide selected from the group consisting of
SEQ ID NO:12 and SEQ ID NO:13; and the complements
thereof. Functional equivalents of means for inhibiting
expression of an essential gene in a hemipteran pest include
single- or double-stranded RNA molecules that are substan
tially homologous to all or part of mRNA transcribed from a
BSB gene comprising SEQID NO:1. A means for protecting
a plant from a hemipteran pest is a DNA molecule comprising
a polynucleotide encoding a means for inhibiting expression
of an essential gene in a hemipteran pest operably linked to a
promoter, wherein the DNA molecule is capable of being
integrated into the genome of a maize plant.
0017 Disclosed are methods for controlling a population
of a hemipteran pest, comprising providing to a hemipteran
pest an iRNA (e.g., dsRNA, siRNA, shRNA, miRNA, and
hpRNA) molecule that functions upon being taken up by the
pest to inhibit a biological function within the pest, wherein
the iRNA molecule comprises all or part of (e.g., at least 15
contiguous nucleotides of) a polynucleotide selected from the
group consisting of: SEQID NO:1; the complement of SEQ
ID NO:1; SEQID NO:2; the complement of SEQID NO:2; a
native coding polynucleotide of a hemipteran organism (e.g.,
BSB) comprising all or part of SEQID NO:1 and/or SEQID
NO:2; the complement of a native coding polynucleotide of a
hemipteran organism comprising all or part of SEQID NO:1
and/or SEQID NO:2; a native non-coding polynucleotide of
a hemipteran organism that is transcribed into a native RNA
molecule comprising all or part of SEQID NO:1 and/or SEQ
ID NO:2; and the complement of a native non-coding poly
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nucleotide of a hemipteran organism that is transcribed into a
native RNA molecule comprising all or part of SEQID NO:1
and/or SEQID NO:2.
0018. In particular examples, methods are disclosed for
controlling a population of a hemipteran pest, comprising
providing to a hemipteran pest an iRNA (e.g., dsRNA,
siRNA, shRNA, miRNA, and hpRNA) molecule that func
tions upon being taken up by the pest to inhibit a biological
function within the pest, wherein the iRNA molecule com
prises a polynucleotide selected from the group consisting of
all or part of: SEQ ID NO:12; the complement of SEQ ID
NO:12: SEQID NO:13; the complement of SEQID NO:13;
a polynucleotide that hybridizes to a native coding polynucle
otide of a hemipteran (e.g., BSB) organism comprising all or
part of SEQID NO:1 or SEQID NO:2; and the complement
of a polynucleotide that hybridizes to a native coding poly
nucleotide of a hemipteran (e.g., BSB) organism comprising
all or part of SEQID NO:1 or SEQID NO:2.
0019. Also disclosed herein are methods wherein dsR
NAs, siRNAs, shRNAs, miRNAs, and/or hpRNAs may be
provided to a hemipteran pest in a diet-based assay, or in
genetically-modified plant cells expressing the dsRNAS, siR
NAs, shRNAs, miRNAs, and/or hpRNAs. In these and further
examples, the dsRNAs, siRNAs, shRNAs, miRNAs, and/or
hpRNAS may be ingested by a hemipteran pest. Ingestion of
dsRNAs, siRNA, shRNAs, miRNAs, and/or hpRNAs of the
invention may then result in RNAi in the pest, which in turn
may result in silencing of a gene essential for a metabolic
process; a reproductive process; and/or nymph development.
Thus, methods are disclosed wherein nucleic acid molecules

comprising exemplary polynucleotide(s) useful for parental
control of hemipteran pests are provided to a hemipteran pest.
In particular examples, the hemipteran pest controlled by use
of nucleic acid molecules of the invention may be BSB. In
Some examples, delivery of the nucleic acid molecules to
hemipteran pests does not result in significant mortality to the
pests, but reduces the number of viable progeny produced
therefrom. In some examples, delivery of the nucleic acid
molecules to hemipteran pests results in significant mortality
to the pests, and also reduces the number of viable progeny
produced therefrom.
0020. The foregoing and other features will become more
apparent from the following Detailed Description of several
embodiments, which proceeds with reference to the accom
panying Figures.
BRIEF DESCRIPTION OF THE FIGURES

0021 FIG. 1A includes a depiction of the strategy used to
generate dsRNA from a single transcription template with a
single pair of primers, and FIG.1B includes a depiction of the
strategy used to generate dsRNA from two transcription tem
plates.
0022 FIG. 2 includes a summary of modeling data show
ing the effect of relative magnitude of a pRNAi effect on
female BSB adults emerging from a “refuge patch” (i.e., that
did not express insecticidal iRNAs or recombinant proteins in
a transgenic crop) on the rate of increase in allele frequencies
for resistance to an insecticidal protein (R) and RNAi (Y)
when non-refuge plants express the insecticidal protein and
parental active iRNA.
0023 FIG. 3 includes a summary of modeling data show
ing the effect of relative magnitude of a pRNAi effect on
female BSB adults emerging from a “refuge patch” (i.e., that
did not express insecticidal iRNAs or recombinant proteins in
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a transgenic crop of plants comprising BSB nymph-active
interfering dsRNA in combination with the BSB-active insec
ticidal protein in the transgenic crop) on the rate of increase in
allele frequencies for resistance to an insecticidal protein (R)
and RNAi (Y) when non-refuge plants express the insecti
cidal protein and both larval active and parental active iRNA
molecules.

0024 FIG. 4 shows relative transcript level for genes of
hunchback (hb) in the ovaries of E. heros females. Insects not
injected with dsRNA were used as a reference;YFP dsRNA
injected insects were used as a negative control. Means com
parisons were performed with Dunnett's test using non-in
jected insects as controls. ** indicates significance at p<0.
OO1.

(0025 FIGS. 5A-5C show oviposition, development and
hatch rates of eggs from hunchback dsRNA-injected E. heros
females. Females were injected with dsRNA at 0 to 2 days
post adult molt. The counts are based on 1342 eggs oviposited
by un-injected females, 1202 eggs byYFPv2 dsRNA-injected
females, and 922 eggs by hb dsRNA-injected females in a
two-week period. Eggs were collected on daily bases starting
at 7 days post injection; the development and hatch rates are
weekly intervals. FIG. 5A shows thenumber of eggs ovipos
ited per day perfemale and averaged in weekly intervals. FIG.
5B shows the percent of eggs that developed past the stage of
visible head pigmentation. FIG. 5C shows the percentiles of
eggs hatched of the eggs oviposited during weeks one and two
of egg collection. Means comparisons were performed with
Dunnett's test using non-injected insects as controls, * indi
cates significance at p-0.001.
(0026 FIGS. 6A-6C show parental hunchback dsRNA
phenotypes in E. heros. E. heros females were injected with
dsRNA at 0 to 2 days post adult molt. FIG. 6A showsa four
day-old embryo dissected from an egg of an hb dsRNA
injected female. The embryo exhibits a phenotype that
includes shortened limbs and head structures. FIG. 6B shows

a four-day-old embryo from a non-injected female shows the
normal arrangement of developing head structures and limbs.
FIG. 6C shows a two-day-old embryo from a non-injected
female shows an earlier stage of development with elongated
appendages.
SEQUENCE LISTING
0027. The nucleic acid sequences listed in the accompa
nying sequence listing are shown using standard letter abbre
viations for nucleotide bases, as defined in 37 C.F.R.S 1.822.
The nucleic acid and amino acid sequences listed define mol
ecules (i.e., polynucleotides and polypeptides, respectively)
having the nucleotide and amino acid monomers arranged in
the manner described. The nucleic acid and amino acid

sequences listed also each define a genus of polynucleotides
or polypeptides that comprise the nucleotide and amino acid
monomers arranged in the manner described. In view of the
redundancy of the genetic code, it will be understood that a
nucleotide sequence including a coding sequence also
describes the genus of polynucleotides encoding the same
polypeptide as a polynucleotide consisting of the reference
sequence. It will further be understood that an amino acid
sequence describes the genus of polynucleotide ORFs encod
ing that polypeptide.
0028. Only one strand of each nucleic acid sequence is
shown, but the complementary strand is understood as
included by any reference to the displayed strand. As the
complement and reverse complement of a primary nucleic
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acid sequence are necessarily disclosed by the primary
sequence, the complementary sequence and reverse comple
mentary sequence of a nucleic acid sequence are included by
any reference to the nucleic acid sequence, unless it is explic
itly stated to be otherwise (or it is clear to be otherwise from
the context in which the sequence appears). Furthermore, as it
is understood in the art that the nucleotide sequence of an
RNA strand is determined by the sequence of the DNA from
which it was transcribed (but for the substitution ofuracil (U)
nucleobases for thymine (T)), an RNA sequence is included
by any reference to the DNA sequence encoding it. In the
accompanying sequence listing:
0029 SEQID NO:1 shows an exemplary BSB hb DNA:
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- Continued
CTTGACAGAATCGCCCTTCGCCTACAGCAGCAAGTCGAAGTGGAAGAGCA
GCCAGAACCGCCAAAACCGATCCCACCACCTGTGGTTTCCGAGCCGGCAA
AATCACCTGAAATTAAGTCCTGCGAAGCTGACAGCGAGCAGCAGAAGGTG
GAGAAAACAGAACAGGAGAATGTGTATAGTTGCACTTTTTGTGATATTTT
ATTTAAGGACATTGTTATGTATACAATGCATATGGGTTACCATGGCTACG
AAGACCCCTTCAAGTGCAACATGTGCGGGCAGCAAACAACCGACAAGGTT
TCTTTCTTCCTCCACATTGCAAGAACATCACACTCATAAGGATTACAATT
CTATTATTAATCAAATAGATTTTTTTCTGGTTTTAAAAGAGAATCCAACT
TGTTACCCAGTTCACGTCATTAACTGTCTCTCGTGGCAGTTTATGTAAATA

GCCCTTTGGGTTTAGTTCTCTACGAGCTGCTCTACCATCCACTAGGACTA

TTTATTATATCATCATTTAGATTATTAATATATTATTTTCCAGATATATT

GCTCTATCTTCTCTCTTATATTAGTTCTGGATATATATCTCTCTCTCTCT

TAGCGTTGGTGTCTAGTCATGTGTATAACAACATAATGTGTAAAAAAAAA

ATCTATATCTACAGCTGGGAACACCGTAGTCGTCTTTTGTTTTATATATA

ATGTGGAATTAGGAAATAGTGTCCTAACATATGAAATATGTAAACAAGAG

TTGCCTGCATGTTGGAATGAGATGATTATAACTCCTGATATATACTTTAA

AAAGGAATAACAAAAATGTTAAAAGTAATTAACATTATTAAGAATATTTG

CAATCCGAGGATGAACATCGGTGTGCAATACGACCCAAGGCATTCCGTCT

AAAAACAATATTATGTTCCCTTCTAATGTTAATGAGCGAGTAAAAAAAGT

TCCCGAATTTGGAGCACCATCCATGGATGGCTTCCCCGACTCCGGCACAA

TAAAACGATTGCATAGTTTTAAGGTATTTTATAGCCG

GTCGTTAAAGAGGAGCCGCGAGATGACGCGGAGTACGGTCAGAACAGCCA

0030 SEQID NO:2 shows an exemplary E. heros hunch
back DNA, of which the complementary strand is transcribed
to become the sense strand of an exemplary BSB hunchback
dsRNA (BSB hb-1):

GGAGAGCCAGCTGCCGCTGACGCCGCCCCCCTTCCAGGGCTACCCCCCGG
GGAACACCTACCGCGAGGCCACGCCCCCTAAGGATACGCCCCCCGCCTCC
ACCCCCTCGCCTCAGGAGAAGCAGGAAGGCAGCTCCAACTCCGAGGGAGA
GTACTACGAGAGCGGAGAGTCCCTAAAGAGGCTGCAGATGGCCCTCCATA
GGACCGGGATGATAACGGAGGAGAAGCTGCAATGTCCTGTATGCGAGTTC
TCTTGCAGTGTCAGGTCACAGTTCAATGAACACCTATTGTCACACGAGAC
TAAATGTTCCATGTGCGACTTCAGTGGAGAAACCAGTGAAAAATTGAGAG
AGCACATGAGGAATGTCCACGACTGCGATGATGACAGCAGCTGGGGAGAA
GAAGAGCTCAACACTCCCAAAGTCAATTCTCAGGGAAAGGTCAAAACGTT
TCGCTGCAAGCAGTGTGAGTTTTCAGCTGTGACGAAACTAGAATTTTGGG
ATCACTCTCGCACCCACATCAAACAGGAGCGATTGCTCACTTGCCCAAAG
TGCCCATTCGTCACTGAATACAAACACCATCTCGAATACCATTTGAGGAA
TCATTTTGGATCGAAACCGTTCAAGTGTGACAAGTGTTCCTACTCTTGCG
TGAACAAATCCATGCTCAATTCTCACTTGAAAAGTCACAGCAACATTTAC
CAGTTCAGATGTGCTGATTGCACCTACGCTACTAAGTATTGTCACAGCTT

GTCCACGACTGCGATGATGACAGCAGCTGGGGAGAAGAAGAGCTCAACAC
TCCCAAAGTCAATTCTCAGGGAAAGGTCAAAACGTTTCGCTGCAAGCAGT
GTGAGTTTTCAGCTGTGACGAAACTAGAATTTTGGGATCACTCTCGCACC
CACATCAAACAGGAGCGATTGCTCACTTGCCCAAAGTGCCCATTCGTCAC
TGAATACAAACACCATCTCGAATACCATTTGAGGAATCATTTTGGATCGA
AACCGTTCAAGTGTGACAAGTGTTCCTACTCTTGCGTGAACAAATCCATG
CT CAATTCTCACTTGAAAAGTCACAGCAACATTTACCAGTTCAGATGTGC
TGATTGCACCTACGCTACTAAGTATTGTCACAGCTTGAAGCTGCATCTGA
GAAAATATGCTCACAACCCAGCCATGGTTCTTAACCCTGACGGTTCTCCT
AATCCTCTACCAATCGTAG

0031 SEQID NO:3 shows the amino acid sequence of a
BSB HUNCHBACK polypeptide encoded by an exemplary
BSB hb DNA:

GAAGCTGCATCTGAGAAAATATGCTCACAACCCAGCCATGGTTCTTAACC
CTGACGGTTCTCCTAATCCTCTACCAATCG TAGATGTATATGGAACTAGG

MIITPDIYFNNPRMNIGVOYDPRHSVFPNLEHHPWMASPTPAOVVKEEPR

CGTGGTCCAAAGCAGAAGCCCAAGAATGAACAGCAACCACAACAACCGCC

DDAEYGONSOESOLPLTPPPFOGYPPGNTYREATPPKDTPPASTPSPOEK

GCAGGTCCCGACTATTTTCAACCCATATTCCTTACTTCCAACACAGATGC

QEGSSNSEGEYYESGESLKRLOMALHRTGMITEEKLOCPVCEFSCSVRSO

CATATTACAACATCCTTAATGGATTTGGAGGATTTCCTTTCCCACAAGAT

FNEHILLSHETKCSMCDFSGETSEKLREHMRNWHDCDDDSSWGEEELNTPK

GTTAACATGGAAGAGAAAAACAACAATGTTGAAAAAGAAGAGATCAGAGA

WNSOGKVKTFRCKOCEFSAVTKLEFWDHSRTHIKOERLLTCPKCPFWTEY

AGATAAAGCTCCTCTTGACTTGAGCTGCCCTGAACCGATGGTAGAAGACA

KHHLEYHLRNHFGSKPFKCDKCSYSCVNKSMLNSHLKSHSNIYOFRCADC

GCAATCAAGAAGCCCCAGTGAAAAACCGTAGAAAAGGGAAAGCCTTCAAA.

TYATKYCHSLKLHLRKYAHNPAMVLNPDGSPNPLPIVDWYGTRRGPKOKP
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KNEOOPOOPPOVPTIFNPYSLLPTOMPYYNILNGFGGFPFPODVNMEEKN
CATCTATGAAGGTTATGCCCTTCCCCACGCCATCCTCCGTCTGGATCTTG

NNWEKEEIREDKAPLDLSCPEPMVEDSNOEAPVKNRRKGKAFKLDRIALR
CTGGACGTGACTTGACTGACTATCTTATGAAGATCCT CACCGAGCGTGGT

LOOOVEVEEOPEPPKPIPPPVVSEPAKSPEIKSCEADSEOOKVEKTEOEN
TACAGCTTCACCACCACCGCTGAAAGGGAAATCGTCAGGGACATCAAGGA

WYSCTFCDILFKDIWMYTMHMGYHGYEDPFKCNMCGOOTTDKVSFFLHIA
AAAACTGTGCTATGTCGCCCTGGACTTTGAGCAGGAAATGGCCACCGCCG
RTSHS
CTGCCTCCACCTCCCTGGAGAAGTCCTATGAACTTCCCGACGGTCAGGTC

0032 SEQ ID NO:4 shows the nucleotide sequence of a
T7 phage promoter.
0033 SEQID NO:5 shows an exemplary DNA encoding a
YFPv2 gene targeting hairpin-RNA-forming RNA; contain
ing a YFPv2 sense polynucleotide, a loop polynucleotide
including an ST-LS1 intron (underlined), and YFPv2 anti
sense polynucleotide (bold font):

ATCACCATCGGTAACGAGAGGTTCCGTTGCCCAGAGGCTCTCTTCCAGCC
TTCCTTCTTGGGTATGGAATCTTGCGGTATCCATGAGACTGTCTACAACT
CCATCATGAAGTGCGACGTTGACATCAGGAAGGACTTGTACGCCAACACC
GTCCTCTCCGGAGGTACCACCATGTACCCAGGTATTGCTGACAGGATGCA
GAAGGAAATCACCGCCCTCGCTCCTTCAACCATCAAGATCAAGATCATTG

ATGTCATCTGGAGCACTTCTCTTTCATGGGAAGATTCCTTACGTTGTGGA

CTCCCCCAGAAAGGAAGTACTCCGTATGGATCGGTGGTTCCATCTTGGCT

GATGGAAGGGAATGTTGATGGCCACACCTTTAGCATACGTGGGAAAGGCT

TCCCTGTCCACCTTCCAGCAGATGTGGATCTCCAAGCAGGAATACGACGA

ACGGAGATGCCTCAGTGGGAAAGGACTAGTACCGGTTGGGAAAGGTATGT

ATCCGGCCCAGGCATCGTCCACCGCAAATGCTTC

TTCTGCTTCTACCTTTGATATATATATAATAATTATCACTAATTAGTAGT

DETAILED DESCRIPTION
AATATAGTATTTCAAGTATTTTTTTCAAAATAAAAGAATGTAGTATATAG
CTATTGCTTTTCTGTAGTTTATAAGTGTGTATATTTTAATTTATAACTTT

I. Overview of Several Embodiments

TCTAATATATGACCAAAACATGGTGATGTGCAGGTTGATCCGCGGTTACT

0040 We developed RNA interference (RNAi) as a tool
for insect pest management, using a target pest species for
transgenic plants that express dsRNA; the Neotropical brown
Stink bug. Thus far, most genes proposed as targets for RNAi
in particular insects do not achieve their purpose, and those
useful targets that have been identified involve typically those
that cause lethality in the nymph stage. Herein, we describe
RNAi-mediated knockdown of hunchback (hb) in the Neo
tropical brown stink bug, which is shown to disrupt embry
onic development when, for example, iRNA are molecules
are delivered via hunchback dsRNA provided to adult
females. Exposure of adult female insects to hunchback
dsRNA did not affect adult longevity when administered
orally. However, there was almost complete absence of hatch
ing in the eggs collected from females exposed to hunchback
dsRNA. In embodiments herein, the ability to deliver hunch
back dsRNA by feeding to adult insects confers a pRNAi
effect that is very useful for insect (e.g., hemipteran) pest
management. Furthermore, the potential to affect multiple
target sequences in both nymph and adult hemipteran pests
may increase opportunities to develop Sustainable
approaches to insect pest management involving RNAi tech
nologies.
0041 Disclosed herein are methods and compositions for
genetic control of hemipteran pest infestations. Methods for
identifying one or more gene(s) essential to the lifecycle of a
hemipteran pest (e.g., gene(s) essential for normal reproduc
tive capacity and/or embryonic and/or nymph development)
for use as a target gene for RNAi-mediated control of a
hemipteran pest population are also provided. DNA plasmid
vectors encoding an RNA molecule may be designed to Sup
press one or more target gene(s) essential for growth, Sur
vival, development, and/or reproduction. In some embodi
ments, the RNA molecule may be capable of forming dsRNA
molecules. In some embodiments, methods are provided for
post-transcriptional repression of expression or inhibition of
a target gene via nucleic acid molecules that are complemen

TTCCCACTGAGGCATCTCCGTAGCCTTTCCCACGTAIGCTAAAGGTGTGG
CCATCAACATTCCCTCCATCTCCACAACGTAAGGAACTTCCCAGAAA
GAGAAGGCTCCAGATGACAT

0034 SEQID NO:6 shows an exemplary DNA compris
ing an ST-LS1 intron.
0035) SEQ ID NOs:7 and 8 show primers used for PCR
amplification of a BSB hb polynucleotide.
0036 SEQ ID NO:9 shows the DNA template for the
sense strand of an exemplary YFPv2 dsRNA.
0037 SEQID NOS:10 and 11 show primers used for PCR
amplification of a YFP gene.
0038 SEQ ID NOS:12 and 13 show exemplary RNAs
transcribed from nucleic acids comprising exemplary hunch
back polynucleotides and fragments thereof.
0039 SEQID NO:14 shows an actin-ORF.
TACAAAATGTGTGACGAAGAAGTTGCTGCTTTAGTTGTAGACAATGGATC
TGGTATGTGCAAAGCCGGTTTCGCTGGAGATGATGCACCCCGAGCTGTAT
TCCCATCAATTGTTGGCAGGCCTAGACACCAGGGTGTCATGGTTGGAATG
GGACAAAAGGACAGTTATGTTGGAGACGAAGCCCAAAGCAAGAGAGGTAT
CCT CACCCTGAAATACCCCATTGAACACGGTATCATCACCAACTGGGACG
ACATGGAAAAGATCTGGCATCACACCTTCTACAACGAGCTGCGAGTCGCT
CCAGAGGAACACCCCATCCTCCTGACTGAGGCTCCCCTCAACCCCAAAGC
CAACAGGGAGAAGATGACCCAGATCATGTTTGAGACCTTCAACACCCCAG
CCATGTATGTCGCCATCCAGGCTGTACTCTCCCTCTATGCCTCCGGTCGT
ACTACCGGTATTGTACTTGACTCAGGAGATGGTGTCTCCCACACCGTACC
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tary to a coding or non-coding sequence of the target gene in
a hemipteran pest. In these and further embodiments, a hemi
pteran pest may ingest one or more dsRNA, siRNA, shRNA,
miRNA, and/or hpRNA molecules transcribed from all or a
portion of a nucleic acid molecule that is complementary to a
coding or non-coding sequence of a target gene, thereby
providing a plant-protective effect.
0042 Some embodiments involve sequence-specific inhi
bition of expression of target gene products, using dsRNA,
siRNA, shRNA, miRNA and/or hpRNA that is complemen
tary to coding and/or non-coding sequences of the target
gene(s) to achieve at least partial control of a hemipteran pest.
Disclosed is a set of isolated and purified nucleic acid mol
ecules comprising a polynucleotide, for example, as set forth
in SEQ ID NO:1, and fragments thereof. In some embodi
ments, a stabilized dsRNA molecule may be expressed from
these polynucleotides, fragments thereof, or a gene compris
ing one of these polynucleotides, for the post-transcriptional
silencing or inhibition of a target gene. In certain embodi
ments, isolated and purified nucleic acid molecules comprise
all or part of either of SEQID NOS:1 and 2.
0043. Other embodiments involve a recombinant host cell
(e.g., a plant cell) having in its genome at least one recombi
nant DNA encoding at least one iRNA (e.g., dsRNA) mol
ecule(s). In particular embodiments, the dsRNA molecule(s)
may be produced when ingested by a hemipteran pest to
post-transcriptionally silence or inhibit the expression of a
target gene in the pest or progeny of the pest. The recombinant
DNA may comprise, for example, either of SEQID NOs: 1
and 2, fragments of either of SEQ ID NOs: 1 and 2, and a
polynucleotide consisting of a partial sequence of a gene
comprising either of SEQID NOs: 1 and 2, and/or comple
ments thereof.

0044 Some embodiments involve a recombinant host cell
having in its genome a recombinant DNA encoding at least
one iRNA (e.g., dsRNA) molecule(s) comprising all or part of
SEQID NO:12 (e.g., SEQID NO:12 and/or SEQID NO:13).
When ingested by a hemipteran pest, the iRNA molecule(s)
may silence or inhibit the expression of a target hunchback
gene (e.g., a DNA comprising all or part of a polynucleotide
selected from the group consisting of SEQID NOS:1 and 2) in
the pest or progeny of the pest, and thereby result in cessation
of reproduction in the pest, and/or growth, development, and/
or feeding in progeny of the pest.
0045. In other embodiments, a recombinant host cell hav
ing in its genome at least one recombinant DNA encoding at
least one RNA molecule capable of forming a dsRNA mol
ecule may be a transformed plant cell. Some embodiments
involve transgenic plants comprising such a transformed
plant cell. In addition to Such transgenic plants, progeny
plants of any transgenic plant generation, transgenic seeds,
and transgenic plant products, are all provided, each of which
comprises recombinant DNA(s). In particular embodiments,
an RNA molecule capable of forming a dsRNA molecule may
be expressed in a transgenic plant cell. Therefore, in these and
other embodiments, a dsRNA molecule may be isolated from
a transgenic plant cell. In particular embodiments, the trans
genic plant is a plant selected from the group comprising corn
(Zea mays), soybean (Glycine max), cotton, and plants of the
family Poaceae.
0046 Certain embodiments involve a method for modu
lating the expression of a target gene in a hemipteran pest cell.
In these and other embodiments, a nucleic acid molecule may
be provided, wherein the nucleic acid molecule comprises a
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polynucleotide encoding an RNA molecule capable of form
ing a dsRNA molecule. In particular embodiments, a poly
nucleotide encoding an RNA molecule capable of forming a
dsRNA molecule may be operatively linked to a promoter,
and may also be operatively linked to a transcription termi
nation sequence. In particular embodiments, a method for
modulating the expression of a target gene in a hemipteran
pest cell may comprise: (a) transforming a plant cell with a
vector comprising a polynucleotide encoding an RNA mol
ecule capable of forming a dsRNA molecule; (b) culturing the
transformed plant cell under conditions sufficient to allow for
development of a plant cell culture comprising a plurality of
transformed plant cells; (c) selecting for a transformed plant
cell that has integrated the vector into its genome; and (d)
determining that the selected transformed plant cell com
prises the RNA molecule capable of forming a dsRNA mol
ecule encoded by the polynucleotide of the vector. A plant
may be regenerated from a plant cell that has the vector
integrated in its genome and comprises the dsRNA molecule
encoded by the polynucleotide of the vector.
0047 Also disclosed is a transgenic plant comprising a
vector having a polynucleotide encoding an RNA molecule
capable of forming a dsRNA molecule integrated in its
genome, wherein the transgenic plant comprises the dsRNA
molecule encoded by the polynucleotide of the vector. In
particular embodiments, expression of an RNA molecule
capable of forming a dsRNA molecule in the plant is suffi
cient to modulate the expression of a target gene in a cell of a
hemipteran pest that contacts the transformed plant or plant
cell (for example, by feeding on the transformed plant, a part
of the plant (e.g., leaves) or plant cell) or in a cell of a progeny
of the hemipteran pest that contacts the transformed plant or
plant cell (for example, by parental transmission). Such that
reproduction of the pest is inhibited. Transgenic plants dis
closed herein may display tolerance and/or protection from
hemipteran pest infestations. Particular transgenic plants may
display protection and/or enhanced protection from one or
more pest(s) selected from the group consisting of
Piezodorus guildini; Halyomorpha haly's, Nezara viridula,
Acrosternum hilare, Euschistus heros, Euschistus serous,

Chinavia hilare, C. marginiatum, Dichelops melacanthus, D.
fircatus, Edessa meditabunda, Thyanta perditor, Horcias
nobilellus, Taedia Stigmosa, Dysdercus peruvianus, Neome
galotomus parvus, Leptoglossus Zonatus, Niesthreasidae,
Lygus hesperus; and L. lineolaris.
0048. Further disclosed herein are methods for delivery of
control agents, such as an iRNA molecule, to a hemipteran
pest. Such control agents may cause, directly or indirectly, an
impairment in the ability of a hemipteran pest population to
feed, grow or otherwise cause damage in a host. In some
embodiments, a method is provided comprising delivery of a
stabilized dsRNA molecule to a hemipteran pest to suppress
at least one target gene in the pest or its progeny, thereby
causing parental RNAi and reducing or eliminating plant
damage in a pest host. In some embodiments, a method of
inhibiting expression of a target gene in a hemipteran pest
may result in cessation of reproduction in the pest, and/or
growth, development, and/or feeding in progeny of the pest.
In some embodiments, the method may significantly reduce
the size of a Subsequent pest generation in an infestation,
without directly resulting in mortality in the pest(s) that con
tact the iRNA molecule. In some embodiments, the method

may significantly reduce the size of a Subsequent pest gen
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eration in an infestation, while also resulting in mortality in

III. Terms

0049. In some embodiments, compositions (e.g., a topical
composition) are provided that comprise an iRNA (e.g.,
dsRNA) molecule for use with plants, animals, and/or the
environment of a plant or animal to achieve the elimination or
reduction of a hemipteran pest infestation. In particular
embodiments, the composition may be a nutritional compo
sition or resource, or food source to be fed to the hemipteran
pest. Some embodiments comprise making the nutritional
composition or food source available to the pest. Ingestion of
a composition comprising iRNA molecules may result in the
uptake of the molecules by one or more cells of the hemi
pteran pest, which may in turn result in the inhibition of
expression of at least one target gene in cell(s) of the pest or
its progeny. Ingestion of or damage to a plant or plant cell by
a hemipteran pest infestation may be limited or eliminated in
or on any host tissue or environment in which the pest is
present by providing one or more compositions comprising
an iRNA molecule in the host of the pest.
0050. The compositions and methods disclosed herein
may be used together in combinations with other methods and
compositions for controlling damage by hemipteran pests.
For example, an iRNA molecule as described herein for pro
tecting plants from hemipteran pests may be used in a method
comprising the additional use of one or more chemical agents
effective against a hemipteran pest, biopesticides effective
against a hemipteran pest, crop rotation, recombinant genetic
techniques that exhibit features different from the features of
RNAi-mediated methods and RNAi compositions (e.g.,
recombinant production of proteins in plants that are harmful
to a hemipteran pest (e.g., Bt toxins)), and/or recombinant
expression of non-parental iRNA molecules (e.g., lethal
iRNA molecules that result in the cessation of growth, devel
opment, and/or feeding in the hemipteran pest that ingests the
iRNA molecule).

(0071. In the description and tables which follow, a number
of terms are used. In order to provide a clear and consistent
understanding of the specification and claims, including the
Scope to be given such terms, the following definitions are
provided:
0072 Contact (with an organism): As used herein, the
term “contact with' or "uptake by an organism (e.g., a hemi
pteran pest), with regard to a nucleic acid molecule, includes
internalization of the nucleic acid molecule into the organism,
for example and without limitation: ingestion of the molecule
by the organism (e.g., by feeding); contacting the organism
with a composition comprising the nucleic acid molecule:
and soaking of organisms with a solution comprising the

the pest(s) that contact the iRNA molecule.

II. Abbreviations

0051 BSB Neotropical brown stink bug (Euschistus
heros)
0052 dsRNA double-stranded ribonucleic acid
0053 GI growth inhibition

0054 NCBI National Center for Biotechnology Informa
t1On

0055 g|DNA genomic deoxyribonucleic acid
0056) iRNA inhibitory ribonucleic acid
0057 ORF open reading frame
0.058 RNAi ribonucleic acid interference
0059 miRNA micro ribonucleic acid

0060
0061
0062
0063
0064
0065
0066
0067
0068

siRNA small inhibitory ribonucleic acid
hpRNA hairpin ribonucleic acid
shRNA short hairpin ribonucleic acid
pRNAi parental RNA interference
UTR untranslated region
PCR Polymerase chain reaction
qPCR quantative polymerase chain reaction
RISC RNA-induced Silencing Complex
RH relative humidity

0069

SEM standard error of the mean

0070 YFP yellow fluorescent protein

nucleic acid molecule.

0073 Contig: As used herein the term "contig” refers to a
DNA sequence that is reconstructed from a set of overlapping
DNA segments derived from a single genetic source.
I0074 Corn plant: As used herein, the term “corn plant”
refers to a plant of the species. Zea mays (maize).
0075) Expression: As used herein, "expression” of a cod
ing polynucleotide (for example, a gene or a transgene) refers
to the process by which the coded information of a nucleic
acid transcriptional unit (including, e.g., gDNA or cDNA) is
converted into an operational, non-operational, or structural
part of a cell, often including the synthesis of a protein. Gene
expression can be influenced by external signals; for
example, exposure of a cell, tissue, or organism to an agent
that increases or decreases gene expression. Expression of a
gene can also be regulated anywhere in the pathway from
DNA to RNA to protein. Regulation of gene expression
occurs, for example, through controls acting on transcription,
translation, RNA transport and processing, degradation of
intermediary molecules such as mRNA, or through activa
tion, inactivation, compartmentalization, or degradation of
specific protein molecules after they have been made, or by
combinations thereof. Gene expression can be measured at
the RNA level or the protein level by any method known in the
art, including, without limitation, northern blot, RT-PCR,
western blot, or in vitro, in situ, or in vivo protein activity
assay(s).

I0076 Genetic material: As used herein, the term “genetic
material' includes all genes, and nucleic acid molecules, such
as DNA and RNA.

0077. Hemipteran pest: As used herein, the term “hemi
pteran pest” refers to pest insects of the order Hemiptera,
including, for example and without limitation, insects in the
families Pentatomidae, Miridae, Pyrrhocoridae, Coreidae,
Alydidae, and Rhopalidae, which feedon a wide range of host
plants and have piercing and sucking mouth parts. In particu
lar examples, a hemipteran pest is selected from the list com
prising Euschistus heros (Fabr) (Neotropical Brown Stink
Bug), Nezara viridula (L.) (Southern Green Stink Bug),
Piezodorus guildinii (Westwood) (Red-banded Stink Bug),
Halyomorpha haly's (Stat) (Brown Marmorated Stink Bug),
Chinavia hilare (Say) (Green Stink Bug). Euschistus servus
(Say) (Brown Stink Bug). Dichelops melacanthus (Dallas),
Dichelops furcatus (F.), Edessa meditabunda (F.), Thyanta
perditor (F) (Neotropical Red Shouldered Stink Bug), Chi
navia marginatum (Palisot de Beauvois), Horcias nobilellus
(Berg) (Cotton Bug), Taedia Stigmosa (Berg), Dysdercus
peruvianus (Guérin-Méneville), Neomegalotomus parvus
(Westwood), Leptoglossus zonatus (Dallas), Niesthreasidae
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(F.), Lygus hesperus (Knight) (Western Tarnished Plant Bug).
and Lygus lineolaris (Palisot de Beauvois).
0078. Inhibition: As used herein, the term “inhibition.
when used to describe an effect on a coding polynucleotide
(for example, a gene), refers to a measurable decrease in the
cellular level of mRNA transcribed from the coding poly
nucleotide and/or peptide, polypeptide, or protein product of
the coding polynucleotide. In some examples, expression of a
coding polynucleotide may be inhibited Such that expression
is approximately eliminated. “Specific inhibition” refers to
the inhibition of a target coding polynucleotide without con
sequently affecting expression of other coding polynucle
otides (e.g., genes) in the cell wherein the specific inhibition
is being accomplished.
0079 Isolated: An "isolated' biological component (such
as a nucleic acid or protein) has been Substantially separated,
produced apart from, or purified away from other biological
components in the cell of the organism in which the compo
nent naturally occurs (i.e., other chromosomal and extra
chromosomal DNA and RNA, and proteins), while effecting
a chemical or functional change in the component (e.g., a
nucleic acid may be isolated from a chromosome by breaking
chemical bonds connecting the nucleic acid to the remaining
DNA in the chromosome). Nucleic acid molecules and pro
teins that have been "isolated include nucleic acid molecules

and proteins purified by standard purification methods. The
term also embraces nucleic acids and proteins prepared by
recombinant expression in a host cell, as well as chemically
synthesized nucleic acid molecules, proteins, and peptides.
0080 Nucleic acid molecule: As used herein, the term
“nucleic acid molecule' may refer to a polymeric form of
nucleotides, which may include both sense and anti-sense
strands of RNA, cDNA, gDNA, and synthetic forms and
mixed polymers of the above. A nucleotide or nucleobase
may refer to a ribonucleotide, deoxyribonucleotide, or a
modified form of either type of nucleotide. A “nucleic acid
molecule' as used herein is synonymous with “nucleic acid
and “polynucleotide. A nucleic acid molecule is usually at
least 10 bases in length, unless otherwise specified. By con
vention, the nucleotide sequence of a nucleic acid molecule is
read from the 5' to the 3' end of the molecule. The “comple
ment of a nucleic acid molecule refers to a polynucleotide
having nucleobases that may form base pairs with the nucleo
bases of the nucleic acid molecule (i.e., A-T/U, and G-C).
0081. Some embodiments include nucleic acids compris
ing a template DNA that is transcribed into an RNA molecule
that is the complement of an mRNA molecule. In these
embodiments, the complement of the nucleic acid transcribed
into the mRNA molecule is present in the 5' to 3' orientation,
such that RNA polymerase (which transcribes DNA in the 5'
to 3’ direction) will transcribe a nucleic acid from the comple
ment that can hybridize to the mRNA molecule. Unless
explicitly stated otherwise, or it is clear to be otherwise from
the context, the term “complement” therefore refers to a poly
nucleotide having nucleobases, from 5' to 3', that may form
base pairs with the nucleobases of a reference nucleic acid.
Similarly, unless it is explicitly stated to be otherwise (or it is
clear to be otherwise from the context), the “reverse comple
ment of a nucleic acid refers to the complement in reverse
orientation. The foregoing is demonstrated in the following
illustration:
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ATGATGATG
TACTACTAC
CATCATCAT

polynucleotide
complement" of the polynucleotide
reverse complement" of the

polynucleotide

Some embodiments of the invention may include hairpin
RNA-forming RNAi molecules. In these RNAi molecules,
both the complement of a nucleic acid to be targeted by RNA
interference and the reverse complement may be found in the
same molecule, such that the single-stranded RNA molecule
may “fold over and hybridize to itself over region compris
ing the complementary and reverse complementary poly
nucleotides.

I0082 “Nucleic acid molecules' include all polynucle
otides, for example: single- and double-stranded forms of
DNA; single-stranded forms of RNA; and double-stranded
forms of RNA (dsRNA). The term “nucleotide sequence' or
“nucleic acid sequence” refers to both the sense and antisense
Strands of a nucleic acid as either individual single strands or
in the duplex. The term “ribonucleic acid (RNA) is inclusive
of iRNA (inhibitory RNA), dsRNA (double stranded RNA),
siRNA (small interfering RNA), shRNA (small hairpin
RNA), mRNA (messenger RNA), miRNA (micro-RNA),
hpRNA (hairpin RNA), tRNA (transfer RNAs, whether
charged or discharged with a corresponding acylated amino
acid), and cFNA (complementary RNA). The term “deoxyri
bonucleic acid” (DNA) is inclusive of cDNA, gDNA, and
DNA-RNA hybrids. The terms “polynucleotide' and
“nucleic acid.” and “fragments’ thereofwill be understood by
those in the art as a term that includes both gldNAs, ribosomal
RNAs, transfer RNAs, messenger RNAs, operons, and
Smaller engineered polynucleotides that encode or may be
adapted to encode, peptides, polypeptides, or proteins.
I0083 Oligonucleotide: An oligonucleotide is a short
nucleic acid polymer. Oligonucleotides may be formed by
cleavage of longer nucleic acid segments, or by polymerizing
individual nucleotide precursors. Automated synthesizers
allow the synthesis of oligonucleotides up to several hundred
bases in length. Because oligonucleotides may bind to a
complementary nucleic acid, they may be used as probes for
detecting DNA or RNA. Oligonucleotides composed of DNA
(oligodeoxyribonucleotides) may be used in PCR, a tech
nique for the amplification of DNAs. In PCR, the oligonucle
otide is typically referred to as a “primer,” which allows a
DNA polymerase to extend the oligonucleotide and replicate
the complementary strand.
I0084. A nucleic acid molecule may include either or both
naturally occurring and modified nucleotides linked together
by naturally occurring and/or non-naturally occurring nucle
otide linkages. Nucleic acid molecules may be modified
chemically or biochemically, or may contain non-natural or
derivatized nucleotide bases, as will be readily appreciated by
those of skill in the art. Such modifications include, for

example, labels, methylation, Substitution of one or more of
the naturally occurring nucleotides with an analog, inter
nucleotide modifications (e.g., uncharged linkages: for
example, methyl phosphonates, phosphotriesters, phospho
ramidates, carbamates, etc., charged linkages: for example,
phosphorothioates, phosphorodithioates, etc.; pendent moi
eties: for example, peptides; intercalators: for example, acri
dine, psoralen, etc.; chelators; alkylators; and modified link
ages: for example, alpha anomeric nucleic acids, etc.). The
term “nucleic acid molecule' also includes any topological
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conformation, including single-stranded, double-stranded,
partially duplexed, triplexed, hairpinned, circular, and pad
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DNA molecule may be introduced into a plant cell, such that
the DNA molecule is integrated into the genome of the plant

locked conformations.

cell. In these and further embodiments, the DNA molecule

I0085. As used herein with respect to DNA, the term "cod
ing polynucleotide.” “structural polynucleotide,” or “struc
tural nucleic acid molecule' refers to a polynucleotide that is
ultimately translated into a polypeptide, via transcription and
mRNA, when placed under the control of appropriate regu
latory elements. With respect to RNA, the term “coding poly
nucleotide' refers to a polynucleotide that is translated into a
peptide, polypeptide, or protein. The boundaries of a coding
polynucleotide are determined by a translation start codon at
the 5'-terminus and a translation stop codon at the 3'-termi
nus. Coding polynucleotides include, but are not limited to:
gDNA, cDNA; EST; and recombinant polynucleotides.
I0086. As used herein, “transcribed non-coding polynucle
otide' refers to segments of mRNA molecules such as 5' UTR,
3'UTR and intron segments that are not translated into a
peptide, polypeptide, or protein. Further, “transcribed non
coding polynucleotide' refers to a nucleic acid that is tran
scribed into an RNA that functions in the cell, for example,
structural RNAs (e.g., ribosomal RNA (rRNA) as exemplified
by 5S rRNA, 5.8S rRNA, 16S rRNA 18S rRNA, 23S rRNA,
and 28S rRNA, and the like); transfer RNA (tRNA); and

may be either integrated into the nuclear DNA of the plant
cell, or integrated into the DNA of the chloroplast or mito
chondrion of the plant cell. The term “genome,” as it applies
to bacteria, refers to both the chromosome and plasmids

snRNAs such as U4, U5, U6, and the like. Transcribed non

coding polynucleotides also include, for example and without
limitation, small RNAs (sRNA), which term is often used to
describe small bacterial non-coding RNAs; small nucleolar
RNAs (snoRNA); microRNAs; small interfering RNAs
(siRNA); Piwi-interacting RNAs (piRNA); and long non
coding RNAs. Further still, “transcribed non-coding poly
nucleotide' refers to a polynucleotide that may natively exist
as an intragenic 'spacer” in a nucleic acid and which is
transcribed into an RNA molecule.

0087

Lethal RNA interference: As used herein, the term

“lethal RNA interference refers to RNA interference that

results in death or a reduction in viability of the subject
individual to which, for example, a dsRNA, miRNA, siRNA,
shRNA, and/or hpRNA is delivered.
0088 Parental RNA interference: As used herein, the term
“parental RNA interference” (pRNAi) refers to a RNA inter
ference phenotype that is observable in progeny of the subject
(e.g., a hemipteran pest) to which, for example, a dsRNA,
miRNA, siRNA, shRNA, and/or hpRNA is delivered. In some
embodiments, pRNAi comprises the delivery of a dsRNA to
a hemipteran pest, wherein the pest is thereby rendered less
able to produce viable offspring. A nucleic acid that initiates
pRNAi may or may not increase the incidence of mortality in
a population into which the nucleic acid is delivered. In cer
tain examples, the nucleic acid that initiates pRNAi does not
increase the incidence of mortality in the population into
which the nucleic acid is delivered. For example, a population
of hemipteran pests may be fed one or more nucleic acids that
initiate pRNAi, wherein the pests survive and mate but pro
duce eggs that are less able to hatch viable progeny than eggs
produced by pests of the same species that are not fed the
nucleic acid(s). In one mechanism of pRNAi, parental RNAi
delivered to a female is able to knockdown Zygotic gene
expression in offspring embryos of the female. Bucher et al.
(2002) Curr. Biol. 12(3):R85-6.
0089 Genome: As used herein, the term “genome' refers
to chromosomal DNA found within the nucleus of a cell, and

also refers to organelle DNA found within subcellular com
ponents of the cell. In some embodiments of the invention, a

within the bacterial cell. In some embodiments of the inven

tion, a DNA molecule may be introduced into a bacterium
such that the DNA molecule is integrated into the genome of
the bacterium. In these and further embodiments, the DNA

molecule may be either chromosomally-integrated or located
as or in a stable plasmid.
0090 Sequence identity: The term “sequence identity” or
“identity,” as used herein in the context of two polynucle
otides or polypeptides, refers to the residues in the sequences
of the two molecules that are the same when aligned for
maximum correspondence over a specified comparison win
dow.

0091. As used herein, the term “percentage of sequence
identity” may refer to the value determined by comparing two
optimally aligned sequences (e.g., nucleic acid sequences or
polypeptide sequences) of a molecule over a comparison
window, wherein the portion of the sequence in the compari
son window may comprise additions or deletions (i.e., gaps)
as compared to the reference sequence (which does not com
prise additions or deletions) for optimal alignment of the two
sequences. The percentage is calculated by determining the
number of positions at which the identical nucleotide or
amino acid residue occurs in both sequences to yield the
number of matched positions, dividing the number of
matched positions by the total number of positions in the
comparison window, and multiplying the result by 100 to
yield the percentage of sequence identity. A sequence that is
identical at every position in comparison to a reference
sequence is said to be 100% identical to the reference
sequence, and Vice-versa.
0092 Methods for aligning sequences for comparison are
well-known in the art. Various programs and alignment algo
rithms are described in, for example: Smith and Waterman
(1981) Adv. Appl. Math. 2:482; Needleman and Wunsch
(1970) J. Mol. Biol. 48:443; Pearson and Lipman (1988)
Proc. Natl. Acad. Sci. U.S.A. 85:2444; Higgins and Sharp
(1988) Gene 73:237-44; Higgins and Sharp (1989) CABIOS
5:151-3: Corpet et al. (1988) Nucleic Acids Res. 16:10881
90; Huang et al. (1992) Comp. Appl. Biosci. 8:155-65; Pear
son et al. (1994) Methods Mol. Biol. 24:307-31; Tatiana et al.
(1999) FEMS Microbiol. Lett. 174:247-50. A detailed con
sideration of sequence alignment methods and homology
calculations can be found in, e.g., Altschul et al. (1990) J.
Mo1. Biol. 215:403-10.

(0093. The National Center for Biotechnology Information
(NCBI) Basic Local Alignment Search Tool (BLASTTM:
Altschul et al. (1990)) is available from several sources,
including the National Center for Biotechnology Information
(Bethesda, Md.), and on the internet, for use in connection
with several sequence analysis programs. A description of
how to determine sequence identity using this program is
available on the internet under the “help' section for
BLASTTM. For comparisons of nucleic acid sequences, the
“Blast 2 sequences' function of the BLASTTM (Blastn) pro
gram may be employed using the default BLOSUM62 matrix
set to default parameters. Nucleic acids with even greater
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sequence similarity to the sequences of the reference poly
nucleotides will show increasing percentage identity when
assessed by this method.
0094 Specifically hybridizable/Specifically complemen
tary: As used herein, the terms “Specifically hybridizable'
and “Specifically complementary are terms that indicate a
Sufficient degree of complementarity Such that stable and
specific binding occurs between the nucleic acid molecule
and a target nucleic acid molecule. Hybridization between
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0099 Moderate Stringency condition (detects polynucle
otides that share at least 80% sequence identity): Hybridiza
tion in 5x-6xSSC buffer at 65-70° C. for 16-20 hours; wash

twice in 2xSSC buffer at room temperature for 5-20 minutes
each; and wash twice in 1xSSC buffer at 55-70° C. for 30
minutes each.

0100. Non-stringent control condition (polynucleotides
that share at least 50% sequence identity will hybridize):
Hybridization in 6xSSC buffer at room temperature to 55° C.

two nucleic acid molecules involves the formation of an anti

for 16-20 hours; wash at least twice in 2x-3XSSC buffer at

parallel alignment between the nucleobases of the two

room temperature to 55° C. for 20-30 minutes each.
0101. As used herein, the term “substantially homolo
gous' or 'substantial homology, with regard to a nucleic
acid, refers to a polynucleotide having contiguous nucleo
bases that hybridize under stringent conditions to the refer
ence nucleic acid. For example, nucleic acids that are Sub
stantially homologous to a reference nucleic acid of either of
SEQ ID NOS:1 and 2 are those nucleic acids that hybridize
under Stringent conditions (e.g., the Moderate Stringency
conditions set forth, Supra) to the reference nucleic acid of
either of SEQ ID NOS:1 and 2. Substantially homologous
polynucleotides may have at least 80% sequence identity. For
example, Substantially homologous polynucleotides may
have from about 80% to 100% sequence identity, such as

nucleic acid molecules. The two molecules are then able to

form hydrogen bonds with corresponding bases on the oppo
site strand to form a duplex molecule that, if it is sufficiently
stable, is detectable using methods well known in the art. A
polynucleotide need not be 100% complementary to its target
nucleic acid to be specifically hybridizable. However, the
amount of complementarity that must exist for hybridization
to be specific is a function of the hybridization conditions
used.

0095 Hybridization conditions resulting in particular
degrees of stringency will vary depending upon the nature of
the hybridization method of choice and the composition and
length of the hybridizing nucleic acids. Generally, the tem
perature of hybridization and the ionic strength (especially
the Na" and/or Mg" concentration) of the hybridization
buffer will determine the stringency of hybridization, though
wash times also influence stringency. Calculations regarding
hybridization conditions required for attaining particular
degrees of stringency are known to those of ordinary skill in
the art, and are discussed, for example, in Sambrook et al.

(ed.) Molecular Cloning: A Laboratory Manual, 2" ed., vol.

1-3, Cold Spring Harbor Laboratory Press, Cold Spring Har
bor, N.Y., 1989, chapters 9 and 11; and Hames and Higgins
(eds.) Nucleic Acid Hybridization, IRL Press, Oxford, 1985.
Further detailed instruction and guidance with regard to the
hybridization of nucleic acids may be found, for example, in
Tijssen, “Overview of principles of hybridization and the
strategy of nucleic acid probe assays, in Laboratory Tech
niques in Biochemistry and Molecular Biology-Hybridiza
tion with Nucleic Acid Probes, Part I, Chapter 2, Elsevier, NY.
1993; and Ausubel et al., Eds., Current Protocols in Molecu

lar Biology, Chapter 2, Greene Publishing and Wiley-Inter
science, NY, 1995.

0096. As used herein, “stringent conditions' encompass
conditions under which hybridization will only occur if there
is less than 20% mismatch between the sequence of the
hybridization molecule and a homologous polynucleotide
within the target nucleic acid molecule. “Stringent condi
tions’ include further particular levels of stringency. Thus, as
used herein, "moderate stringency' conditions are those
under which molecules with more than 20% sequence mis
match will not hybridize; conditions of “high stringency” are
those under which sequences with more than 10% mismatch
will not hybridize; and conditions of “very high stringency’
are those under which sequences with more than 5% mis
match will not hybridize.
0097. The following are representative, non-limiting
hybridization conditions.
0098 High Stringency condition (detects polynucleotides
that share at least 90% sequence identity): Hybridization in
5xSSC buffer at 65° C. for 16 hours; wash twice in 2XSSC

buffer at room temperature for 15 minutes each; and wash
twice in 0.5xSSC buffer at 65° C. for 20 minutes each.

79%; 80%; about 81%; about 82%; about 83%; about 84%:
about 85%; about 86%; about 87%; about 88%; about 89%;
about 90%; about 91%; about 92%; about 93%; about 94%
about 95%; about 96%; about 97%; about 98%; about 98.5%:

about 99%; about 99.5%; and about 100%. The property of
Substantial homology is closely related to specific hybridiza
tion. For example, a nucleic acid molecule is specifically
hybridizable when there is a sufficient degree of complemen
tarity to avoid non-specific binding of the nucleic acid to
non-target polynucleotides under conditions where specific
binding is desired, for example, under Stringent hybridization
conditions.

0102. As used herein, the term “ortholog” refers to a gene
in two or more species that has evolved from a common
ancestral nucleic acid, and may retain the same function in the
two or more species.
(0103 As used herein, two nucleic acid molecules are said
to exhibit “complete complementarity” when every nucle
otide of a polynucleotide read in the 5' to 3’ direction is
complementary to every nucleotide of the other polynucle
otide when read in the 3' to 5' direction. A polynucleotide that
is complementary to a reference polynucleotide will exhibit a
sequence identical to the reverse complement of the reference
polynucleotide. These terms and descriptions are well defined
in the art and are easily understood by those of ordinary skill
in the art.

0104 Operably linked: A first polynucleotide is operably
linked with a second polynucleotide when the first polynucle
otide is in a functional relationship with the second poly
nucleotide. When recombinantly produced, operably linked
polynucleotides are generally contiguous, and, where neces
sary to join two protein-coding regions, in the same reading
frame (e.g., in a translationally fused ORF). However, nucleic
acids need not be contiguous to be operably linked.
0105. The term, “operably linked,” when used in reference
to a regulatory genetic element and a coding polynucleotide,
means that the regulatory element affects the expression of
the linked coding polynucleotide. “Regulatory elements.” or
“control elements.” refer to polynucleotides that influence the
timing and level/amount of transcription, RNA processing or
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stability, or translation of the associated coding polynucle
otide. Regulatory elements may include promoters; transla
tion leaders; introns; enhancers; stem-loop structures; repres
Sor binding polynucleotides; polynucleotides with a
termination sequence; polynucleotides with a polyadenyla
tion recognition sequence; etc. Particular regulatory elements
may be located upstream and/or downstream of a coding
polynucleotide operably linked thereto. Also, particular regu
latory elements operably linked to a coding polynucleotide
may be located on the associated complementary strand of a
double-stranded nucleic acid molecule.

0106 Promoter: As used herein, the term “promoter'
refers to a region of DNA that may be upstream from the start
of transcription, and that may be involved in recognition and
binding of RNA polymerase and other proteins to initiate
transcription. A promoter may be operably linked to a coding
polynucleotide for expression in a cell, or a promoter may be
operably linked to a polynucleotide encoding a signal peptide
which may be operably linked to a coding polynucleotide for
expression in a cell. A "plant promoter” may be a promoter
capable of initiating transcription in plant cells. Examples of
promoters under developmental control include promoters
that preferentially initiate transcription in certain tissues,
Such as leaves, roots, seeds, fibers, xylem vessels, tracheids,
or sclerenchyma. Such promoters are referred to as “tissue
preferred. Promoters which initiate transcription only in cer
tain tissues are referred to as “tissue-specific''. A "cell type
specific' promoter primarily drives expression in certain cell
types in one or more organs, for example, vascular cells in
roots or leaves. An “inducible' promoter may be a promoter
which may be under environmental control. Examples of
environmental conditions that may initiate transcription by
inducible promoters include anaerobic conditions and the
presence of light. Tissue-specific, tissue-preferred, cell type
specific, and inducible promoters constitute the class of “non
constitutive' promoters. A “constitutive' promoter is a pro
moter which may be active under most environmental condi
tions or in most tissue or cell types.
0107 Any inducible promoter can be used in some
embodiments of the invention. See Ward et al. (1993) Plant
Mol. Biol. 22:361-366. With an inducible promoter, the rate
of transcription increases in response to an inducing agent.
Exemplary inducible promoters include, but are not limited
to: Promoters from the ACEI system that respond to copper;
In2 gene from maize that responds to benzenesulfonamide
herbicide safeners; Tet repressor from Tn 10; and the induc
ible promoter from a steroid hormone gene, the transcrip
tional activity of which may be induced by a glucocorticos
teroid hormone (Schena et al. (1991) Proc. Natl. Acad. Sci.
USA 88:0421).
0108 Exemplary constitutive promoters include, but are
not limited to: Promoters from plant viruses, such as the 35S
promoter from Cauliflower Mosaic Virus (CaMV); promoters
from rice actin genes: ubiquitin promoters; pl.MU; MAS:
maize H3 histone promoter; and the ALS promoter, Xbal/
Ncol fragment 5' to the Brassica napus ALS3 structural gene
(or a polynucleotide similar to said Xbal/Ncol fragment) (In
ternational PCT Publication No. WO96/30530).
0109 Additionally, any tissue-specific or tissue-preferred
promoter may be utilized in some embodiments of the inven
tion. Plants transformed with a nucleic acid molecule com

prising a coding polynucleotide operably linked to a tissue
specific promoter may produce the product of the coding
polynucleotide exclusively, or preferentially, in a specific
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tissue. Exemplary tissue-specific or tissue-preferred promot
ers include, but are not limited to: A seed-preferred promoter,
Such as that from the phaseolin gene; a leaf-specific and
light-induced promoter Such as that from cab or rubisco; an
anther-specific promoter such as that from LAT52; a pollen
specific promoter Such as that from Zm13; and a microspore
preferred promoter Such as that from apg.
0110 Soybean plant: As used herein, the term “soybean
plant” refers to a plant of the species Glycine sp.: for example,
G. max.

0111

Transformation: As used herein, the term “transfor

mation' or “transduction” refers to the transfer of one or more

nucleic acid molecule(s) into a cell. A cell is “transformed by
a nucleic acid molecule transduced into the cell when the

nucleic acid molecule becomes stably replicated by the cell,
either by incorporation of the nucleic acid molecule into the
cellular genome, or by episomal replication. As used herein,
the term “transformation' encompasses all techniques by
which a nucleic acid molecule can be introduced into Such a

cell. Examples include, but are not limited to: transfection
with viral vectors; transformation with plasmid vectors; elec
troporation (Fromm et al. (1986) Nature 319:791-3); lipofec
tion (Feigner et al. (1987) Proc. Natl. Acad. Sci. USA
84:7413-7); microinjection (Mueller et al. (1978) Cell
15:579-85); Agrobacterium-mediated transfer (Fraley et al.
(1983) Proc. Natl. Acad. Sci. USA 80:4803-7); direct DNA
uptake; and microprojectile bombardment (Klein et al.
(1987) Nature 327:70).
0112 Transgene: An exogenous nucleic acid. In some
examples, a transgene may be a DNA that encodes one or both
strand(s) of an RNA capable of forming a dsRNA molecule
that comprises a polynucleotide that is complementary to a
nucleic acid molecule found in a hemipteran pest. In further
examples, a transgene may be an antisense polynucleotide,
wherein expression of the antisense polynucleotide inhibits
expression of a target nucleic acid, thereby producing a paren
tal RNAi phenotype. In still further examples, a transgene
may be a gene (e.g., a herbicide-tolerance gene, a gene encod
ing an industrially orpharmaceutically useful compound, or a
gene encoding a desirable agricultural trait). In these and
other examples, a transgene may contain regulatory elements
operably linked to a coding polynucleotide of the transgene
(e.g., a promoter).
0113 Vector: A nucleic acid molecule as introduced into a
cell, for example, to produce a transformed cell. A vector may
include genetic elements that permit it to replicate in the host
cell. Such as an origin of replication. Examples of vectors
include, but are not limited to: a plasmid, cosmid; bacterioph
age; or virus that carries exogenous DNA into a cell. A vector
may also include one or more genes, including ones that
produce antisense molecules, and/or selectable marker genes
and other genetic elements known in the art. A vector may
transduce, transform, or infect a cell, thereby causing the cell
to express the nucleic acid molecules and/or proteins encoded
by the vector. A vector optionally includes materials to aid in
achieving entry of the nucleic acid molecule into the cell (e.g.,
a liposome, protein coating, etc.).
0114 Yield: A stabilized yield of about 100% or greater
relative to the yield of check varieties in the same growing
location growing at the same time and under the same condi
tions. In particular embodiments, “improved yield' or
“improving yield’ means a cultivar having a stabilized yield
of 105% or greater relative to the yield of check varieties in
the same growing location containing significant densities of
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the hemipteran pests that are injurious to that crop growing at
the same time and under the same conditions, which are

targeted by the compositions and methods herein.
0115 Unless specifically indicated or implied, the terms
“a,” “an and “the signify "at least one as used herein.
0116. Unless otherwise specifically explained, all techni
cal and Scientific terms used herein have the same meaning as
commonly understood by those of ordinary skill in the art to
which this disclosure belongs. Definitions of common terms
in molecular biology can be found in, for example, Lewin's
Genes X. Jones & Bartlett Publishers, 2009 (ISBN 10
0763766321); Krebs et al. (eds.), The Encyclopedia of
Molecular Biology, Blackwell Science Ltd., 1994 (ISBN
0-632-02182-9); and Meyers R. A. (ed.), Molecular Biology
and Biotechnology: A Comprehensive Desk Reference, VCH
Publishers, Inc., 1995 (ISBN 1-56081-569-8). All percent
ages are by weight and all solvent mixture proportions are by
Volume unless otherwise noted. All temperatures are in
degrees Celsius.
IV. Nucleic Acid Molecules Comprising a
Hemipteran Pest Polynucleotide
0117. A. Overview
0118. Described herein are nucleic acid molecules useful
for the control of hemipteran pests. Described nucleic acid
molecules include target polynucleotides (e.g., native genes,
and non-coding polynucleotides), dsRNAs, siRNAs, shR
NAs, hpRNAs, and miRNAs. For example, dsRNA, siRNA,
miRNA, shRNA, and/or hpRNA molecules are described in
Some embodiments that may be specifically complementary
to all or part of one or more native nucleic acids in a hemi
pteran pest. In these and further embodiments, the native
nucleic acid(s) may be one or more target gene(s), the product
of which may be, for example and without limitation:
involved in a reproductive process or involved in nymph
development. Nucleic acid molecules described herein, when
introduced into a cell (e.g., through parental transmission)
comprising at least one native nucleic acid(s) to which the
nucleic acid molecules are specifically complementary, may
initiate RNAi in the cell, and consequently reduce or elimi
nate expression of the native nucleic acid(s). In some
examples, reduction or elimination of the expression of a
target gene by a nucleic acid molecule specifically comple
mentary thereto may result in reduction or cessation of repro
duction in the hemipteran pest, and/or growth, development,
and/or feeding in progeny of the pest. These methods may
significantly reduce the size of a Subsequent pest generation
in an infestation, for example, without directly resulting in
mortality in the pest(s) that contact the iRNA molecule.
0119. In some embodiments, at least one target gene in a
hemipteran pest may be selected, wherein the target gene
comprises a hunchback polynucleotide. In particular
examples, a target gene in a hemipteran pest is selected,
wherein the target gene comprises a polynucleotide selected
from among either of SEQID NOS:1 and 2.
0120 In other embodiments, a target gene may be a
nucleic acid molecule comprising a polynucleotide that can
be reverse translated in silico to a polypeptide comprising a
contiguous amino acid sequence that is at least about 85%
identical (e.g., at least 84%, 85%, about 90%, about 95%,
about 96%, about 97%, about 98%, about 99%, about 100%,

or 100% identical) to the amino acid sequence of a protein
product of a hunchback polynucleotide (i.e., a HUNCH
BACK polypeptide, for example, SEQ ID NO:3). A target
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gene may be any nucleic acid in a hemipteran pest, the post
transcriptional inhibition of which has a deleterious effect on
the capacity of the pest to produce viable offspring, for
example, to provide a protective benefit against the pest to a
plant. In particular examples, a target gene is a nucleic acid
molecule comprising a polynucleotide that can be reverse
translated in silico to a polypeptide comprising a contiguous
amino acid sequence that is at least about 85% identical,
about 90% identical, about 95% identical, about 96% identi
cal, about 97% identical, about 98% identical, about 99%
identical, about 100% identical, or 100% identical to the

amino acid sequence that is the in silico translation product of
SEQID NO:1.
0121 Provided in some embodiments are DNAs, the
expression of which results in an RNA molecule comprising
a polynucleotide that is specifically complementary to all or
part of a native RNA molecule that is encoded by a coding
polynucleotide in a hemipteran pest. In some embodiments,
after ingestion of the expressed RNA molecule by a hemi
pteran pest, down-regulation of the coding polynucleotide in
cells of the pest, or in cells of progeny of the pest, may be
obtained. In particular embodiments, down-regulation of the
coding polynucleotide in cells of the hemipteran pest may
result in reduction or cessation of reproduction and/or prolif
eration in the pest, and/or growth, development, and/or feed
ing in progeny of the pest.
I0122. In some embodiments, target polynucleotides
include transcribed non-coding RNAs, such as 5'UTRs:
3'UTRs; spliced leaders; introns; outrons (e.g., 5'UTR RNA
Subsequently modified in trans splicing); donatrons (e.g.,
non-coding RNA required to provide donor sequences for
trans splicing); and other non-coding transcribed RNA of
target hemipteran pest genes. Such polynucleotides may be
derived from both mono-cistronic and poly-cistronic genes.
Thus, also described herein in connection with some embodi

ments are iRNA molecules (e.g., dsRNAs, siRNAs, miRNAs,
shRNAs, and hpRNAs) that comprise at least one polynucle
otide that is specifically complementary to all or part of a
target nucleic acid in a hemipteran pest. In some embodi
ments an iRNA molecule may comprise polynucleotide(s)
that are complementary to all or part of a plurality of target
nucleic acids; for example, 2, 3, 4, 5, 6, 7, 8, 9, 10, or more
target nucleic acids. In particular embodiments, an iRNA
molecule may be produced in vitro, or in vivo by a geneti
cally-modified organism, Such as a plant or bacterium. Also
disclosed are cDNAs that may be used for the production of
dsRNA molecules, siRNA molecules, miRNA molecules,

shRNA molecules, and/or hpRNA molecules that are specifi
cally complementary to all or part of a target nucleic acid in a
hemipteran pest. Further described are recombinant DNA
constructs for use in achieving stable transformation of par
ticular host targets. Transformed host targets may express
effective levels of dsRNA, siRNA, miRNA, shRNA, and/or

hpRNA molecules from the recombinant DNA constructs.
Therefore, also described is a plant transformation vector
comprising at least one polynucleotide operably linked to a
heterologous promoter functional in a plant cell, wherein
expression of the polynucleotide(s) results in an RNA mol
ecule comprising a string of contiguous nucleobases that is
specifically complementary to all or part of a target nucleic
acid in a hemipteran pest.
I0123. In particular embodiments, nucleic acid molecules
useful for the control of hemipteran pests may include: all or
part of a native nucleic acid isolated from Euschistus com
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prising a hunchback polynucleotide (e.g., SEQID NO:1 or
SEQID NO:2); DNAs that when expressed result in an RNA
molecule comprising a polynucleotide that is specifically
complementary to all or part of a native RNA molecule that is
encoded by hunchback: iRNA molecules (e.g., dsRNAs, siR
NAS, miRNAs, shRNAs, and hpRNAs) that comprise at least
one polynucleotide that is specifically complementary to all
or part of an RNA molecule encoded by hunchback; cDNAs
that may be used for the production of dsRNA molecules,
siRNA molecules, miRNA molecules, shRNA molecules,

and/or hpRNA molecules that are specifically complemen
tary to all or part of an RNA molecule encoded by hunchback;
and recombinant DNA constructs for use in achieving stable
transformation of particular host targets, wherein a trans
formed host target comprises one or more of the foregoing
nucleic acid molecules.

0.124 B. Nucleic Acid Molecules
0.125. The present invention provides, inter alia, iRNA
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) mol
ecules that inhibit target gene expression in a cell, tissue, or
organ of a hemipteran pest; and DNA molecules capable of
being expressed as an iRNA molecule in a cell or microor
ganism to inhibit target gene expression in a cell, tissue, or
organ of a hemipteran pest.
0126 Some embodiments of the invention provide an iso
lated nucleic acid molecule comprising at least one (e.g., one,
two, three, or more) polynucleotide(s) selected from the
group consisting of: SEQID NO:1; the complement of SEQ
ID NO:1; a fragment of at least 15 contiguous nucleotides
(e.g., at least 19 contiguous nucleotides) of SEQ ID NO:1
(e.g., SEQID NO:2); the complement of a fragment of at least
15 contiguous nucleotides of SEQID NO:1; a native coding
polynucleotide of a hemipteran organism (e.g., BSB) com
prising SEQ ID NO:1; the complement of a native coding
polynucleotide of a hemipteran organism comprising SEQID
NO:1; a fragment of at least 15 contiguous nucleotides of a
native coding polynucleotide of a hemipteran organism com
prising SEQID NO:1; and the complement of a fragment of
at least 15 contiguous nucleotides of a native coding poly
nucleotide of a hemipteran organism comprising SEQ ID
NO:1. In particular embodiments, contact with or uptake by a
hemipteran pest of the isolated polynucleotide inhibits the
growth, development, reproduction and/or feeding of the
pest.

0127. In some embodiments, an isolated nucleic acid mol
ecule of the invention may comprise at least one (e.g., one,
two, three, or more) polynucleotide(s) selected from the
group consisting of: SEQID NO:12; the complement of SEQ
ID NO:12; SEQ ID NO:13; the complement of SEQ ID
NO:13; a fragment of at least 15 contiguous nucleotides of
SEQ ID NO:12 or SEQ ID NO:13; the complement of a
fragment of at least 15 contiguous nucleotides of SEQ ID
NO:12 or SEQ ID NO:13; a native polyribonucleotide tran
scribed in a hemipteran organism from a gene comprising
SEQ ID NO:1; the complement of a native polyribonucle
otide transcribed in a hemipteran organism from a gene com
prising SEQID NO:1; a fragment of at least 15 contiguous
nucleotides of a native polyribonucleotide transcribed in a
hemipteran organism from a gene comprising SEQID NO:1;
and the complement of a fragment of at least 15 contiguous
nucleotides of a native polyribonucleotide transcribed in a
hemipteran organism from a gene comprising SEQID NO:1.
In particular embodiments, contact with or uptake by a hemi
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pteran pest of the isolated polynucleotide inhibits the growth,
development, reproduction and/or feeding of the pest.
0128. In certain embodiments, a nucleic acid molecule of
the invention may comprise at least one (e.g., one, two, three,
or more) DNA(s) capable of being expressed as an iRNA
molecule in a cell or microorganism to inhibit target gene
expression in a cell, tissue, or organ of a hemipteran pest.
Such DNA(s) may be operably linked to a promoter that
functions in a cell comprising the DNA molecule to initiate or
enhance the transcription of the encoded RNA capable of
forming a dsRNA molecule(s). In one embodiment, the at
least one (e.g., one, two, three, or more) DNA(s) may be
derived from the polynucleotide of SEQ ID NO:1. Deriva
tives of SEQID NO:1 include fragments of SEQID NO:1. In
Some embodiments, such a fragment may comprise, for
example, at least about 15 contiguous nucleotides of SEQID
NO:1 or a complement thereof. Thus, such a fragment may
comprise, for example, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24,
25, 26, 27, 28, 29, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120,

130, 140, 150, 160, 170, 180, 190, 200 or more contiguous
nucleotides of SEQ ID NO:1, or a complement thereof. In
Some examples, such a fragment may comprise, for example,
at least 19 contiguous nucleotides (e.g., 19, 20, 21, 22, 23, 24.
25, 26, 27, 28, 29, or 30 contiguous nucleotides) of SEQID
NO:1, or a complement thereof
I0129. Some embodiments comprise introducing partially
or fully-stabilized dsRNA molecules into a hemipteran pest to
inhibit expression of a target gene in a cell, tissue, or organ of
the hemipteran pest. When expressed as an iRNA molecule
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) and
taken up by a hemipteran pest, polynucleotides comprising
one or more fragments of SEQIDNO:1 and/or SEQIDNO:2,
and the complements thereof, may cause one or more of
death, developmental arrest, growth inhibition, change in sex
ratio, reduction in brood size, cessation of infection, and/or

cessation of feeding by a hemipteran pest. In particular
examples, polynucleotides comprising one or more frag
ments (e.g., polynucleotides including about 15 to about 300
nucleotides) of SEQID NO:1 and/or SEQID NO:2, and the
complements thereof cause a reduction in the capacity of an
existing generation of the pest to produce a Subsequent gen
eration of the pest.
0.130. In particular embodiments, dsRNA molecules pro
vided by the invention comprise polynucleotides comple
mentary to a transcript from a target gene comprising SEQID
NO:1 and/or SEQID NO:2, and/or polynucleotides comple
mentary to a fragment of SEQID NO:1 and/or SEQID NO:2,
the inhibition of which target gene inahemipteran pest results
in the reduction or removal of a polypeptide or polynucleotide
agent that is essential for the pests or the pest’s progeny's
growth, development, or other biological function. A selected
polynucleotide may exhibit from about 80% to about 100%
sequence identity to of SEQID NO:1 and/or SEQID NO:2, a
contiguous fragment of SEQID NO:1 and/or SEQID NO:2,
or the complement of either of the foregoing. For example, a
selected polynucleotide may exhibit 79%; 80%; about 81%;
about 82%; about 83%; about 84%; about 85%; about 86%:
about 87%; about 88%; about 89%; about 90%; about 91%:
about 92%; about 93%; about 94% about 95%; about 96%:
about 97%; about 98%; about 98.5%; about 99%; about

99.5%; or about 100% sequence identity to of SEQID NO:1
and/or SEQID NO:2, a contiguous fragment of SEQID NO:1
and/or SEQ ID NO:2, or the complement of either of the
foregoing.
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0131. In some embodiments, a DNA molecule capable of
being expressed as an iRNA molecule in a cell or microor
ganism to inhibit target gene expression may comprise a
single polynucleotide that is specifically complementary to
all or part of a native polynucleotide found in one or more
target hemipteran pest species, or the DNA molecule can be
constructed as a chimera from a plurality of such specifically
complementary polynucleotides.
0.132. In other embodiments, a nucleic acid molecule may
comprise a first and a second polynucleotide separated by a
“linker. A linker may be a region comprising any sequence of
nucleotides that facilitates secondary structure formation
between the first and second polynucleotides, where this is
desired. In one embodiment, the linker is part of a sense or
antisense coding polynucleotide for mRNA. The linker may
alternatively comprise any combination of nucleotides or
homologues thereof that are capable of being linked
covalently to a nucleic acid molecule. In some examples, the
linker may comprise an intron (e.g., as ST-LS1 intron).
0.133 For example, in some embodiments, the DNA mol
ecule may comprise a polynucleotide coding for one or more

RNase III enzymes from heterologous nucleic acid molecules
may efficiently mediate the down-regulation of target genes
in hemipteran pests.
0.135. In some embodiments, a nucleic acid molecule of
the invention may include at least one non-naturally occur
ring polynucleotide that can be transcribed into a single
stranded RNA molecule capable of forming a dsRNA mol
ecule in vivo through intermolecular hybridization. Such
dsRNAs typically self-assemble, and can be provided in the
nutrition Source of a hemipteran pest to achieve the post
transcriptional inhibition of a target gene. In these and further
embodiments, a nucleic acid molecule of the invention may
comprise two different non-naturally occurring polynucle
otides, each of which is specifically complementary to a
different target gene in a hemipteran pest. When such a
nucleic acid molecule is provided as a dsRNA molecule to a
hemipteran pest, the dsRNA molecule inhibits the expression
of at least two different target genes in the pest.
(0.136 C. Obtaining Nucleic Acid Molecules
0.137. A variety of polynucleotides in hemipteran pests
may be used as targets for the design of nucleic acid mol

different RNA molecules, wherein each of the different RNA

encoding iRNAs. Selection of native polynucleotides is not,
however, a straight-forward process. Only a small number of
native polynucleotides in the hemipteran pest will be effective
targets. For example, it cannot be predicted with certainty
whether a particular native polynucleotide can be effectively
down-regulated by nucleic acid molecules of the invention, or
whether down-regulation of a particular native polynucle
otide will have a detrimental effect on the growth, viability,
proliferation, and/or reproduction of the hemipteran pest. The
vast majority of native hemipteran pest polynucleotides, such

molecules comprises a first polynucleotide and a second
polynucleotide, wherein the first and second polynucleotides
are complementary to each other. The first and second poly
nucleotides may be connected within an RNA molecule by a
spacer. The spacer may constitute part of the first polynucle
otide or the second polynucleotide. Expression of an RNA
molecule comprising the first and second nucleotide poly
nucleotides may lead to the formation of a dsRNA molecule
of the present invention, by specific intramolecular base
pairing of the first and second nucleotide polynucleotides.
The first polynucleotide or the second polynucleotide may be
Substantially identical to a polynucleotide native to a hemi
pteran pest (e.g., a target gene, or transcribed non-coding
polynucleotide), a derivative thereof, or a complementary
polynucleotide thereto.
0134 dsRNA nucleic acid molecules comprise double
Strands of polymerized ribonucleotides, and may include
modifications to either the phosphate-Sugar backbone or the
nucleoside. Modifications in RNA structure may be tailored
to allow specific inhibition. In one embodiment, dsRNA mol
ecules may be modified through a ubiquitous enzymatic pro
cess so that siRNA molecules may be generated. This enzy
matic process may utilize an RNase III enzyme, such as
DICER in eukaryotes, either in vitro or in vivo. See Elbashir
etal. (2001) Nature 411:494-8; and Hamilton and Baulcombe
(1999) Science 286(5441):950-2. DICER or functionally
equivalent RNase III enzymes cleave larger dsRNA strands
and/or hpRNA molecules into Smaller oligonucleotides (e.g.,
siRNAs), each of which is about 19-25 nucleotides in length.
The siRNA molecules produced by these enzymes have 2 to
3 nucleotide 3' overhangs, and 5' phosphate and 3' hydroxyl
termini. The siRNA molecules generated by RNase III
enzymes are unwound and separated into single-stranded
RNA in the cell. The siRNA molecules then specifically
hybridize with RNAs transcribed from a target gene, and both
RNA molecules are subsequently degraded by an inherent
cellular RNA-degrading mechanism. This process may result
in the effective degradation or removal of the RNA encoded
by the target gene in the target organism. The outcome is the
post-transcriptional silencing of the targeted gene. In some
embodiments, siRNA molecules produced by endogenous

ecules of the invention, such as iRNAs and DNA molecules

as ESTs isolated therefrom do not have a detrimental effection

the growth, viability, proliferation, and/or reproduction of the
pest. Neither is it predictable which of the native polynucle
otides that may have a detrimental effect on a hemipteran pest
are able to be used in recombinant techniques for expressing
nucleic acid molecules complementary to Such native poly
nucleotides in a host plant and providing the detrimental
effect on the pest upon feeding without causing harm to the
host plant.
0.138. In particular embodiments, nucleic acid molecules
of the invention (e.g., dsRNA molecules to be provided in the
host plant of a hemipteran pest) are selected to target cloNAS
that encode proteins or parts of proteins essential for hemi
pteran pest reproduction and/or development, such as
polypeptides involved in metabolic or catabolic biochemical
pathways, cell division, reproduction, energy metabolism,
embryonic development, nymph development, transcrip
tional regulation, and the like. As described herein, contact of
compositions by a target organism containing one or more
dsRNAs (e.g., by injection or topical contact), at least one
segment of which is specifically complementary to at least a
substantially identical segment of RNA produced in the cells
of the target pest organism, can result in failure or reduction of
the capacity to mate, oviposit, or produce viable progeny. A
polynucleotide, either DNA or RNA, derived from a hemi
pteran pest can be used to construct plant cells resistant to
infestation by the pests. The host plant of the hemipteran pest
(e.g., Z. mays, G. max, and cotton), for example, can be
transformed to contain one or more of the polynucleotides
derived from the hemipteran pest as provided herein. The
polynucleotide transformed into the host may encode one or
more RNAs that form into a dsRNA structure in the cells or
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biological fluids within the transformed host, thus making the
dsRNA available if/when the pest forms a nutritional relation
ship with the transgenic host. This may result in the Suppres
sion of expression of one or more genes in the cells of the pest,
and ultimately inhibition of reproduction and/or develop
ment.

0.139. In some embodiments, a gene is targeted that is
essentially involved in the growth, development and repro
duction of a hemipteran pest. Other target genes for use in the
present invention may include, for example, those that play
important roles in hemipteran pest viability, movement,
migration, growth, development, infectivity, and establish
ment offeeding sites. A target gene may therefore be a house
keeping gene or a transcription factor. Additionally, a native
hemipteran pest polynucleotide for use in the present inven
tion may also be derived from a homolog (e.g., an ortholog),
of a plant, viral, bacterial or insect gene, the function of which
is known to those of skill in the art, and the polynucleotide of
which is specifically hybridizable with a target gene in the
genome of the target hemipteran pest. Methods of identifying
a homolog of a gene with a known nucleotide sequence by
hybridization are known to those of skill in the art.
0140. In other embodiments, the invention provides meth
ods for obtaining a nucleic acid molecule comprising a poly
nucleotide for producing an iRNA (e.g., dsRNA, siRNA,
miRNA, shRNA, and hpRNA) molecule. One such embodi
ment comprises: (a) analyzing one or more target gene(s) for
their expression, function, and phenotype upon dsRNA-me
diated gene Suppression in a hemipteran pest; (b) probing a
cDNA or gldNA library with a probe comprising all or a
portion of a polynucleotide or a homolog thereof from a
targeted hemipteran pest that displays an altered (e.g.,
reduced) reproduction or development phenotype in a
dsRNA-mediated Suppression analysis; (c) identifying a
DNA clone that specifically hybridizes with the probe; (d)
isolating the DNA clone identified in step (b); (e) sequencing
the cDNA or g|NA fragment that comprises the clone iso
lated in step (d), wherein the sequenced nucleic acid molecule
comprises all or a substantial portion of the RNA or a
homolog thereof, and (f) chemically synthesizing all or a
substantial portion of a gene, oran siRNA, miRNA, hpRNA,
mRNA, shRNA, or dsRNA.

0141. In further embodiments, a method for obtaining a
nucleic acid fragment comprising a polynucleotide for pro
ducing a substantial portion of an iRNA (e.g., dsRNA,
siRNA, miRNA, shRNA, and hpRNA) molecule includes: (a)
synthesizing first and second oligonucleotide primers specifi
cally complementary to a portion of a native polynucleotide
from a targeted hemipteran pest, and (b) amplifying a cDNA
org)NA insert present in a cloning vector using the first and
second oligonucleotide primers of step (a), wherein the
amplified nucleic acid molecule comprises a Substantial por
tion of a siRNA, miRNA, hpRNA, mRNA, shRNA, ordsERNA
molecule.

0142 Nucleic acids of the invention can be isolated,
amplified, or produced by a number of approaches. For
example, an iRNA (e.g., dsRNA, siRNA, miRNA, shRNA,
and hpRNA) molecule may be obtained by PCR amplification
of a target polynucleotide (e.g., a target gene or a target
transcribed non-coding polynucleotide) derived from a
gDNA or cDNA library, or portions thereof. DNA or RNA
may be extracted from a target organism, and nucleic acid
libraries may be prepared therefrom using methods known to
those ordinarily skilled in the art. gldNA or cDNA libraries
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generated from a target organism may be used for PCR ampli
fication and sequencing of target genes. A confirmed PCR
product may be used as a template for in vitro transcription to
generate sense and antisense RNA with minimal promoters.
Alternatively, nucleic acid molecules may be synthesized by
any of a number of techniques (See, e.g., Ozaki et al. (1992)
Nucleic Acids Research, 20: 5205-5214; and Agrawal et al.
(1990) Nucleic Acids Research, 18: 5419-5423), including
use of an automated DNA synthesizer (for example, a P.E.
Biosystems, Inc. (Foster City, Calif.) model 392 or 394 DNA/
RNA Synthesizer), using standard chemistries, such as phos
phoramidite chemistry. See, e.g., Beaucage et al. (1992) Tet
rahedron, 48: 2223-2311; U.S. Pat. Nos. 4,980,460, 4,725,
677, 4,415,732, 4,458,066, and 4,973,679. Alternative

chemistries resulting in non-natural backbone groups, such as
phosphorothioate, phosphoramidate, and the like, can also be
employed.
0.143 An RNA, dsRNA, siRNA, miRNA, shRNA, or
hpRNA molecule of the present invention may be produced
chemically or enzymatically by one skilled in the art through
manual or automated reactions, or in vivo in a cell comprising
a nucleic acid molecule comprising a polynucleotide encod
ing the RNA, dsRNA, siRNA, miRNA, shRNA, or hpRNA
molecule. RNA may also be produced by partial or total
organic synthesis—any modified ribonucleotide can be intro
duced by in vitro enzymatic or organic synthesis. An RNA
molecule may be synthesized by a cellular RNA polymerase
or a bacteriophage RNA polymerase (e.g., T3 RNA poly
merase, T7 RNA polymerase, and SP6 RNA polymerase).
Expression constructs useful for the cloning and expression
of polynucleotides are known in the art. See, e.g., Interna
tional PCT Publication No. WO97/32016; and U.S. Pat. Nos.
5,593,874, 5,698,425, 5,712,135, 5,789,214, and 5,804,693.

RNA molecules that are synthesized chemically or by in vitro
enzymatic synthesis may be purified prior to introduction into
a cell. For example, RNA molecules can be purified from a
mixture by extraction with a solvent or resin, precipitation,
electrophoresis, chromatography, or a combination thereof.
Alternatively, RNA molecules that are synthesized chemi
cally or by in vitro enzymatic synthesis may be used with no
or a minimum of purification, for example, to avoid losses due
to sample processing. The RNA molecules may be dried for
storage or dissolved in an aqueous solution. The Solution may
contain buffers or salts to promote annealing, and/or stabili
zation of dsRNA molecule duplex strands.
0144. In embodiments, a dsRNA molecule may beformed
by a single self-complementary RNA strand or from two
complementary RNA strands. dsRNA molecules may be syn
thesized either in vivo or in vitro. An endogenous RNA poly
merase of the cell may mediate transcription of the one or two
RNA strands in vivo, or cloned RNA polymerase may be used
to mediate transcription in vivo or in vitro. Post-transcrip
tional inhibition of a target gene in a hemipteran pest may be
host-targeted by specific transcription in an organ, tissue, or
cell type of the host (e.g., by using a tissue-specific promoter);
stimulation of an environmental condition in the host (e.g., by
using an inducible promoter that is responsive to infection,
stress, temperature, and/or chemical inducers); and/or engi
neering transcription at a developmental stage or age of the
host (e.g., by using a developmental stage-specific promoter).
RNA strands that form a dsRNA molecule, whether tran

scribed in vitro or in Vivo, may or may not be polyadenylated,
and may or may not be capable of being translated into a
polypeptide by a cells translational apparatus.
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0145

D. Recombinant Vectors and Host Cell Transforma

tion

0146 In some embodiments, the invention also provides a
DNA molecule for introduction into a cell (e.g., a bacterial
cell, a yeast cell, or a plant cell), wherein the DNA molecule
comprises a polynucleotide that, upon expression to RNA and
ingestion by a hemipteran pest, achieves Suppression of a
target gene in a cell, tissue, or organ of the pest. Thus, some
embodiments provide a recombinant nucleic acid molecule
comprising a polynucleotide capable of being expressed as an
iRNA (e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA)
molecule in a plant cell to inhibit target gene expression in a
hemipteran pest. In order to initiate or enhance expression,
Such recombinant nucleic acid molecules may comprise one
or more regulatory elements, which regulatory elements may
be operably linked to the polynucleotide capable of being
expressed as an iRNA. Methods to express agene Suppression
molecule in plants are known, and may be used to express a
polynucleotide of the present invention. See, e.g., Interna
tional PCT Publication No. WO06/073727; and U.S. Patent

Publication No. 2006/0200878 A1)
0147 In specific embodiments, a recombinant DNA mol
ecule of the invention may comprise a polynucleotide encod
ing an RNA that may form a dsRNA molecule. Such recom
binant DNA molecules may encode RNAs that may form
dsRNA molecules capable of inhibiting the expression of
endogenous target gene(s) in a hemipteran pest cell upon
ingestion. In many embodiments, a transcribed RNA may
form a dsRNA molecule that may be provided in a stabilized
form; e.g., as a hairpin and stem and loop structure.
0148. In other embodiments, one strand of a dsRNA mol
ecule may be formed by transcription from a polynucleotide
that is Substantially homologous to a polynucleotide selected
from the group consisting of SEQID NO:1; of SEQID NO:2:
the complement of SEQID NO:1; the complement of SEQID
NO:2; a fragment of at least 15 contiguous nucleotides of
SEQID NO:1 and/or 2; the complement of a fragment of at
least 15 contiguous nucleotides of SEQID NO:1 and/or 2; a
native coding polynucleotide of a hemipteran organism (e.g.,
BSB) comprising SEQID NO:1 and/or 2; the complement of
a native coding polynucleotide of a hemipteran organism
comprising SEQID NO:1 and/or 2; a fragment of at least 15
contiguous nucleotides of a native coding polynucleotide of a
hemipteran organism comprising SEQID NO:1 and/or 2; and
the complement of a fragment of at least 15 contiguous nucle
otides of a native coding polynucleotide of a hemipteran
organism comprising SEQID NO:1 and/or 2.
0149. In particular embodiments, a recombinant DNA
molecule encoding an RNA that may form a dsRNA molecule
may comprise a coding region wherein at least two polynucle
otides are arranged Such that one polynucleotide is in a sense
orientation, and the other polynucleotide is in an antisense
orientation, relative to at least one promoter, wherein the
sense polynucleotide and the antisense polynucleotide are
linked or connected by a spacer of for example, from about
five (-5) to about one thousand (~1000) nucleotides. The
spacer may form a loop between the sense and antisense
polynucleotides. The sense polynucleotide or the antisense
polynucleotide may be substantially homologous to an RNA
encoded by a target gene (e.g., a hunchback gene comprising
SEQ ID NO: 1) or fragment thereof. In some embodiments,
however, a recombinant DNA molecule may encode an RNA
that may form a dsRNA molecule without a spacer. In
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embodiments, a sense coding polynucleotide and an anti
sense coding polynucleotide may be different lengths.
0150 Polynucleotides identified as having a deleterious
effect on hemipteran pests or a plant-protective effect with
regard to hemipteran pests may be readily incorporated into
expressed dsRNA molecules through the creation of appro
priate expression cassettes in a recombinant nucleic acid mol
ecule of the invention. For example, such polynucleotides
may be expressed as a hairpin with stem and loop structure by
taking a first segment corresponding to an RNA encoded by a
target gene polynucleotide (e.g., a hunchback gene compris
ing SEQID NO:1, and fragments of either of the foregoing);
linking this polynucleotide to a second segment spacer region
that is not homologous or complementary to the first segment;
and linking this to a third segment, wherein at least a portion
of the third segment is substantially complementary to the
first segment. Such a construct forms a stem and loop struc
ture by intramolecular base-pairing of the first segment with
the third segment, wherein the loop structure forms compris
ing the second segment. See, e.g., U.S. Patent Publication
Nos. 2002/0048814 and 2003/0018993; and International
PCT Publication NOS. WO94/O1550 and WO98/O5770. A

dsRNA molecule may be generated, for example, in the form
of a double-stranded structure Such as a stem-loop structure
(e.g., hairpin), whereby production of siRNA targeted for a
native hemipteran pest polynucleotide is enhanced by co
expression of a fragment of the targeted gene, for instance on
an additional plant expressible cassette, that leads to
enhanced siRNA production, or reduces methylation to pre
vent transcriptional gene silencing of the dsRNA hairpin pro
moter.

0151. Embodiments of the invention include introduction
of a recombinant nucleic acid molecule of the present inven
tion into a plant (i.e., transformation) to achieve hemipteran
pest-inhibitory levels of expression of one or more iRNA
molecules. A recombinant DNA molecule may, for example,
be a vector, Such as a linear or a closed circular plasmid. The
vector System may be a single vector or plasmid, or two or
more vectors or plasmids that together contain the total DNA
to be introduced into the genome of a host. In addition, a
vector may be an expression vector. Nucleic acids of the
invention can, for example, be suitably inserted into a vector
under the control of a suitable promoter that functions in one
or more hosts to drive expression of a linked coding poly
nucleotide or other DNA element. Many vectors are available
for this purpose, and selection of the appropriate vector will
depend mainly on the size of the nucleic acid to be inserted
into the vector and the particular host cell to be transformed
with the vector. Each vector contains various components
depending on its function (e.g., amplification of DNA or
expression of DNA) and the particular host cell with which it
is compatible.
0152 To impart protection from hemipteran pests to a
transgenic plant, a recombinant DNA may, for example, be
transcribed into an iRNA molecule (e.g., an RNA molecule
that forms a dsRNA molecule) within the tissues or fluids of
the recombinant plant. An iRNA molecule may comprise a
polynucleotide that is Substantially homologous and specifi
cally hybridizable to a corresponding transcribed polynucle
otide within a hemipteran pest that may cause damage to the
host plant species. The hemipteran pest may contact the iRNA
molecule that is transcribed in cells of the transgenic host
plant, for example, by ingesting cells or fluids of the trans
genic host plant that comprise the iRNA molecule. Thus,
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expression of a target gene is Suppressed by the iRNA mol
ecule within hemipteran pests that infest the transgenic host
plant. In some embodiments, Suppression of expression of the
target gene in the target hemipteran pest may result in the
plant being tolerant to attack by the pest.
0153. In order to enable delivery of iRNA molecules to a
hemipteran pest in a nutritional relationship with a plant cell
that has been transformed with a recombinant nucleic acid

molecule of the invention, expression (i.e., transcription) of
iRNA molecules in the plant cell is required. Thus, a recom
binant nucleic acid molecule may comprise a polynucleotide
of the invention operably linked to one or more regulatory
elements, such as a heterologous promoter element that func
tions in a host cell. Such as a bacterial cell wherein the nucleic

acid molecule is to be amplified, and a plant cell wherein the
nucleic acid molecule is to be expressed.
0154 Promoters suitable for use in nucleic acid molecules
of the invention include those that are inducible, viral, syn
thetic, or constitutive, all of which are well known in the art.

Non-limiting examples describing Such promoters include
U.S. Pat. No. 6,437.217 (maize RS81 promoter); U.S. Pat.
No. 5,641,876 (rice actin promoter); U.S. Pat. No. 6,426,446
(maize RS324 promoter); U.S. Pat. No. 6,429,362 (maize
PR-1 promoter); U.S. Pat. No. 6,232,526 (maize A3 pro
moter); U.S. Pat. No. 6,177,611 (constitutive maize promot
ers); U.S. Pat. Nos. 5,322.938, 5,352,605, 5,359,142, and
5,530,196 (CaMV 35S promoter); U.S. Pat. No. 6,433,252
(maize L3 oleosin promoter); U.S. Pat. No. 6,429.357 (rice
actin2 promoter, and rice actin2 intron); U.S. Pat. No. 6.294,
714 (light-inducible promoters); U.S. Pat. No. 6,140,078
(salt-inducible promoters); U.S. Pat. No. 6,252,138 (patho
gen-inducible promoters); U.S. Pat. No. 6,175,060 (phospho
rous deficiency-inducible promoters); U.S. Pat. No. 6,388,
170 (bidirectional promoters); U.S. Pat. No. 6,635,806
(gamma-coixin promoter); and U.S. Patent Publication No.
2009/757,089 (maize chloroplast aldolase promoter). Addi
tional promoters include the nopaline synthase (NOS) pro
moter (Ebert et al. (1987) Proc. Natl. Acad. Sci. USA 84(16):
5745-9) and the octopine synthase (OCS) promoters (which
are carried on tumor-inducing plasmids of Agrobacterium
tumefaciens); the caulimovirus promoters such as the cauli
flower mosaic virus (CaMV) 19S promoter (Lawton et al.
(1987) Plant Mol. Biol. 9:315-24); the CaMV 35S promoter
(Odell et al. (1985) Nature 313:810-2; the figwort mosaic
virus 35S-promoter (Walker et al. (1987) Proc. Natl. Acad.
Sci. USA 84(19):6624-8); the sucrose synthase promoter
(Yang and Russell (1990) Proc. Natl. Acad. Sci. USA
87:4144-8); the R gene complex promoter (Chandler et al.
(1989) Plant Cell 1:1175-83); the chlorophyll a?b binding
protein gene promoter: CaMV35S (U.S. Pat. Nos. 5,322,938,
5,352,605, 5,359,142, and 5,530,196); FMV 35S (U.S. Pat.
Nos. 6,051,753, and 5,378,619); a PC1SV promoter (U.S.
Pat. No. 5,850,019); the SCP1 promoter (U.S. Pat. No. 6,677,
503); and AGRtu.nos promoters (GenBankTM Accession No.
V00087: Depicker et al. (1982) J. Mol. Appl. Genet. 1:561
73; Bevanet al. (1983) Nature 304:184-7).
0155. In particular embodiments, nucleic acid molecules
of the invention comprise a tissue-specific promoter. Such as
a leaf-specific promoter or pollen-specific promoter. In some
embodiments, a polynucleotide or fragment for hemipteran
pest control according to the invention may be cloned
between two tissue-specific promoters oriented in opposite
transcriptional directions relative to the polynucleotide or
fragment, and which are operable in a transgenic plant cell
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and expressed thereinto produce RNA molecules in the trans
genic plant cell that Subsequently may form dsRNA mol
ecules, as described, supra. The iRNA molecules expressed in
plant tissues may be ingested by a hemipteran pest so that
Suppression of target gene expression is achieved.
0156 Additional regulatory elements that may optionally
be operably linked to a nucleic acid molecule of interest
include 5' UTRs located between a promoter element and a
coding polynucleotide that function as a translation leader
element. The translation leader element is present in the fully
processed mRNA, and it may affect processing of the primary
transcript, and/or RNA stability. Examples of translation
leader elements include maize and petunia heat shock protein
leaders (U.S. Pat. No. 5,362,865), plant virus coat protein
leaders, plant rubisco leaders, and others. See, e.g., Turner
and Foster (1995) Molecular Biotech.3(3):225-36. Non-lim
iting examples of 5' UTRs include GmHsp (U.S. Pat. No.
5,659,122); PhDnaK (U.S. Pat. No. 5,362,865); AtAntl:TEV
(Carrington and Freed (1990).J. Virol. 64:1590-7); and AGR
tunos (GenBankTM Accession No. V00087; and Bevan et al.
(1983) Nature 304:184-7).
0157 Additional regulatory elements that may optionally
be operably linked to a nucleic acid molecule of interest also
include 3' non-translated elements, 3' transcription termina
tion regions, or polyadenylation regions. These are genetic
elements located downstream of a polynucleotide, and
include polynucleotides that provide polyadenylation signal,
and/or other regulatory signals capable of affecting transcrip
tion or mRNA processing. The polyadenylation signal func
tions in plants to cause the addition of polyadenylate nucle
otides to the 3' end of the mRNA precursor. The
polyadenylation element can be derived from a variety of
plant genes, or from T-DNA genes. A non-limiting example
of a 3' transcription termination region is the nopaline Syn
thase 3' region (nos 3; Fraley et al. (1983) Proc. Natl. Acad.
Sci. USA 80:4803-7). An example of the use of different 3'
nontranslated regions is provided in Ingelbrecht et al., (1989)
Plant Cell 1:671-80. Non-limiting examples of polyadenyla
tion signals include one from a Pisum sativum RbcS2 gene
(Ps.RbcS2-E9; Coruzzi et al. (1984) EMBO.J. 3:1671-9) and
AGRtu.nos (GenBankTM Accession No. E01312).
0158. Some embodiments may include a plant transfor
mation vector that comprises an isolated and purified DNA
molecule comprising at least one of the above-described
regulatory elements operatively linked to one or more poly
nucleotides of the present invention. When expressed, the one
or more polynucleotides result in one or more RNA molecule
(s) comprising a polynucleotide that is specifically comple
mentary to all or part of a native RNA molecule in a hemi
pteran pest. Thus, the polynucleotide(s) may comprise a
segment encoding all or part of a polyribonucleotide present
within a targeted hemipteran pest RNA transcript, and may
comprise inverted repeats of all or a part of a targeted pest
transcript. A plant transformation vector may contain poly
nucleotides specifically complementary to more than one
target polynucleotide, thus allowing production of more than
one dsRNA for inhibiting expression of two or more genes in
cells of one or more populations or species of target hemi
pteran pests. Segments of polynucleotides specifically
complementary to polynucleotides present in different genes
can be combined into a single composite nucleic acid mol
ecule for expression in a transgenic plant. Such segments may
be contiguous or separated by a spacer.
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0159. In other embodiments, a plasmid of the present
invention already containing at least one polynucleotide(s) of
the invention can be modified by the sequential insertion of
additional polynucleotide(s) in the same plasmid, wherein the
additional polynucleotide(s) are operably linked to the same
regulatory elements as the original at least one polynucleotide
(s). In some embodiments, a nucleic acid molecule may be
designed for the inhibition of multiple target genes. In some
embodiments, the multiple genes to be inhibited can be
obtained from the same hemipteran pest species, which may
enhance the effectiveness of the nucleic acid molecule. In

other embodiments, the genes can be derived from different
hemipteran pests, which may broaden the range of pests
against which the agent(s) is/are effective. When multiple
genes are targeted for Suppression or a combination of expres
sion and Suppression, a polycistronic DNA element can be
engineered.
0160 A recombinant nucleic acid molecule or vector of
the present invention may comprise a selectable marker that
confers a selectable phenotype on a transformed cell. Such as
a plant cell. Selectable markers may also be used to select for
plants or plant cells that comprise a recombinant nucleic acid
molecule of the invention. The marker may encode biocide
resistance, antibiotic resistance (e.g., kanamycin, Geneticin
(G418), bleomycin, hygromycin, etc.), or herbicide tolerance
(e.g., glyphosate, etc.). Examples of selectable markers
include, but are not limited to: a neogene which codes for
kanamycin resistance and can be selected for using kanamy
cin, G418, etc.; a bar gene which codes for bialaphos resis
tance; a mutant EPSP synthase gene which encodes glypho
sate tolerance; a nitrilase gene which confers resistance to
bromoxynil; a mutant acetolactate synthase (ALS) gene
which confers imidazolinone or Sulfonylurea resistance; and
a methotrexate resistant DHFR gene. Multiple selectable
markers are available that confer resistance to ampicillin,
bleomycin, chloramphenicol, gentamycin, hygromycin,
kanamycin, lincomycin, methotrexate, phosphinothricin,
puromycin, spectinomycin, rifampicin, Streptomycin and tet
racycline, and the like. Examples of Such selectable markers
are illustrated in, e.g., U.S. Pat. Nos. 5,550,318; 5.633,435:
5,780,708 and 6,118,047.
0161. A recombinant nucleic acid molecule or vector of

the present invention may also include a screenable marker.
Screenable markers may be used to monitor expression.
Exemplary screenable markers include a B-glucuronidase or
uidA gene (GUS) which encodes an enzyme for which vari
ous chromogenic Substrates are known (Jefferson et al.
(1987) Plant Mol. Biol. Rep. 5:387-405); an R-locus gene,
which encodes a product that regulates the production of
anthocyanin pigments (red color) in plant tissues (Dellaporta
et al. (1988) “Molecular cloning of the maize R-njallele by

transposon tagging with Ac.” In 18' Stadler Genetics Sym

posium, P. Gustafson and R. Appels, eds. (New York: Ple
num), pp. 263-82); a B-lactamase gene (Sutcliffe et al. (1978)
Proc. Natl. Acad. Sci. USA 75:3737-41); a gene which
encodes an enzyme for which various chromogenic Sub
strates are known (e.g., PADAC, a chromogenic cepha
losporin); a luciferase gene (Ow et al. (1986) Science 234:
856-9); an Xy/E gene that encodes a catechol dioxygenase
that can convert chromogenic catechols (Zukowski et al.
(1983) Gene 46(2-3):247-55); an amylase gene (Ikatu et al.
(1990) Bio/Technol. 8:241-2); a tyrosinase gene which
encodes an enzyme capable of oxidizing tyrosine to DOPA
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and dopaquinone which in turn condenses to melanin (Katz, et
al. (1983) J. Gen. Microbiol. 129:2703-14); and an O-galac
tosidase.

(0162. In some embodiments, recombinant nucleic acid
molecules, as described, Supra, may be used in methods for
the creation of transgenic plants and expression of heterolo
gous nucleic acids in plants to prepare transgenic plants that
exhibit reduced susceptibility to hemipteran pests. Plant
transformation vectors can be prepared, for example, by
inserting nucleic acid molecules encoding iRNA molecules
into plant transformation vectors and introducing these into
plants.
(0163 Suitable methods for transformation of host cells
include any method by which DNA can be introduced into a
cell. Such as by transformation of protoplasts (See, e.g., U.S.
Pat. No. 5,508,184), by desiccation/inhibition-mediated
DNA uptake (See, e.g., Potrykus et al. (1985) Mol. Gen.
Genet. 199:183-8), by electroporation (See, e.g., U.S. Pat.
No. 5,384.253), by agitation with silicon carbide fibers (See,
e.g., U.S. Pat. Nos. 5,302,523 and 5,464,765), by Agrobacte
rium-mediated transformation (See, e.g., U.S. Pat. Nos.
5,563,055; 5,591,616; 5,693,512; 5,824,877; 5,981,840; and

6,384.301) and by acceleration of DNA-coated particles (See,
e.g., U.S. Pat. Nos. 5,015,580: 5,550,318; 5,538,880; 6,160,
208; 6.399,861; and 6,403,865), etc. Techniques that are par
ticularly useful for transforming corn are described, for
example, in U.S. Pat. Nos. 7,060,876 and 5,591,616; and
International PCT Publication WO95/06722. Through the

application of techniques such as these, the cells of virtually
any species may be stably transformed. In some embodi
ments, transforming DNA is integrated into the genome of the
host cell. In the case of multicellular species, transgenic cells
may be regenerated into a transgenic organism. Any of these
techniques may be used to produce a transgenic plant, for
example, comprising one or more nucleic acids encoding one
or more iRNA molecules in the genome of the transgenic
plant.
0164. The most widely utilized method for introducing an
expression vector into plants is based on the natural transfor
mation system of Agrobacterium. A. tumefaciens and A.
rhizogenes are plant pathogenic soil bacteria which geneti
cally transform plant cells. The Ti and Ri plasmids of A.
tumefaciens and A. rhizogenes, respectively, carry genes
responsible for genetic transformation of the plant. The Ti
(tumor-inducing)-plasmids contain a large segment, known
as T-DNA, which is transferred to transformed plants.
Another segment of the Tiplasmid, the Vir region, is respon
sible for T-DNA transfer. The T-DNA region is bordered by
terminal repeats. In modified binary vectors, the tumor-in
ducing genes have been deleted, and the functions of the Vir
region are utilized to transfer foreign DNA bordered by the
T-DNA border elements. The T-region may also contain a
selectable marker for efficient recovery of transgenic cells
and plants, and a multiple cloning site for inserting polynucle
otides for transfer Such as a dsRNA encoding nucleic acid.
0.165. In some embodiments, a plant transformation vector
is derived from a Tiplasmid of A. tumefaciens (See, e.g., U.S.
Pat. Nos. 4,536,475, 4,693,977, 4,886,937, and 5,501,967:

and European Patent No. EP 0122791) or a Riplasmid of A.
rhizogenes. Additional plant transformation vectors include,
for example and without limitation, those described by Her
rera-Estrella et al. (1983) Nature 303:209-13: Bevan et al.
(1983) Nature 304:184-7; Klee et al. (1985) Bio/Technol.
3:637-42; and in European Patent No. EP 0120516, and
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those derived from any of the foregoing. Other bacteria such
as Sinorhizobium, Rhizobium, and Mesorhizobium that inter

act with plants naturally can be modified to mediate gene
transfer to a number of diverse plants. These plant-associated
symbiotic bacteria can be made competent for gene transfer
by acquisition of both a disarmed Tiplasmid and a Suitable
binary vector.
0166. After providing exogenous DNA to recipient cells,
transformed cells are generally identified for further culturing
and plant regeneration. In order to improve the ability to
identify transformed cells, one may desire to employ a select
able or screenable marker gene, as previously set forth, with
the transformation vector used to generate the transformant.
In the case where a selectable marker is used, transformed

cells are identified within the potentially transformed cell
population by exposing the cells to a selective agentoragents.
In the case where a screenable marker is used, cells may be
screened for the desired marker gene trait.
0167 Cells that survive the exposure to the selective
agent, or cells that have been scored positive in a screening
assay, may be cultured in media that Supports regeneration of
plants. In some embodiments, any Suitable plant tissue cul
ture media (e.g., MS and N6 media) may be modified by
including further Substances, such as growth regulators. Tis
Sue may be maintained on a basic medium with growth regu
lators until Sufficient tissue is available to begin plant regen
eration efforts, or following repeated rounds of manual
selection, until the morphology of the tissue is suitable for
regeneration (e.g., at least 2 weeks), then transferred to media
conducive to shoot formation. Cultures are transferred peri
odically until sufficient shoot formation has occurred. Once
shoots are formed, they are transferred to media conducive to
root formation. Once Sufficient roots are formed, plants can
be transferred to soil for further growth and maturation.
0168 To confirm the presence of a nucleic acid molecule
of interest (for example, a DNA encoding one or more iRNA
molecules that inhibit target gene expression in a hemipteran
pest) in the regenerating plants, a variety of assays may be
performed. Such assays include, for example: molecular bio
logical assays, such as Southern and northern blotting, PCR,
and nucleic acid sequencing; biochemical assays, such as
detecting the presence of a protein product, e.g., by immuno
logical means (ELISA and/or western blots) or by enzymatic
function; plant part assays, such as leaf or root assays; and
analysis of the phenotype of the whole regenerated plant.
0169 Integration events may be analyzed, for example, by
PCR amplification using, e.g., oligonucleotide primers spe
cific for a nucleic acid molecule of interest. PCR genotyping
is understood to include, but not be limited to, polymerase
chain reaction (PCR) amplification of gldNA derived from
isolated host plant callus tissue predicted to contain a nucleic
acid molecule of interest integrated into the genome, fol
lowed by Standard cloning and sequence analysis of PCR
amplification products. Methods of PCR genotyping have
been well described (for example, Rios, G. et al. (2002) Plant
J. 32:243-53) and may be applied to gldNA derived from any
plant species (e.g., Z. mays, G. max, and cotton) or tissue type,
including cell cultures.
0170 A transgenic plant formed using Agrobacterium
dependent transformation methods typically contains a single
recombinant DNA inserted into one chromosome. The poly
nucleotide of the single recombinant DNA is referred to as a
“transgenic event' or “integration event. Such transgenic
plants are heterozygous for the inserted exogenous poly
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nucleotide. In some embodiments, a transgenic plant
homozygous with respect to a transgene may be obtained by
sexually mating (selfing) an independent segregant trans
genic plant that contains a single exogenous gene to itself, for
example a To plant, to produce Ti seed. One fourth of the Ti
seed produced will be homozygous with respect to the trans
gene. Germinating Ti seed results in plants that can be tested
for heterozygosity, typically using an SNP assay or a thermal
amplification assay that allows for the distinction between
heterozygotes and homozygotes (i.e., a Zygosity assay).
0171 In particular embodiments, at least 2, 3, 4, 5, 6, 7, 8,
9 or 10 or more different iRNA molecules are produced in a
plant cell that have a hemipteran pest-inhibitory effect. The
iRNA molecules (e.g., dsRNA molecules) may be expressed
from multiple nucleic acids introduced in different transfor
mation events, or from a single nucleic acid introduced in a
single transformation event. In some embodiments, a plural
ity of iRNA molecules are expressed under the control of a
single promoter. In other embodiments, a plurality of iRNA
molecules are expressed under the control of multiple pro
moters. Single iRNA molecules may be expressed that com
prise multiple polynucleotides that are each homologous to
different loci within one or more hemipteran pests (for
example, the loci defined by SEQID NOs: 1 and 2), both in
different populations of the same species of hemipteran pest,
or in different species of hemipteran pests.
0172. In addition to direct transformation of a plant with a
recombinant nucleic acid molecule, transgenic plants can be
prepared by crossing a first plant having at least one trans
genic event with a second plant lacking such an event. For
example, a recombinant nucleic acid molecule comprising a
polynucleotide that encodes an iRNA molecule may be intro
duced into a first plant line that is amenable to transformation
to produce a transgenic plant, which transgenic plant may be
crossed with a second plant line to introgress the polynucle
otide that encodes the iRNA molecule into the second plant
line.

0173 The invention also includes commodity products
containing one or more of the polynucleotides of the present
invention. Particular embodiments include commodity prod
ucts produced from a recombinant plant or seed containing
one or more of the polynucleotides of the present invention. A
commodity product containing one or more of the polynucle
otides of the present invention is intended to include, but not
be limited to, meals, oils, crushed or whole grains or seeds of
a plant, or any food product comprising any meal, oil, or
crushed or whole grain of a recombinant plant or seed con
taining one or more of the polynucleotides of the present
invention. The detection of one or more of the polynucle
otides of the present invention in one or more commodity or
commodity products contemplated herein is de facto evi
dence that the commodity or commodity product is produced
from a transgenic plant designed to express one or more of the
polynucleotides of the present invention for the purpose of
controlling plant pests using dsRNA-mediated gene Suppres
sion methods.

0.174. In some aspects, seeds and commodity products
produced by transgenic plants derived from transformed plant
cells are included, wherein the seeds or commodity products
comprise a detectable amount of a nucleic acid of the inven
tion. In some embodiments, such commodity products may
be produced, for example, by obtaining transgenic plants and
preparing food or feed from them. Commodity products com
prising one or more of the polynucleotides of the invention
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includes, for example and without limitation: meals, oils,
crushed or whole grains or seeds of a plant, and any food
product comprising any meal, oil, or crushed or whole grain
of a recombinant plant or seed comprising one or more of the
nucleic acids of the invention. The detection of one or more of

the polynucleotides of the invention in one or more commod
ity or commodity products is de facto evidence that the com
modity or commodity product is produced from a transgenic
plant designed to express one or more of the iRNA molecules
of the invention for the purpose of controlling hemipteran
pests.

0.175. In some embodiments, a transgenic plant or seed
comprising a nucleic acid molecule of the invention also may
comprise at least one other transgenic event in its genome,
including without limitation: a transgenic event from which is
transcribed an iRNA molecule targeting a locus in a hemi
pteran pest other than the ones defined by SEQID NOs: 1 and
2; a transgenic event from which is transcribed an iRNA
molecule targeting a gene in an organism other than a hemi
pteran pest (e.g., a plant-parasitic nematode); a gene encoding
an insecticidal protein (e.g., a Bacillus thuringiensis, Alcali
genes spp., or Pseudomonas spp. insecticidal protein); a her
bicide tolerance gene (e.g., a gene providing tolerance to
glyphosate); and a gene contributing to a desirable phenotype
in the transgenic plant, such as increased yield, altered fatty
acid metabolism, or restoration of cytoplasmic male Sterility.
In particular embodiments, polynucleotides encoding iRNA
molecules of the invention may be combined with other insect
control and disease traits in a plant to achieve desired traits for
enhanced control of plant disease and insect damage. Com
bining insect control traits that employ distinct modes-of
action may provide protected transgenic plants with Superior
durability over plants harboring a single control trait, for
example, because of the reduced probability that resistance to
the trait(s) will develop in the field.
V. Target Gene Suppression in a Hemipteran Pest
(0176 A. Overview
0177. In some embodiments of the invention, at least one
nucleic acid molecule useful for the control of hemipteran
pests may be provided to a hemipteran pest, wherein the
nucleic acid molecule leads to RNAi-mediated gene silencing
in the pest(s). In particular embodiments, an iRNA molecule
(e.g., dsRNA, siRNA, miRNA, shRNA, and hpRNA) may be
provided to the hemipteran host. In some embodiments, a
nucleic acid molecule useful for the control of hemipteran
pests may be provided to a pest by contacting the nucleic acid
molecule with the pest. In these and further embodiments, a
nucleic acid molecule useful for the control of hemipteran
pests may be provided in a feeding Substrate of the pest, for
example, a nutritional composition. In these and further
embodiments, a nucleic acid molecule useful for the control

of a hemipteran pest may be provided through ingestion of
plant material comprising the nucleic acid molecule that is
ingested by the pest(s). In certain embodiments, the nucleic
acid molecule is present in plant material through expression
of a recombinant nucleic acid introduced into the plant mate
rial, for example, by transformation of a plant cell with a
vector comprising the recombinant nucleic acid and regen
eration of a plant material or whole plant from the trans
formed plant cell.
0.178 B. RNAi-mediated Target Gene Suppression
0179. In certain embodiments, the invention provides
iRNA molecules (e.g., dsRNA, siRNA, miRNA, shRNA, and

hpRNA) that may be designed to target essential native poly
nucleotides (e.g., essential genes) in the transcriptome of a
hemipteran (e.g., BSB) pest, for example by designing an
iRNA molecule that comprises at least one strand comprising
a polynucleotide that is specifically complementary to the
target polynucleotide. The sequence of an iRNA molecule so
designed may be identical to that of the target polynucleotide,
or may incorporate mismatches that do not prevent specific
hybridization between the iRNA molecule and its target poly
nucleotide.

0180 iRNA molecules of the invention may be used in
methods for gene Suppression in a hemipteran pest, thereby
reducing the level or incidence of damage caused by the pest
on a plant (for example, a protected transformed plant com
prising an iRNA molecule). As used herein the term “gene
suppression” refers to any of the well-known methods for
reducing the levels of protein produced as a result of gene
transcription to mRNA and subsequent translation of the
mRNA, including the reduction of protein expression from a
gene or a coding polynucleotide including post-transcrip
tional inhibition of expression and transcriptional Suppres
sion. Post-transcriptional inhibition is mediated by specific
homology between all or a part of an mRNA transcribed from
a gene targeted for Suppression and the corresponding iRNA
molecule used for Suppression. Additionally, post-transcrip
tional inhibition refers to the substantial and measurable
reduction of the amount of mRNA available in the cell for

binding by ribosomes.
0181. In specific embodiments wherein an iRNA mol
ecule is a dsRNA molecule, the dsRNA molecule may be
cleaved by the enzyme, DICER, into short siRNA molecules
(approximately 20 nucleotides in length). The double
stranded siRNA molecule generated by DICER activity upon
the dsRNA molecule may be separated into two single
stranded siRNAs; the “passenger strand' and the “guide
Strand. The passenger strand may be degraded, and the guide
strand may be incorporated into RISC. Post-transcriptional
inhibition occurs by specific hybridization of the guide strand
with a specifically complementary polynucleotide of an
mRNA molecule, and Subsequent cleavage by the enzyme,
Argonaute (catalytic component of the RISC complex).
0182. In particular embodiments of the invention, any
form of iRNA molecule may be used. Those of skill in the art
will understand that dsRNA molecules typically are more
stable during preparation and during the step of providing the
iRNA molecule to a cell than are single-stranded RNA mol
ecules, and are typically also more stable in a cell. Thus, while
siRNA and miRNA molecules, for example, may be equally
effective in some embodiments, a dsRNA molecule may be
chosen due to its stability.
0183. In certain embodiments, a nucleic acid molecule is
provided that comprises a polynucleotide, which polynucle
otide may be expressed in vitro to produce an iRNA molecule
that is substantially homologous to a nucleic acid molecule
encoded by a polynucleotide within the genome of a hemi
pteran pest. In certain embodiments, the in vitro transcribed
iRNA molecule may be a stabilized dsRNA molecule that
comprises a stem-loop structure. After a hemipteran pest con
tacts the in vitro transcribed iRNA molecule, post-transcrip
tional inhibition of a target gene in the pest (for example, an
essential gene) may occur.
0184. In some embodiments of the invention, expression
of an iRNA from a nucleic acid molecule comprising at least
15 contiguous nucleotides (e.g., at least 19 contiguous nucle
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otides) of a polynucleotide are used in a method for post
transcriptional inhibition of a target gene in a hemipteran
pest, wherein the polynucleotide is selected from the group
consisting of: SEQ ID NO:1; the complement of SEQ ID
NO:1; SEQ ID NO:2; the complement of SEQ ID NO:2; a
fragment of at least 15 contiguous nucleotides of SEQ ID
NO:1; the complement of a fragment of at least 15 contiguous
nucleotides of SEQID NO:1; a fragment of at least 15 con
tiguous nucleotides of SEQ ID NO:2; the complement of a
fragment of at least 15 contiguous nucleotides of SEQ ID
NO:2; a native coding polynucleotide of a hemipteran organ
ism comprising SEQ ID NO:1; the complement of a native
coding polynucleotide of a hemipteran organism comprising
SEQ ID NO:1; a native coding polynucleotide of a hemi
pteran organism comprising SEQID NO:2; the complement
of a native coding polynucleotide of a hemipteran organism
comprising SEQID NO:2; a fragment of at least 15 contigu
ous nucleotides of a native coding polynucleotide of a hemi
pteran organism comprising SEQID NO:1; the complement
of a fragment of at least 15 contiguous nucleotides of a native
coding polynucleotide of a hemipteran organism comprising
SEQ ID NO:1; a fragment of at least 15 contiguous nucle
otides of a native coding polynucleotide of a hemipteran
organism comprising SEQID NO:2; and the complement of
a fragment of at least 15 contiguous nucleotides of a native
coding polynucleotide of a hemipteran organism comprising
SEQ ID NO:2. In certain embodiments, expression of a
nucleic acid molecule that is at least about 80% identical (e.g.,
79%, about 80%, about 81%, about 82%, about 83%, about
84%, about 85%, about 86%, about 87%, about 88%, about
89%, about 90%, about 91%, about 92%, about 93%, about
94%, about 95%, about 96%, about 97%, about 98%, about

99%, about 100%, and 100%) with any of the foregoing may
be used. In these and further embodiments, a nucleic acid

molecule may be expressed that specifically hybridizes to an
RNA molecule present in at least one cell of a hemipteran
pest.

0185. It is an important feature of some embodiments
herein that the RNAi post-transcriptional inhibition system is
able to tolerate sequence variations among target genes that
might be expected due to genetic mutation, strain polymor
phism, or evolutionary divergence. The introduced nucleic
acid molecule may not need to be absolutely homologous to
either a primary transcription product or a fully-processed
mRNA of a target gene, so long as the introduced nucleic acid
molecule is specifically hybridizable to either a primary tran
scription product or a fully-processed mRNA of the target
gene. Moreover, the introduced nucleic acid molecule may
not need to be full-length, relative to either a primary tran
scription product or a fully processed mRNA of the target
gene.

0186 Inhibition of a target gene using the iRNA technol
ogy of the present invention is sequence-specific; i.e., poly
nucleotides substantially homologous to the iRNA molecule
(s) are targeted for genetic inhibition. In some embodiments,
an RNA molecule comprising a polynucleotide with a nucle
otide sequence that is identical to that of a portion of a target
gene may be used for inhibition. In these and further embodi
ments, an RNA molecule comprising a polynucleotide with
one or more insertion, deletion, and/or point mutations rela
tive to a target polynucleotide may be used. In particular
embodiments, an iRNA molecule and a portion of a target
gene may share, for example, at least from about 80%, at least
from about 81%, at least from about 82%, at least from about
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83%, at least from about 84%, at least from about 85%, at
least from about 86%, at least from about 87%, at least from
about 88%, at least from about 89%, at least from about 90%,
at least from about 91%, at least from about 92%, at least from
about 93%, at least from about 94%, at least from about 95%,
at least from about 96%, at least from about 97%, at least from
about 98%, at least from about 99%, at least from about

100%, and 100% sequence identity. Alternatively, the duplex
region of a dsRNA molecule may be specifically hybridizable
with a portion of a target gene transcript. In specifically
hybridizable molecules, a less than full length polynucleotide
exhibiting a greater homology compensates for a longer, less
homologous polynucleotide. The length of the polynucle
otide of a duplex region of a dsRNA molecule that is identical
to a portion of a target genetranscript may beat least about 25,
50, 100, 200, 300, 400, 500, or at least about 1000 bases. In

some embodiments, a polynucleotide of greater than 20-100
nucleotides may be used; for example, a polynucleotide of
100-200 or 300-500 nucleotides may be used. In particular
embodiments, a polynucleotide of greater than about 200-300
nucleotides may be used. In particular embodiments, a poly
nucleotide of greater than about 500-1000 nucleotides may be
used, depending on the size of the target gene.
0187. In certain embodiments, expression of a target gene
in a hemipteran pest may be inhibited by at least 10%; at least
33%;at least 50%; or at least 80% within a cell of the pest,
Such that a significant inhibition takes place. Significant inhi
bition refers to inhibition over a threshold that results in a

detectable phenotype (e.g., cessation of reproduction, feed
ing, development, etc.), or a detectable decrease in RNA
and/or gene product corresponding to the target gene being
inhibited. Although in certain embodiments of the invention
inhibition occurs in substantially all cells of the pest, in other
embodiments inhibition occurs only in a subset of cells
expressing the target gene.
0188 In some embodiments, transcriptional suppression
is mediated by the presence in a cell of a dsRNA molecule
exhibiting substantial sequence identity to a promoter DNA
or the complement thereof to effect what is referred to as
“promoter trans Suppression. Gene Suppression may be
effective against target genes in a hemipteran pest that may
ingest or contact Such dsRNA molecules, for example, by
ingesting or contacting plant material containing the dsRNA
molecules. dsRNA molecules for use in promoter trans Sup
pression may be specifically designed to inhibit or Suppress
the expression of one or more homologous or complementary
polynucleotides in the cells of the hemipteran pest. Post
transcriptional gene Suppression by antisense or sense ori
ented RNA to regulate gene expression in plant cells is dis
closed in U.S. Pat. Nos. 5,107,065; 5,759,829:5,283, 184; and
5,231,020.

(0189 C. Expression of IRNA Molecules Provided to a
Hemipteran Pest
(0190. Expression of iRNA molecules for RNAi-mediated
gene inhibition in a hemipteran pest may be carried out in any
one of many in vitro or in vivo formats. The iRNA molecules
may then be provided to a hemipteran pest, for example, by
contacting the iRNA molecules with the pest, or by causing
the pest to ingest or otherwise internalize the iRNA mol
ecules. Some embodiments of the invention include trans

formed host plants of a hemipteran pest, transformed plant
cells, and progeny of transformed plants. The transformed
plant cells and transformed plants may be engineered to
express one or more of the iRNA molecules, for example,
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under the control of a heterologous promoter, to provide a
pest-protective effect. Thus, when a transgenic plant or plant
cell is consumed by a hemipteran pest during feeding, the pest
may ingest iRNA molecules expressed in the transgenic
plants or cells. The polynucleotides of the present invention
may also be introduced into a wide variety of prokaryotic and
eukaryotic microorganism hosts to produce iRNA molecules.
The term “microorganism’ includes prokaryotic and eukary
otic species, such as bacteria and fungi.
0191 Modulation of gene expression may include partial
or complete Suppression of Such expression. In another
embodiment, a method for Suppression of gene expression in
ahemipteran pest comprises providing in the tissue of the host
of the pest a gene-suppressive amount of at least one dsRNA
molecule formed following transcription of a polynucleotide
as described herein, at least one segment of which is comple
mentary to an mRNA within the cells of the hemipteran pest.
A dsRNA molecule, including its modified form such as an
siRNA, miRNA, shRNA, or hpRNA molecule, ingested by a
hemipteran pest in accordance with the invention may be at
least from about 80%, 81%, 82%, 83%, 84%, 85%, 86%,
87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%,
97%, 98%, 99%, or about 100% identical to an RNA mol
ecule transcribed from a hunchback DNA molecule, for

example, comprising a polynucleotide selected from the
group consisting of SEQID NOS:1 and 2. Isolated and sub
stantially purified nucleic acid molecules including, but not
limited to, non-naturally occurring polynucleotides and
recombinant DNA constructs for providing dsRNA mol
ecules of the present invention are therefore provided, which
Suppress or inhibit the expression of an endogenous coding
polynucleotide or a target coding polynucleotide in the hemi
pteran pest when introduced thereto.
0.192 Particular embodiments provide a delivery system
for the delivery of iRNA molecules for the post-transcrip
tional inhibition of one or more target gene(s) in a hemipteran
plant pest and control of a population of the plant pest. In
Some embodiments, the delivery system comprises ingestion
of a host transgenic plant cell or contents of the host cell
comprising RNA molecules transcribed in the host cell. In
these and further embodiments, a transgenic plant cell or a
transgenic plant is created that contains a recombinant DNA
construct providing a stabilized dsRNA molecule of the
invention. Transgenic plant cells and transgenic plants com
prising nucleic acids encoding a particular iRNA molecule
may be produced by employing recombinant DNA technolo
gies (which basic technologies are well-known in the art) to
construct a plant transformation vector comprising a poly
nucleotide encoding an iRNA molecule of the invention (e.g.,
a stabilized dsRNA molecule); to transform a plant cell or
plant; and to generate the transgenic plant cell or the trans
genic plant that contains the transcribed iRNA molecule.
0193 To impart protection from hemipteran pests to a
transgenic plant, a recombinant DNA molecule may, for
example, be transcribed into an iRNA molecule, such as a
dsRNA molecule, an siRNA molecule, an miRNA molecule,

an shRNA molecule, or an hpRNA molecule. In some
embodiments, an RNA molecule transcribed from a recom

binant DNA molecule may form a dsRNA molecule within
the tissues or fluids of the recombinant plant. Such a dsRNA
molecule may be comprised in part of a polynucleotide that is
identical to a corresponding polynucleotide transcribed from
a DNA within a hemipteran pest of a type that may infest the
host plant. Expression of a target gene within the hemipteran

pest is suppressed by the dsRNA molecule, and the Suppres
sion of expression of the target gene in the hemipteran pest
results in the transgenic plant being resistant to the pest. The
modulatory effects of dsRNA molecules have been shown to
be applicable to a variety of genes expressed in pests, includ
ing, for example, endogenous genes responsible for cell divi
Sion, chromosomal remodeling, and cellular metabolism or
cellular transformation, including house-keeping genes; tran
Scription factors; molting-related genes; and other genes
which encode polypeptides involved in cellular metabolism
or normal growth and development.
0194 For transcription from a transgene in vivo or an
expression construct, a regulatory region (e.g., promoter,
enhancer, silencer, and polyadenylation signal) may be used
in some embodiments to transcribe the RNA strand (or
Strands). Therefore, in Some embodiments, as set forth, Supra,
a polynucleotide for use in producing iRNA molecules may
be operably linked to one or more promoter elements func
tional in a plant host cell. The promoter may be an endog
enous promoter, normally resident in the host genome. The
polynucleotide of the present invention, under the control of
an operably linked promoter element, may further be flanked
by additional elements that advantageously affect its tran
Scription and/or the stability of a resulting transcript. Such
elements may be located upstream of the operably linked
promoter, downstream of the 3' end of the expression con
struct, and may occur both upstream of the promoter and
downstream of the 3' end of the expression construct.
0.195. In embodiments, suppression of a target gene (e.g.,
a hunchback gene) results in a parental RNAi phenotype; a
phenotype that is observable in progeny of the Subject (e.g., a
hemipteran pest) contacted with the iRNA molecule. In some
embodiments, the pRNAi phenotype comprises the pest
being rendered less able to produce viable offspring. In par
ticular examples of pRNAi, a nucleic acid that initiates
pRNAi does not increase the incidence of mortality in a
population into which the nucleic acid is delivered. In other
examples of pRNAi, a nucleic acid that initiates pRNAi also
increases the incidence of mortality in a population into
which the nucleic acid is delivered.

0196. In some embodiments, a population of hemipteran
pests is contacted with an iRNA molecule, thereby resulting
in pRNAi, wherein the pests survive and mate but produce
eggs that are less able to hatch viable progeny than eggs
produced by pests of the same species that are not provided
the nucleic acid(s). In some examples, such pests do not
oviposit or produce fewer eggs than what is observable in
pests of the same species that are not contacted with the iRNA
molecule. In some examples, the eggs oviposited by Such
pests do not hatch or hatch at a rate that is significantly less
than what is observable in pests of the same species that are
not contacted with the iRNA molecule. In some examples, the
nymphs that hatch from eggs oviposited by Such pests are not
viable or are less viable than what is observable in pests of the
same species that are not contacted with the iRNA molecule.
0.197 Transgenic crops that produce substances that pro
vide protection from insect feeding are vulnerable to adapta
tion by the target insect pest population reducing the durabil
ity of the benefits of the insect protection substance(s).
Traditionally, delays in insect pest adaptation to transgenic
crops are achieved by (1) the planting of “refuges” (crops that
do not contain the pesticidal Substances, and therefore allow
survival of insects that are susceptible to the pesticidal sub
stance(s)); and/or (2) combining insecticidal Substances with
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multiple modes of action against the target pests, so that
individuals that are resistant to one mode of action are killed

by a second mode of action.
0198 In particular examples, iRNA molecules (e.g.,
expressed from a transgene in a host plant) represent new
modes of action for combining with Bacillus thuringiensis,
Alcaligenes spp., or Pseudomonas spp. insecticidal protein
technology and/or lethal RNAi technology in Insect Resis
tance Management gene pyramids to mitigate against the
development of insect populations resistant to either of these
control technologies.
0199 Parental RNAi may result in some embodiments in
a type of pest control that is different from the control
obtained by lethal RNAi, and which may be combined with
lethal RNAi to result in synergistic pest control. Thus, in
particular embodiments, iRNA molecules for the post-tran
Scriptional inhibition of one or more target gene(s) in a hemi
pteran plant pest can be combined with otheriRNA molecules
to provide redundant RNAi targeting and synergistic RNAi
effects.

0200 Parental RNAi (pRNAi) that causes egg mortality or
loss of egg viability has the potential to bring further durabil
ity benefits to transgenic crops that use RNAi and other
mechanisms for insect protection. pRNAi prevents exposed
insects from producing progeny, and therefore from passing
on to the next generation any alleles they carry that confer
resistance to the pesticidal Substance(s). pRNAi is particu
larly useful in extending the durability of insect-protected
transgenic crops when it is combined with one or more addi
tional pesticidal Substances that provide protection from the
same pest populations. Such additional pesticidal Substances
may in some embodiments include, for example, dsRNA;
nymph-active dsRNA; insecticidal proteins (such as those
derived from Bacillus thuringiensis, Alcaligenes spp.,
Pseudomonas spp. or other organisms); and other insecticidal
Substances. This benefit arises because insects that are resis

tant to the pesticidal Substances occur as a higher proportion
of the population in the transgenic crop than in the refuge
crop. If a ratio of resistance alleles to susceptible alleles that
are passed on to the next generation is lower in the presence of
pRNAi than in the absence of pRNAi, the evolution of resis
tance will be delayed.
0201 For example, pRNAi may not reduce the number of
individuals in a first pest generation that are inflicting damage
on a plant expressing an iRNA molecule. However, the ability
of Such pests to Sustain an infestation through Subsequent
generations may be reduced. Conversely, lethal RNAi may
kill pests that already are infesting the plant. When pRNAi is
combined with lethal RNAi, pests that are contacted with a
parental iRNA molecule may breed with pests from outside
the system that have not been contacted with the iRNA, how
ever, the progeny of such a mating may be non-viable or less
viable, and thus may be unable to infest the plant. At the same
time, pests that are contacted with a lethal iRNA molecule
may be directly affected. The combination of these two
effects may be synergistic; i.e., the combined pRNAi and
lethal RNAi effect may be greater than the sum of the pRNAi
and lethal RNAi effects independently. pRNAi may be com
bined with lethal RNAi, for example, by providing a plant that
expresses both lethal and parental iRNA molecules; by pro
viding in the same location a first plant that expresses lethal
iRNA molecules and a second plant that expresses parental
iRNA molecules; and/or by contacting female pests with the
pRNAi molecule, and Subsequently releasing the contacted
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pests into the plant environment, such that they can mate
unproductively with the plant pests.
0202 Some embodiments provide methods for reducing
the damage to a host plant (e.g., a Soybean plant) caused by a
hemipteran pest that feeds on the plant, wherein the method
comprises providing in the host planta transformed plant cell
expressing at least one nucleic acid molecule of the invention,
wherein the nucleic acid molecule(s) functions upon being
taken up by the pest(s) to inhibit the expression of a target
polynucleotide within the pest(s), which inhibition of expres
sion results in reduced reproduction, for example, in addition
to mortality and/or reduced growth of the pest(s), thereby
reducing the damage to the host plant caused by the pest(s). In
Some embodiments, the nucleic acid molecule(s) comprise
dsRNA molecules. In these and further embodiments, the

nucleic acid molecule(s) comprise dsRNA molecules that
each comprise more than one polynucleotide that is specifi
cally hybridizable to a nucleic acid molecule expressed in a
hemipteran pest cell. In some embodiments, the nucleic acid
molecule(s) consist of one polynucleotide that is specifically
hybridizable to a nucleic acid molecule expressed in a hemi
pteran pest cell.
0203. In alternative embodiments, a method for increasing
the yield of a corn crop is provided, wherein the method
comprises introducing into a corn plant at least one nucleic
acid molecule of the invention; and cultivating the corn plant
to allow the expression of an iRNA molecule comprising the
nucleic acid, wherein expression of an iRNA molecule com
prising the nucleic acid inhibits hemipteran pest damage and/
or growth, thereby reducing or eliminating a loss of yield due
to hemipteran pest infestation. In some embodiments, the
iRNA molecule is a dsRNA molecule. In these and further

embodiments, the nucleic acid molecule(s) comprise dsRNA
molecules that each comprise more than one polynucleotide
that is specifically hybridizable to a nucleic acid molecule
expressed in a hemipteran pest cell. In some embodiments,
the nucleic acid molecule(s) consists of one polynucleotide
that is specifically hybridizable to a nucleic acid molecule
expressed in a hemipteran pest cell.
0204. In other embodiments, a method for increasing the
yield of a plant crop is provided, wherein the method com
prises introducing into a female hemipteran pest (e.g., by
injection, by ingestion, by spraying, and by expression from
a DNA) at least one nucleic acid molecule of the invention;
and releasing the female pest into the crop, wherein mating
pairs including the female pest are unable or less able to
produce viable offspring, thereby reducing or eliminating a
loss of yield due to hemipteran pest infestation. In particular
embodiments, such a method provides control of Subsequent
generations of the pest. In similar embodiments, the method
comprises introducing the nucleic acid molecule of the inven
tion into a male hemipteran pest, and releasing the male pest
into the crop (e.g., wherein pRNAi male pests produce less
sperm than untreated controls). In some embodiments, the
nucleic acid molecule is a DNA molecule that is expressed to
produce an iRNA molecule. In some embodiments, the
nucleic acid molecule is a dsRNA molecule. In these and

further embodiments, the nucleic acid molecule(s) comprise
dsRNA molecules that each comprise more than one poly
nucleotide that is specifically hybridizable to a nucleic acid
molecule expressed in a hemipteran pest cell. In some
embodiments, the nucleic acid molecule(s) consists of one
polynucleotide that is specifically hybridizable to a nucleic
acid molecule expressed in a hemipteran pest cell.
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0205. In some embodiments, a method for modulating the
expression of a target gene in a hemipteran pest is provided,
the method comprising: transforming a plant cell with a vec
tor comprising a polynucleotide encoding at least one iRNA
molecule of the invention, wherein the polynucleotide is
operatively-linked to a promoter and a transcription termina
tion element; culturing the transformed plant cell under con
ditions sufficient to allow for development of a plant cell
culture including a plurality of transformed plant cells; select
ing for transformed plant cells that have integrated the poly
nucleotide into their genomes; Screening the transformed
plant cells for expression of an iRNA molecule encoded by
the integrated polynucleotide; selecting a transgenic plant
cell that expresses the iRNA molecule; and feeding the
selected transgenic plant cell to the hemipteran pest. Plants
may also be regenerated from transformed plant cells that
express an iRNA molecule encoded by the integrated nucleic
acid molecule. In some embodiments, the iRNA molecule is
a dsRNA molecule. In these and further embodiments, the

nucleic acid molecule(s) comprise dsRNA molecules that
each comprise more than one polynucleotide that is specifi
cally hybridizable to a nucleic acid molecule expressed in a
hemipteran pest cell. In some embodiments, the nucleic acid
molecule(s) consists of one polynucleotide that is specifically
hybridizable to a nucleic acid molecule expressed in a hemi
pteran pest cell.
0206 iRNA molecules of the invention can be incorpo
rated within the seeds of a plant species (e.g., soybean), either
as a product of expression from a recombinant gene incorpo
rated into a genome of the plant cells, or as incorporated into
a coating or seed treatment that is applied to the seed before
planting. A plant cell comprising a recombinant gene is con
sidered to be a transgenic event. Also included in embodi
ments of the invention are delivery systems for the delivery of
iRNA molecules to hemipteran pests. For example, the iRNA
molecules of the invention may be directly introduced into the
cells of a pest(s). Methods for introduction may include direct
mixing of iRNA into the diet of the hemipteran pest (e.g., by
mixing with plant tissue from a host for the pest), as well as
application of compositions comprising iRNA molecules of
the invention to host plant tissue. For example, iRNA mol
ecules may be sprayed onto a plant Surface. Alternatively, an
iRNA molecule may be expressed by a microorganism, and
the microorganism may be applied onto the plant Surface, or
introduced into a root or stem by a physical means Such as an
injection. As discussed, Supra, a transgenic plant may also be
genetically engineered to express at least one iRNA molecule
in an amount Sufficient to kill the hemipteran pests known to
infest the plant. iRNA molecules produced by chemical or
enzymatic synthesis may also be formulated in a manner
consistent with common agricultural practices, and used as
spray-on products for controlling plant damage by a hemi
pteran pest. The formulations may include the appropriate
adjuvants (e.g., Stickers and wetters) required for efficient
foliar coverage, as well as UV protectants to protect iRNA
molecules (e.g., dsRNA molecules) from UV damage. Such
additives are commonly used in the bioinsecticide industry,
and are well known to those skilled in the art. Such applica
tions may be combined with other spray-on insecticide appli
cations (biologically based or otherwise) to enhance plant
protection from hemipteran pests.
0207 All references, including publications, patents, and
patent applications, cited herein are hereby incorporated by
reference to the extent they are not inconsistent with the
explicit details of this disclosure, and are so incorporated to
the same extent as if each reference were individually and

specifically indicated to be incorporated by reference and
were set forth in its entirety herein. The references discussed
herein are provided solely for their disclosure prior to the
filing date of the present application. Nothing herein is to be
construed as an admission that the inventors are not entitled to

antedate such disclosure by virtue of prior invention.
0208. The following Examples are provided to illustrate
certain particular features and/or aspects. These Examples
should not be construed to limit the disclosure to the particu
lar features or aspects described.
EXAMPLES

Example 1
RNAi Constructs

Template Preparation by PCR and dsRNA Synthesis
0209. The strategies used to provide specific templates for
hunchback dsRNA production are shown in FIG. 1A and FIG.
1B. Template DNAs intended for use in hunchback dsRNA
synthesis are prepared by PCR using specific primers and
first-strand cDNA prepared from total RNA. For hunchback
selected target gene regions, two separate PCR amplifications
are performed. FIG. 1. A The first PCR amplification intro
duces a T7 promoter sequence at the 5' end of the amplified
sense Strands. The second reaction incorporates the T7 pro
motersequence at the 5' ends of the antisense strands. The two
PCR amplified fragments for each region of the target genes
are then mixed in approximately equal amounts, and the
mixture is used as transcription template for dsRNA produc
tion. FIG. 1A.

0210 For the YFP negative control, a single PCR ampli
fication is performed. FIG. 1B. The PCR amplification intro
duced a T7 promoter sequence at the 5' ends of the amplified
sense and antisense strands. The two PCR amplified frag
ments for each region of the target genes were then mixed in
approximately equal amounts, and the mixture was used as
transcription template for dsRNA production. FIG. 1B.
dsRNA for the negative control YFP coding region was pro
duced using specific primers and a DNA clone of the YFP
coding region as template. The PCR product amplified for
hunchback and YFP were used as a template for in vitro
synthesis of dsRNAs using the MEGAScript high-yield tran
scription kit (Applied Biosystems Inc., Foster City, Calif.).
The synthesized dsRNAs were purified using the RNeasy
Mini kit (Qiagen, Valencia, Calif.) or an AMBIONR MEGA
script(R) RNAi kit, essentially as prescribed by the manufac
turer's instructions. dsRNA preparations were quantified
using a NANODROPTM 8000 spectrophotometer (THERMO
SCIENTIFIC, Wilmington, Del.) or equivalent means, and
analyzed by gel electrophoresis to determine purity.
Example 2
Real-Time PCR Analysis
0211 Quantitative Real-Time PCR. E. heros tissues for
qRT-PCR were collected from Zero to three day-old females
injected with dsRNA as described in Example 6. After seven
days, female ovaries were dissected under a stereo micro
scope in nuclease-free 1xPBS (pH 7.4) and frozen individu
ally on dry ice in collection microtubes. Tissue disruption was
performed with the RL lysis buffer and the KleckoTM tissue
pulverizer (Garcia Manufacturing, Visalia, Calif.). Following
tissue maceration, the total RNA was isolated in high
throughput format using the Norgen Total RNA Purification
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96-well kit (Norgen BioteK Corp., Ontario, Canada) follow
ing the manufacturer's protocol using TurboTM DNase (Life
Technologies, Carlsbad, Calif.) for 1 hour at 37° C. on the
elutant. cDNA synthesis was performed using the high capac
ity clNARTkit (Life technologies, Carlsbad, Calif.) accord
ing to the manufacturer's protocol with the following modi
fications. Total RNA was adjusted to 50 ng/ul with nuclease
free water. RNA samples were heated to 70° C. for 10 minutes
and cooled to 4°C. Half reactions were initiated by addition
of 5ul of 2x mix. The primer mix, which is supplied solely as
random primers, was first spiked with custom synthesized
T20VN oligo (Integrated DNA Technologies, Coralville,
Iowa) to a final concentration of 2 in order to improve the
sensitivity of 3'UTR based assays. Following first strand syn
thesis, the samples were diluted 1:3 with nuclease free.
0212 E. heros qRT-PCR primers and hydrolysis probes
were designed using LightCycler Probe Design Software 2.0
(Roche, Basel, Switzerland) for the reference gene and
Primer Express(R) Software Version3.0 (Applied Biosystems,
Grand Island, N.Y.) for the target genes (Supplemental Table
2). Non-injected insects were used as controls. E. heros actin
was used as the reference gene. Probes were labeled with
FAM (6-Carboxy Fluorescein Amidite). The final primer con
centrations were 0.4 uMand probe concentrations were 0.2 in
10 ul reaction volumes. Relative transcript levels were ana
lyzed by probe hydrolysis qRT-PCR using Roche LightCy
cler480 (Roche, Basel, Switzerland). All assays included
negative controls of no-template (mix only). For the standard
curves, a blank was included in the source plate to check for
sample cross-contamination. PCR cycling conditions
included a 10 minute target activation incubation at 95°C.,
followed by 40 cycles of denaturation at 95°C. for 10 sec
onds, anneal/extend at 60° C. for 40 seconds, and FAM acqui
sition at 72°C. for 1 second. The reaction was followed by a
10 second cool-down at 40°C. The data was analyzed using
LightCyclerTM Software v1.5 and relative changes in expres

sion were calculated using 2^* method (Livak and Schmit

tgen (2001) Methods 25(4):402-08).
0213 Non-injected insects and YFP dsRNA-injected
insects were used as controls. The BSB Actin (SEQ ID
NO:14) was used as a reference gene (Ponton et al. (2011) J
Insect Physiol 57 (6):840-50). The primers and probes for the
gene of interest (GOI) and reference genes appear in Table 1.
TABLE 1.

Oligonucleotides and probes for BSB probe
hydrolysis CPCR assay.
NAME

SEQUENCE

Actin

Actin-F

TCAAGGAAAAACTGTGCTATGT

Actin

Actin-R

TACCGATGGTGATGACCTGA

Actin

Actin-Fam

ACCGCCGCTGCC

Reference GENE

Target
hio

Example 3
Construction of Plant Transformation Vectors

0215. An entry vector harboring a target gene construct for
dsRNA hairpin formation comprising segments of hunch
back (SEQ ID NO: 1) is assembled using a combination of
chemically synthesized fragments (DNA2.0, Menlo Park,
Calif.) and standard molecular cloning methods. Intramo
lecular hairpin formation by RNA primary transcripts is
facilitated by arranging (within a single transcription unit)
two copies of a target gene segment in opposite orientation to
one another, the two segments being separated by a linker
sequence (e.g. ST-LS1 intron, SEQID NO:6; Vancanneyt et
al. (1990) Mol. Gen. Genet. 220:245-250). Thus, the primary
mRNA transcript contains the two hunchback gene segment
sequences as large inverted repeats of one another, separated
by the linker sequence. A copy of a promoter (e.g. maize
ubiquitin 1, U.S. Pat. No. 5,510,474; 35S from Cauliflower
Mosaic Virus (CaMV); promoters from rice actin genes:
ubiquitin promoters; pEMU; MAS; maize H3 histone pro
moter, ALS promoter, phaseolin gene promoter; cab: rubisco;
LAT52: Zm 13; and/or apg) is used to drive production of the
primary mRNA hairpintranscript, and a fragment comprising
a 3' untranslated region, for example and without limitation, a
maize peroxidase 5 gene (ZmPer53'UTR v2; U.S. Pat. No.
6,699.984), Atubi10, AtEf1, or StPinII is used to terminate
transcription of the hairpin-RNA-expressing gene.
0216. The entry vector described above is used in standard
GATEWAYR recombination reactions with a typical binary
destination vector to produce hunchback hairpin RNA
expression transformation vectors for Agrobacterium-medi
ated plant embryo transformations.
0217. A negative control binary vector which comprises a
gene that expresses a YFP hairpin dsRNA is constructed by
means of standard GATEWAYR recombination reactions

with a typical binary destination vector and entry vector. The
entry vector comprises a YFP hairpin sequence under the
expression control of a maize ubiquitin 1 promoter and a
fragment comprising a 3' untranslated region from a maize
peroxidase 5 gene.
0218. A binary destination vector comprises a herbicide
tolerance gene (aryloxyalknoate dioxygenase; (AAD-1 V3,
U.S. Pat. No. 7,838,733, and Wright et al. (2010) Proc. Natl.
Acad. Sci. U.S.A. 107:20240-5)) under the regulation of a
plant operable promoter (e.g., Sugarcane bacilliform badnavi
rus (Sc3V) promoter (Schenk et al. (1999) Plant Mol. Biol.
39:1221-30) or ZmUbil (U.S. Pat. No. 5,510.474)). 5' UTR
and intron from these promoters, are positioned between the
3' end of the promoter segment and the start codon of the
AAD-1 coding region. A fragment comprising a 3' untrans
lated region from a maize lipase gene (ZmLip 3'UTR; U.S.
Pat. No. 7,179,902) is used to terminate transcription of the
AAD-1 mRNA.

0219. A further negative control binary vector that com
prises a gene that expresses a YFP protein, is constructed by
ho-FMGB

CCCGACTCCGGCACAA

hio

hb-R MGB

TGACCGTACTCCGCGTCAT

hio

ho-FAMMGB

TCGTTAAAGAGGAGCCGCGA

0214. The hb transcript levels in E. heros ovary drop sig
nificantly (by over 80%) after hb dsRNA injection (FIG. 4).

means of standard GATEWAYR recombination reactions

with a typical binary destination vector and entry vector. The
binary destination vector comprises a herbicide tolerance
gene (aryloxyalknoate dioxygenase; AAD-1 V3) (as above)
under the expression regulation of a maize ubiquitin 1 pro
moter and a fragment comprising a 3' untranslated region
from a maize lipase gene (ZmLip 3'UTR). The entry vector
comprises a YFP coding region under the expression control
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of a maize ubiquitin 1 promoter and a fragment comprising a
3' untranslated region from a maize peroxidase 5 gene.
Example 4
Insect Rearing and Candidate Gene Selection in
Neotropical Brown Stink Bug (Euschistus heros)
0220 Insect Rearing.
0221) Neotropical Brown Stink Bugs (BSB; Euschistus
heros) were reared in a 27°C. incubator, at 65% relative
humidity, with 16:8 hour light: dark cycle. One gram of eggs
collected over 2-3 days was seeded in 5 L containers with
filter paper discs at the bottom; the containers were covered
with #18 mesh for ventilation. Each rearing containeryielded
approximately 300-400 adult BSB. At all stages, the insects
were fed fresh green beans three times per week and a sachet
of seed mixture containing Sunflower seeds, soybeans, and
peanuts (3:1:1 by weight ratio) was replaced once a week.
Water was supplemented in vials with cotton plugs as wicks.
After the initial two weeks, insects were transferred to a new
container once a week.

0222 RNAi Target Selection.
0223 Six stages of BSB development were selected for
mRNA library preparation. Total RNA was extracted from
insects frozen at -70° C. and homogenized in 10 volumes of
Lysis/Binding buffer in Lysing MATRIX A 2 mL tubes (MP
BIOMEDICALS, Santa Ana, Calif.) on a FastPrep R-24
Instrument (MP BIOMEDICALS). Total mRNA was
extracted using a mirVana TM miRNA. Isolation Kit (AM
BION: INVITROGEN) according to the manufacturer's pro
tocol. RNA sequencing using an Illumina R. HiSegTM system
(San Diego, Calif.) provided candidate target gene sequences
for use in RNAi insect control technology. HiSegTM generated
a total of about 378 million reads for the six samples. Reads
were assembled individually for each sample using TRINITY
assembler software (Grabherr et al. (2011) Nature Biotech.
29:644-652). The assembled transcripts were combined to
generate a pooled transcriptome. This BSB pooled transcrip
tome contains 378,457 sequences.
0224 BSB Hunchback Ortholog Identification.
0225. A tBLASTn search of the BSB pooled transcrip
tome was performed using sequences of the Drosophila
hunchback (hb-PA, GENBANKAccession No. NP 731267)
protein. BSB hunchback (SEQID NO:1) was identified as a
Euschistus heros candidate target gene that may lead to hemi
pteran pest mortality, or inhibition of growth, development, or
reproduction. This gene encodes a HUNCHBACK protein,
which corresponds to a C2H2-type Zinc-finger protein family
transcription factor that is also defined as a gap gene, a gene
loss of which produces a gap in the body plan.
0226. The sequence of SEQID NO:1 is novel. There was
no significant homologous nucleotide sequence found with a
search in GENBANK. The closest homolog of the BSB
HUNCHBACK amino acid sequence (SEQ ID NO:3) is a
Oncopeltus fasciatus protein having GENBANK Accession
No. AAR23151.1 (80% similar; 73% identical over the
homology region).
0227 Template Preparation and dsRNA Synthesis.
0228 cDNA was prepared from total BSB RNA extracted
from a single young adult insect (about 90 mg) using TRI
ZolR Reagent (LIFE TECHNOLOGIES, Grand Island,
N.Y.). The insect was homogenized at room temperature in a
1.5 mL microcentrifuge tube with 200LL of TRIZolR using a
pellet pestle (FISHERBRAND, Grand Island, N.Y.) and

Pestle Motor Mixer (COLE-PARMER, Vernon Hills, Ill.).
Following homogenization, an additional 800 uL of TRIZolR)
was added, the homogenate was Vortexed, and then incubated
at room temperature for five minutes. Cell debris was
removed by centrifugation and the Supernatant was trans
ferred to a new tube. Following manufacturer-recommended
TRIZolR extraction protocol for 1 mL of TRIZol(R), the RNA
pellet was dried at room temperature and resuspended in 200
uL Tris Buffer from a GFX PCR DNA AND GEL EXTRAC
TION KIT (IllustraTM; GE HEALTHCARE LIFE SCI
ENCES, Pittsburgh, Pa.) using Elution Buffer Type 4 (i.e. 10
mM Tris-HCl pH8.0). RNA concentration was determined
using a NANODROPTM 8000 spectrophotometer (THERMO
SCIENTIFIC, Wilmington, Del.).
0229 cDNA was reverse-transcribed from 5ug BSB total
RNA template and oligo dT primer using a SUPERSCRIPT
III FIRST-STRAND SYNTHESIS SYSTEMTM for RT-PCR

(INVITROGEN), following the supplier's recommended
protocol. The final volume of the transcription reaction was
brought to 100 uL with nuclease-free water.
0230 Primers for BSB hb-1 dsRNA BSB hb-1-F (SEQ
ID NO:7) and BSB hb-1-R (SEQ ID NO:8) were used to
amplify DNA templates for dsRNA transcription. The DNA
templates were amplified using “touch-down” PCR (anneal
ing temperature lowered from 60°C. to 50° C. in a 1° C./cycle
decrease) with 1 uL of cDNA (above) as the template. Frag
ments comprising a 469 bp segment of hunchback (i.e. BSB
hb-1, SEQ ID NO:2) were generated during 35 cycles of
PCR. The above procedure was used to amplify a 301 bp
negative control template YFPv2 (SEQID NO:9) using prim
ers YFPv2 F (SEQ ID NO:10) and YFPv2. R (SEQ ID
NO:11). The BSB-specific and YFPv2 primers containeda T7
phage promoter sequence (SEQ ID NO:4) at their 5' ends,
enabling the use of the aforementioned BSB DNA fragments
for dsRNA transcription.
0231 dsRNAs were synthesized using 2 ul of PCR prod
uct (above) as the template with a MEGAScriptTM RNAi kit
(AMBION) or HiScribe(RT7 In Vitro Transcription Kit, used
according to the manufacturer's instructions. See FIGS. 1A
and 1B. dsRNA was quantified on a NANODROPTM 8000
spectrophotometer and diluted to 1 ug/uI in nuclease-free
0.1XTE buffer (1 mM Tris HCL, 0.1 mM EDTA, pH 7.4).
Example 5

dsRNA Injection into 2" Instar Neotropical Brown
Stink Bug (Euschistus heros) Nymphs
0232 BSB Artificial Diet.
0233 bsb artificial diet was prepared as follows and used
within two weeks of preparation. Lyophilized green beans
were blended to a fine powder in a MAGIC BULLETR)
blender while raw (organic) peanuts were blended in a sepa
rate MAGIC BULLETR) blender. Blended dry ingredients
were combined (weight percentages: greenbeans, 35%; pea
nuts, 35%; sucrose, 5%; Vitamin complex (e.g. Vanderzant
Vitamin Mixture for insects, SIGMA-ALDRICH), 0.9%); in
a large MAGIC BULLETR) blender, which was capped and
shaken well to mix the ingredients. The mixed dry ingredients
were then added to a mixing bowl. In a separate container,
water and benomyl anti-fungal agent (50 ppm; 25uL 20,000
ppm solution/50 mL diet solution) were mixed well and then
added to the dry ingredient mixture. All ingredients were
mixed by hand until the solution was fully blended. The diet
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was shaped into desired sizes, wrapped loosely in aluminum
foil, heated for 4 hours at 60°C., then cooled and stored at 4°
C.

0234. Injection of dsRNA into BSB Hemocoel.
0235 BSB were reared on a green bean and seed diet, as
the colony described above, in a 27°C. incubator at 65%
relative humidity and 16:8 hour light: dark photoperiod. Sec
ond instar nymphs (each weighing 1 to 1.5 mg) were gently
handled with a small brush to prevent injury and were placed
in a Petridish on ice to chill and immobilize the insects. Each

insect was injected with 55.2 mL of a 500 ng/uL dsRNA
Solution (i.e., 27.6 ng dsRNA; dosage of 18.4 to 27.6 g/g,
body weight). Injections were performed using a
NANOJECTTM II injector (DRUMMOND SCIENTIFIC,
Broomhall, Pa.) equipped with an injection needle pulled
from a Drummond 3.5 inch #3-000-203-G/X glass capillary.
The needle tip was broken and the capillary was backfilled
with light mineral oil, then filled with 2 to 3 uI of dsRNA.
dsRNA was injected into the abdomen of the nymphs (10
insects injected per dsRNA per trial), and the trials were
repeated on three different days. Injected insects (5 per well)
were transferred into 32-well trays (Bio-RT-32 Rearing Tray:
BIO-SERV, Frenchtown, N.J.) containing a pellet of artificial
BSB diet and covered with Pull-N-PeelTM tabs (BIO-CV-4:
BIO-SERV). Moisture was supplied by means of 1.25 mL
water in a 1.5 mL microcentrifuge tube with a cotton wick.
The trays were incubated at 26.5°C., 60% humidity and 16:
8 hour light: dark photoperiod. Viability counts and weights
were taken on day 7 after the injections.
0236. Injection of dsRNA that Targets Hunchback mRNA

in BSB 2" Instar Nymphs.

0237 dsRNA homologous to a YFP coding region,
YFPv2, was used as a negative control in BSB injection
experiments. As summarized in Table 2, 27.6 ng BSB hb-1

dsRNA injected into the hemocoel of 2" instar BSB did not
lead to increased mortality within seven days.
TABLE 2

Results of BSB hunchback dsRNA injection into the hemocoel of 2"

instar Brown Stink Bug nymphs seven days after injection.
Table shows mean percent mortality, N number of trials, standard error
of the mean (SEM) and a p-value of two-tailed student t-test.
Treatment

Mean % mortality

SEM

N trials

t-test (p)

BSB hb-1
Not injected

1O.O
13.3

5.77
3.33

3
3

1.OOE--OO
6.43E-O1

YFPv2 dsRNA

1O.O

5.77

3

Example 6
Egg Hatch Following dsRNA Injection in Euschistus
heros

0238. Injection of dsRNA into BSB Hemocoel.
0239 BSB were reared as described above for the colony.
In the following exemplification, young adults (up to one
week post adult molt) were collected and chilled in a second
ary container on ice. The females and males were separated
based on structural dimorphism of the genitalia. Female BSB
were handled with Featherweight entomology forceps and

injected with dsRNA using a NANOJECTTM II injector
(DRUMMOND SCIENTIFIC, Broomhall, Pa.) equipped
with an injection needle pulled from a Drummond 3.5 inch
#3-000-203-G/X glass capillary. The needle tip was broken
and the capillary was backfilled with light mineral oil then
filled with 3 ul, dsRNA. Ten females (approximately 90 mg
each) per treatment were injected with dsRNA. Each female
was injected into the abdomen twice consecutively with 69
nL 1 lug/uL dsRNA for a total of 138 n (138 ng). Each batch
often females was moved into a 1 quart (-950 mL) bin with
an opening in the lid and #18 mesh for ventilation. Two adult
males were added to each bin often females. The insects were

Supplied with a vial of water, green beans, and seeds as
described in the rearing procedure. The insects were kept at
26.5°C., 60% humidity and 16:8 light: dark photoperiod.
0240 Surviving female counts, oviposited eggs and egg
hatch numbers were collected on a daily basis starting seven
to nine days after injection and continued for up to 24 days.
Eggs were removed daily and kept in Petri dishes or multi
well plates on a layer of 1% agarose in water. The adult insects
were transferred into bins with fresh water and food every
week.

0241 Injections of dsRNA that targets hunchback in BSB
females decrease egg oviposition. In one exemplification,
females injected with dsRNA that targets a 301 nt sequence
(SEQ ID NO:9) of the YFP coding region were used as a
negative control and compared to un-injected and females
injected with BSB hb-1 dsRNA (SEQID NO:2). As summa
rized in Table 3 and Table 5 hunchback dsRNA-injected
females oviposited lower numbers of eggs from YFPv2
dsRNA injected and not injected controls. Table 7 shows a
statistical difference in the number of eggs oviposited by
females injected with hunchback dsRNA when compared to
those injected with YFP dsRNA. The hatch rates from the
above eggs were dramatically reduced in all trials (Table 4.
Table 6, and Table 8). Results from the first two weeks of
oviposition in trial 1 were also binned by week, as presented
in FIGS. 5A-5C. While oviposition was not affected both
development and egg hatch were reduced. Eggs that showed
development had a phenotype with underdeveloped limbs
and head structures (FIGS. 6A-6C.)
TABLE 3

Number of eggs oviposited per female per day in trial 1. Ten females
were injected with dsRNA targeted against BSB hunchback or negative
control YFPv2. Counts of eggs were collected starting on day 7 post
injection and continued for 21 consecutive days post injection.
Two-tailed T-tests were performed in Excel.
total

mean ii of

number
of eggs

eggs day.
female

BSB hb-1
YFPv2

971
1280

8.53
10.1

2.39
2.05

O616
O.S29

2.94E-O1

not inj.

1429

9.53

2.89

0.747

7.S2E-O1

dsRNA

Std.
Deviation Std. Error t-test (p)
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TABLE 4

Number of eggs hatched per female per day in trial 1. Ten females were injected with dsRNA
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were
collected starting on day 7 post injection and continued for 21 consecutive days post
injection. Two-tailed t-tests were performed in Excel for mean # hatched day? female.
dsRNA

% egg total number of
mean # eggs
Std.
Std.
hatch eggs hatched hatched day? female Deviation Error

BSB hb-1

27.29

26S

2.42

1.44

O.37

YFPv2

85.55

1095

8.66

1.84

O48

not inj.

76.84

1098

7.32

2.66

O.69

t-test
(p)
2.24E-O3*

112E-O1

*indicates significant difference (p-value < 0.05)

TABLE 5

Number of eggs oviposited per female per day in trial 2. Ten females
were injected with dsRNA targeted against BSB hunchback or negative
control YFPv2. Counts of eggs were collected starting on day 9 post
injection and continued for 24 consecutive days post injection.
Two-tailed T-tests were performed in Excel.
mean ii of

dsRNA

total number eggs day.
of eggs
female

Std.
Deviation

Std.
Error

t-test (p)
2.82E-O1

BSB hb-1

625

7.27

1.69

0.437

YFPv2

740

6.53

1.97

O.S.09

TABLE 6

Number of eggs hatched per female per day in trial 2. Ten females were injected with dsRNA
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were
collected starting on day 9 post injection and continued for 24 consecutive days post
injection. Two-tailed t-tests were performed in Excel for mean # hatched day? female.

dsRNA

% egg total number of
mean # eggs
Std.
Std.
hatch eggs hatched hatched day? female Deviation Error

BSB hb-1

18.08

113

1.59

1.94

O49

YFPv2

77.84

576

5.14

1.79

O45

*indicates significant difference (p-value < 0.05)

TABLE 7

Number of eggs oviposited per female per day in trial 3. Ten females
were injected with dsRNA targeted against BSB hunchback or
negative control YFPv2. Counts of eggs were collected starting
on day 9 post injection and continued for 23 consecutive days
post iniection. Two-tailed T-tests were performed in Excel.
mean ii of

dsRNA

total number eggs day.
of eggs
female

Std.
Std.
Deviation Error

BSB hb-1

555

5.60

1.72

0.444

YFPv2

921

6.8O

1.38

O.356

*indicates significant difference (p-value <0.05)

t-test (p)
4.46E-02*

t-test
(p)
3.99E-OS*
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TABLE 8

Number of eggs hatched per female per day in trial 3. Ten females were injected with dsRNA
targeted against BSB hunchback or negative control YFPv2. Counts of eggs hatched were
collected starting on day 9 post injection and continued for 23 consecutive days post
injection. Two-tailed t-tests were performed in Excel for mean H hatched/day/female.
dsRNA

% egg total number of
mean # eggs
Std.
hatch eggs hatched hatched day? female Deviation Error

BSB hb-1

14.05

78

O.83

O.83

O.213

YFPv2

83.61

770

5.72

1.21

O311

t-test
(p)
2.48E-13*

*indicates significant difference (p-value < 0.05)

Example 7
Transgenic Zea mays Comprising Hemipteran Pest
Sequences
0242 Ten to 20 transgenic To Zea mays plants harboring
expression vectors for nucleic acids comprising SEQ ID
NO:1 and/or SEQ ID NO:2 are generated as described in
EXAMPLE3. A further 10-20 Ti Zea mays independent lines
expressing hairpin dsRNA for an RNAi construct are
obtained for BSB challenge. Hairpin dsRNA may be derived
comprising a segment of SEQID NO:1. These are confirmed
through RT-PCR or other molecular analysis methods. Total
RNA preparations from selected independent Ti lines are
optionally used for RT-PCR with primers designed to bind in
the linker of the hairpin expression cassette in each of the
RNAi constructs. In addition, specific primers for each target
gene in an RNAi construct are optionally used to amplify and
confirm the production of the pre-processed mRNA required
for siRNA production in planta. The amplification of the
desired bands for each target gene confirms the expression of
the hairpin RNA in each transgenic Zea mays plant. Process
ing of the dsRNA hairpin of the target genes into siRNA is
Subsequently optionally confirmed in independent transgenic
lines using RNA blot hybridizations.
0243 Moreover, RNAi molecules having mismatch
sequences with more than 80% sequence identity to target
genes affect hemipterans in a way similar to that seen with
RNAi molecules having 100% sequence identity to the target
genes. The pairing of mismatch sequence with native
sequences to form a hairpin dsRNA in the same RNAi con
struct delivers plant-processed siRNAs capable of affecting
the growth, development, reproduction, and viability offeed
ing hemipteran pests.
0244. In planta delivery of dsRNA, siRNA, shRNA,
hpRNA, or miRNA corresponding to target genes and the
Subsequent uptake by hemipteran pests through feeding
results in down-regulation of the target genes in the hemi
pteran pest through RNA-mediated gene silencing. When the
function of a target gene is important at one or more stages of
development, the growth, development, and/or reproduction
of the hemipteran pest is affected, and in the case of at least
one of Euschistus heros, Piezodorus guildinii, Halyomorpha
haly's, Nezara viridula, Acrosternum hilare, and Euschistus
servus leads to failure to successfully infest, feed, develop,
and/or reproduce, or leads to death of the hemipteran pest.
The choice of target genes and the Successful application of
RNAi is then used to control hemipteran pests.
0245 Phenotypic Comparison of Transgenic RNAi Lines
and Non-Transformed Zea mays.
0246 Target hemipteran pest genes or sequences selected
for creating hairpin dsRNA have no similarity to any known

plant gene sequence. Hence it is not expected that the pro
duction or the activation of (systemic) RNAi by constructs
targeting these hemipteran pest genes or sequences will have
any deleterious effect on transgenic plants. However, devel
opment and morphological characteristics of transgenic lines
are compared with non-transformed plants, as well as those of
transgenic lines transformed with an “empty vector having
no hairpin-expressing gene. Plant root, shoot, foliage and
reproduction characteristics are compared. There is no
observable difference in root length and growth patterns of
transgenic and non-transformed plants. Plant shoot charac
teristics Such as height, leaf numbers and sizes, time of flow
ering, floral size and appearance are similar. In general, there
are no observable morphological differences between trans
genic lines and those without expression of target iRNA mol
ecules when cultured in vitro and in Soil in the glasshouse.
Example 8
Transgenic Glycine max Comprising Hemipteran
Pest Sequences
0247 Ten to 20 transgenic To Glycine max plants harbor
ing expression vectors for nucleic acids comprising SEQID
NO:2 or a segment of SEQID NO:1 are generated as is known
in the art, including for example by Agrobacterium-mediated
transformation, as follows. Mature Soybean (Glycine max)
seeds are sterilized overnight with chlorine gas for sixteen
hours. Following sterilization with chlorine gas, the seeds are
placed in an open container in a LAMINARTM flow hood to
dispel the chlorine gas. Next, the sterilized seeds are imbibed
with sterile HO for sixteen hours in the dark using a black
box at 24°C.

0248 Preparation of Split-Seed Soybeans.
0249. The split soybean seed comprising a portion of an
embryonic axis protocol requires preparation of soybean seed
material which is cut longitudinally, using a #10 blade affixed
to a scalpel, along the hilum of the seed to separate and
remove the seed coat, and to split the seed into two cotyledon
sections. Careful attention is made to partially remove the
embryonic axis, wherein about /2-/3 of the embryo axis
remains attached to the nodal end of the cotyledon.
0250

Inoculation.

0251. The split soybean seeds comprising a partial portion
of the embryonic axis are then immersed for about 30 minutes
in a solution of Agrobacterium tumefaciens (e.g., strain EHA
101 or EHA 105) containing binary plasmid comprising SEQ
ID NO:1 and/or SEQID NO:2. The Agrobacterium tumefa
ciens solution is diluted to a final concentration of W-0.6

ODso before immersing the cotyledons comprising the
embryo axis.
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0252 Co-Cultivation.
0253) Following inoculation, the split soybean seed is
allowed to co-cultivate with the Agrobacterium tumefaciens
strain for 5 days on co-cultivation medium (Agrobacterium

Protocols, vol. 2, 2" Ed., Wang, K. (Ed.) Humana Press, New

Jersey, 2006) in a Petri dish covered with a piece of filter
paper.

0254 Shoot Induction.
0255. After 5 days of co-cultivation, the split soybean
seeds are washed in liquid Shoot Induction (SI) media con
sisting of B5 salts, B5 vitamins, 28 mg/L Ferrous, 38 mg/L
Na2EDTA, 30 g/L sucrose, 0.6 g/L MES, 1.11 mg/L BAP
100 mg/L TIMENTINTM,200 mg/L cefotaxime, and 50 mg/L
Vancomycin (pH 5.7). The split soybean seeds are then cul
tured on Shoot Induction I (SII) medium consisting of B5
salts, B5 vitamins, 7 g/L Noble agar, 28 mg/L Ferrous, 38
mg/L Na2EDTA, 30 g/L Sucrose, 0.6 g/L MES, 1.11 mg/L
BAP.50 mg/L TIMENTINTM,200 mg/L cefotaxime, 50 mg/L
Vancomycin (pH 5.7), with the flat side of the cotyledon
facing up and the nodal end of the cotyledon imbedded into
the medium. After 2 weeks of culture, the explants from the
transformed split soybean seed are transferred to the Shoot
Induction II (SIII) medium containing SI I medium supple
mented with 6 mg/L glufosinate (LIBERTYR).
0256 Shoot Elongation.
0257. After 2 weeks of culture on SI II medium, the coty
ledons are removed from the explants and a flush shoot pad
containing the embryonic axis are excised by making a cut at
the base of the cotyledon. The isolated shoot pad from the
cotyledon is transferred to Shoot Elongation (SE) medium.
The SE medium consists of MS salts, 28 mg/L Ferrous, 38
mg/L NaEDTA, 30 g/L Sucrose and 0.6g/L IVIES, 50 mg/L
asparagine, 100 mg/L L-pyroglutamic acid, 0.1 mg/L IAA,
0.5 mg/L GA3, 1 mg/L Zeatin riboside, 50 mg/L TIMEN
TINTM, 200 mg/L cefotaxime, 50 mg/L. Vancomycin, 6 mg/L
glufosinate, 7 g/L Noble agar, (pH 5.7). The cultures are
transferred to fresh SE medium every 2 weeks. The cultures
are grown in a CONVIRONTM growth chamber at 24°C. with

an 18hphotoperiod at a light intensity of 80-90 umol/m sec.

0258 Rooting.
0259 Elongated shoots which developed from the cotyle
don shoot pad are isolated by cutting the elongated shoot at
the base of the cotyledon shootpad, and dipping the elongated
shoot in 1 mg/LIBA (Indole 3-butyric acid) for 1-3 minutes to
promote rooting. Next, the elongated shoots are transferred to
rooting medium (MS salts, B5 vitamins, 28 mg/L Ferrous, 38
mg/L Na-EDTA, 20g/L sucrose and 0.59 g/LIVIES, 50 mg/L
asparagine, 100 mg/L L-pyroglutamic acid 7 g/L Noble agar,
pH 5.6) in phyta trays.
0260 Cultivation.
0261) Following culture in a CONVIRONTM growth
chamber at 24°C., 18hphotoperiod, for 1-2 weeks, the shoots
which have developed roots are transferred to a soil mix in a
covered sundae cup and placed in a CONVIRONTM growth
chamber (models CMP4030 and CMP3244, Controlled Envi
ronments Limited, Winnipeg, Manitoba, Canada) under long
day conditions (16 hours light/8 hours dark) at a light inten

sity of 120-150 umol/m secunder constant temperature (22°

C.) and humidity (40-50%) for acclimatization of plantlets.
The rooted plantlets are acclimated in Sundae cups for several
weeks before they are transferred to the greenhouse for fur
ther acclimatization and establishment of robust transgenic
Soybean plants.

0262. A further 10-20 T. Glycine max independent lines
expressing hairpin dsRNA for an RNAi construct are
obtained for BSB challenge. Hairpin dsRNA may be derived
as set forth in SEQID NO:2 or otherwise further comprising
SEQIDNO:1. These are confirmed through RT-PCR or other
molecular analysis methods, as known in the art. Total RNA
preparations from selected independent T lines are option
ally used for RT-PCR with primers designed to bind in the
linker of the hairpin expression cassette in each of the RNAi
constructs. In addition, specific primers for each target gene
in an RNAi construct are optionally used to amplify and
confirm the production of the pre-processed mRNA required
for siRNA production in planta. The amplification of the
desired bands for each target gene confirms the expression of
the hairpin RNA in each transgenic Glycine max plant. Pro
cessing of the dsRNA hairpin of the target genes into siRNA
is Subsequently optionally confirmed in independent trans
genic lines using RNA blot hybridizations.
0263. RNAi molecules having mismatch sequences with
more than 80% sequence identity to target genes affect BSB
in a way similar to that seen with RNAi molecules having
100% sequence identity to the target genes. The pairing of
mismatch sequence with native sequences to form a hairpin
dsRNA in the same RNAi construct delivers plant-processed
siRNAs capable of affecting the growth, development, repro
duction, and viability of feeding hemipteran pests.
0264. In planta delivery of dsRNA, siRNA, or miRNA
corresponding to target genes and the Subsequent uptake by
hemipteran pests through feeding results in down-regulation
of the target genes in the hemipteran pest through RNA
mediated gene silencing. When the function of a target gene is
important at one or more stages of development, the growth,
development, and/or reproduction of the hemipteran pest is
affected, and in the case of at least one of Euschistus heros,

Piezodorus guildinii, Halyomorpha haly's, Nezara viridula,

Acrosternum hilare, and Euschistus servus leads to failure to

Successfully infest, feed, develop, and/or reproduce, or leads
to death of the hemipteran pest. The choice of target genes and
the successful application of RNAi is then used to control
hemipteran pests.
0265 Phenotypic comparison of transgenic RNAi lines
and non-transformed Glycine max. Target hemipteran pest
genes or sequences selected for creating hairpin dsRNA have
no similarity to any known plant gene sequence. Hence it is
not expected that the production or the activation of (sys
temic) RNAi by constructs targeting these hemipteran pest
genes or sequences will have any deleterious effect on trans
genic plants. However, development and morphological char
acteristics of transgenic lines are compared with non-trans
formed plants, as well as those of transgenic lines
transformed with an "empty' Vector having no hairpin-ex
pressing gene. Plant root, shoot, foliage and reproduction
characteristics are compared. There is no observable differ
ence in root length and growth patterns of transgenic and
non-transformed plants. Plant shoot characteristics such as
height, leaf numbers and sizes, time of flowering, floral size
and appearance are similar. In general, there are no observ
able morphological differences between transgenic lines and
those without expression of target iRNA molecules when
cultured in vitro and in soil in the glasshouse.
Example 9
E. heros Bioassays on Artificial Diet
0266. In dsRNA feeding assays on artificial diet, 32-well
trays are set up with an ~18 mg pellet of artificial diet and
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water, as for injection experiments. dsRNA at a concentration
of 200 ng/uL is added to the food pellet and water sample, 100

uL to each of two wells. Five 2" instar E. heros nymphs are

introduced into each well. Water samples and dsRNA that
targets YFP transcript are used as negative controls. The
experiments are repeated on three different days. Surviving
insects are weighed and the mortality rates are determined
after 7 days of treatment.
0267 Feeding bioassays on adult female E. heros are per
formed as 32-well trays as described above. Young (less than
one week of adulthood) mated females are introduced into
bioassay trays with artificial diet, one pertray. After 7 days of
exposure to dsRNA up to ten adult females are moved to
containers with green beans, water, seeds, and two males.
Female viability as well as the numbers of eggs oviposited
and eggs hatched are recorded for the following two weeks.
The data shows that the numbers of eggs oviposited and/or
hatched are significantly reduced.
Example 10
Transgenic Arabidopsis thaliana Comprising
Hemipteran Pest Sequences
0268 Arabidopsis transformation vectors containing a
target gene construct for hairpin formation comprising seg
ments of hunchback (SEQ ID NO: 1) are generated using
standard molecular methods similar to EXAMPLE 4. Arabi

dopsis transformation is performed using standard Agrobac
terium-based procedure. Ti seeds are selected with glufosi
nate tolerance selectable marker. Transgenic T Arabidopsis
plants are generated and homozygous simple-copy T trans
genic plants are generated for insect studies. Bioassays are
performed on growing Arabidopsis plants with inflores
cences. Five to ten insects are placed on each plant and moni
tored for survival within 14 days.
0269 Construction of Arabidopsis Transformation Vec
tOrS.

0270 Entry clones based on an entry vector harboring a
target gene construct for hairpin formation comprising a seg
ment of hunchback (SEQ ID NO: 1) are assembled using a
combination of chemically synthesized fragments (DNA2.0,
Menlo Park, Calif.) and standard molecular cloning methods.
Intramolecular hairpin formation by RNA primary transcripts
is facilitated by arranging (within a single transcription unit)
two copies of a target gene segment in opposite orientations,
the two segments being separated by an linker sequence (e.g.
ST-LS1 intron: SEQID NO:6) (Vancanneytet al. (1990) Mol.
Gen. Genet. 22002):245-50). Thus, the primary mRNA tran
Script contains the two hunchback gene segment sequences as
large inverted repeats of one another, separated by the linker
sequence. A copy of a promoter (e.g. Arabidopsis thaliana
ubiquitin 10 promoter (Callis et al. (1990) J. Biological
Chem. 265:12486-12493)) is used to drive production of the
primary mRNA hairpintranscript, and a fragment comprising
a 3' untranslated region from Open Reading Frame 23 of
Agrobacterium tumefaciens (AtuORF233' UTR v1; U.S. Pat.
No. 5,428, 147) is used to terminate transcription of the hair
pin-RNA-expressing gene.
0271 The hairpin clone within the entry vector described
above is used in standard GATEWAYOR) recombination reac

tion with a typical binary destination vector to produce hair
pin RNA expression transformation vectors for Agrobacte
rium-mediated Arabidopsis transformation.
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0272. The binary destination vector comprises a herbicide
tolerance gene, DSM-2v2 (U.S. Patent App. No. 2011/
01.07455), under the regulation of a Cassava vein mosaic
virus promoter (CsVMV Promoter v2, U.S. Pat. No. 7,601,
885; Verdaguer et al. (1996) Plant Mol. Biol. 31:1129-39). A
fragment comprising a 3' untranslated region from Open
Reading Frame 1 of Agrobacterium tumefaciens (AtuORF1
3' UTR v6; Huang et al. (1990).J. Bacteriol. 172:1814-22) is
used to terminate transcription of the DSM2v2 mRNA.
0273 A negative control binary construct which com
prises a gene that expresses a YFP hairpin RNA, is con
structed by means of standard GATEWAYR recombination
reactions with a typical binary destination vector and entry
vector. An entry construct comprises a YFP hairpin sequence
(hpyFPv2, SEQID NO:5) under the expression control of an
Arabidopsis Ubiquitin 10 promoter (as above) and a fragment
comprising an ORF23 3' untranslated region from Agrobac
terium tumefaciens (as above).
0274 Production of Transgenic Arabidopsis Comprising
Insecticidal Hairpin RNAs. Agrobacterium-Mediated Trans
formation.

0275 Binary plasmids containing hairpin sequences are
electroporated into Agrobacterium strain GV3101
(pMP9CRK). The recombinant Agrobacterium clones are
confirmed by restriction analysis of plasmids preparations of
the recombinant Agrobacterium colonies. A Qiagen Plasmid
Max Kit (Qiagen, Catil 12162) is used to extract plasmids
from Agrobacterium cultures following the manufacture rec
ommended protocol.
(0276 Arabidopsis Transformation and T. Selection.
0277 Twelve to fifteen Arabidopsis plants (c.V. Columbia)
are grown in 4" pots in the greenhouse with light intensity of

250 umol/m, 25°C., and 18:6 hours of light: dark conditions.
Primary flower stems are trimmed one week before transfor
mation. Agrobacterium inoculums are prepared by incubat
ing 10 LL recombinant Agrobacterium glycerol stock in 100
mL LB broth (Sigma L3022)+100 mg/L Spectinomycin-50
mg/L Kanamycin at 28°C. and shaking at 225 rpm for 72
hours. Agrobacterium cells are harvested and Suspended into
5% sucrose+0.04% Silwet-L77 (Lehle Seeds Cat #VIS-02)+
10 ug/L benzamino purine (BA) solution to ODoo 0.8-1.0
before floral dipping. The above-ground parts of the plant are
dipped into the Agrobacterium solution for 5-10 minutes,
with gentle agitation. The plants are then transferred to the
greenhouse for normal growth with regular watering and
fertilizing until seed set.
Example 11
Growth and Bioassays of Transgenic Arabidopsis
(0278. Selection of TArabidopsis Transformed with Hair
pin RNAi Constructs.
(0279. Up to 200 mg of T seeds from each transformation
are stratified in 0.1% agarose solution. The seeds are planted
in germination trays (10.5"x21"x1"; T.O. Plastics Inc., Clear
water, Minn.) with #5 sunshine media. Transformants are
selected for tolerance to Ignite R (glufosinate) at 280 g/ha at 6
and 9 days postplanting. Selected events are transplanted into
4" diameter pots. Insertion copy analysis is performed within
a week of transplanting via hydrolysis quantitative Real-Time
PCR (qPCR) using Roche LightCycler480TM. The PCR prim
ers and hydrolysis probes are designed against DSM2V2
selectable marker using LightCyclerTM Probe Design Soft
ware 2.0 (Roche). Plants are maintained at 24°C., with a 16:8
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hour light: dark photoperiod under fluorescent and incandes

cent lights at intensity of 100-150 mE/ms.

0280 E. heros Nymph Plant Feeding Bioassay.
0281 At least four low copy (1-2 insertions), four medium
copy (2-3 insertions), and four high copy (>4 insertions)
events are selected for each construct. Plants are grown to a
reproductive stage (plants containing flowers and siliques).
The surface of soil is covered with ~50 mL volume of white

sand for easy insect identification. Five to ten 2" instar E.

heros nymphs are introduced onto each plant. The plants are
covered with plastic tubes that are 3" in diameter, 16" tall, and
with wall thickness of 0.03" (Item No. 484485, Visipack
Fenton Mo.); the tubes are covered with nylon mesh to isolate
the insects. The plants are kept under normal temperature,
light, and watering conditions in a conviron. In 14 days, the
insects are collected and weighed; percent mortality as well
as growth inhibition (1-weight treatment/weight control) are
calculated. YFP hairpin-expressing plants are used as con
trols.

0282. The pRNAi Arabidopsis T plants are selected and
grown in greenhouse, as described above. One to 5 newly
emerged BSB adults are released on each plant and the entire
plant is covered as described above to prevent adults from
escaping. One week after release, female adults are recovered
from each plant and maintained in the laboratory for egg
collection. Depending on the parental RNAi target and
expected phenotype, parameters such as number of eggs per
female, percent egg hatch and nymph mortality are recorded
and compared with control plants.
0283 T. Arabidopsis Seed Generation and T Bioassays.
0284. T seed is produced from selected low copy (1-2
insertions) events for each construct. Plants (homozygous
and/or heterozygous) are subjected to E. heros nymph and
adult feeding bioassay, as described above. T. Seed is har
Vested from homozygotes and stored for future analysis.
Example 12
Transformation of Additional Crop Species
0285 Cotton is transformed with hunchback (with or
without a chloroplast transit peptide) to provide control of
stink bugs by utilizing a method known to those of skill in the
art, for example, Substantially the same techniques previously
described in EXAMPLE 14 of U.S. Pat. No. 7,838,733, or

Example 12 of PCT International Patent Publication No. WO
2007/053482.

Example 13
pRNAi-Mediated Insect Protection
0286 Parental RNAi that causes egg mortality or loss of
egg viability brings further durability benefits to transgenic
crops that use RNAi and other mechanisms for insect protec
tion. A basic two-patch model was used to demonstrate this
utility.
0287. One patch contained a transgenic crop expressing
insecticidal ingredients, and the second patch contained a
refuge crop not expressing insecticidal ingredients. Eggs
were oviposited in the two modeled patches according to their
relative proportions. In this example, the transgenic patch
represented 95% of the landscape, and the refuge patch rep
resented 5%. The transgenic crop expressed an insecticidal
protein active against the insect.

0288 Pest to the insecticidal protein was modeled as
monogenic, with two possible alleles; one (S) conferring
susceptibility, and the other (R) conferring resistance. The
insecticidal protein was modeled to cause 97% mortality of
homozygous susceptible (SS) nymphs that feed on it. There
was assumed to be no mortality of nymphs that are homozy
gous for the resistance allele (RR). Resistance to the insecti
cidal protein was assumed to be incompletely recessive,
whereby the functional dominance is 0.3 (there is 67.9%
mortality of nymphs that are heterozygous (RS) for resistance
to the protein that feed on the transgenic crop).
0289. The transgenic crop also expressed parentally active
dsRNA that, through RNA-interference (pRNAi), causes the
eggs of adult female insects that are exposed to the transgenic
crop to be non-viable. Insect resistance to the pRNAi was also
considered to be monogenic with two possible alleles; one
(X) conferring susceptibility of the adult female to RNAi, and
the other (Y) conferring resistance of the adult female to
RNAi. Assuming a high level of exposure to the dsRNAs, the
pRNAi was modeled to cause 99.9% of eggs produced by a
homozygous susceptible (XX) female to be non-viable. The
model assumed that pRNAi has no effect on the viability of
eggs produced by homozygous resistant (YY) females. Resis
tance to the dsRNA was assumed to be recessive, whereby the
functional dominance is 0.01 (98.9% of eggs produced by a
female that is heterozygous (XY) for resistance to dsRNA are
non-viable).
0290. In the model, there was random mating among sur
viving adults and random oviposition across the two patches
in accordance with their relative proportions. The genotypic
frequencies of viable offspring followed Mendelian genetics
for a two-locus genetic system.
0291. The effect of pRNAi required the adult females to
feed on plant tissue expressing parental active dsRNA. The
interference with egg development may be lower for adult
females emerging from the refuge crop than from the trans
genic crop; adults may feed more extensively in the patch in
which they emerged following nymph development. There
fore, the relative magnitude of the pRNAi effect on female
adults emerging from the refuge patch was varied, with the
proportion of the pRNAi effect ranging from 0 (no effect of
pRNAi on adult females emerging from the refuge patch) to 1
(same effect of pRNAi on adult females emerging from the
refuge patch as on adult females emerging from the trans
genic patch).
0292. This model could be easily adjusted to demonstrate
the situation when the effect of pRNAi is also or alternatively
achieved by feeding of adult males on plant tissue expressing
parental active dsRNA.
0293 Frequencies of the two resistance alleles were cal
culated across generations. The initial frequencies of both of
the resistance alleles (R and Y) were assumed to be 0.005.
Results were presented as the number of insect generations
for the frequencies of each of the resistance alleles to reach
0.05. To examine the resistance delay caused by the pRNAi,
simulations that included pRNAi were compared to simula
tions that did not include pRNAi, but were identical in every
other way. FIG. 2.
0294 The model was also modified to include nymph
active interfering dsRNA in combination with the insecticidal
protein in the transgenic crop. Therein, the nymph RNAi was
assigned an effect of 97% nymph mortality for homozygous
RNAi-susceptible nymph (genotype XX), and no effect on
nymph that are homozygous RNAi-resistant (YY). There was
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67.9% mortality of nymph that were heterozygous for RNAi
resistance (XY). It was assumed that the same mechanism of
resistance applied to both nymph active RNAi and pRNAi. As
before, the pRNAi effect on adult females emerging from the
refuge patch relative to the effect on adult females emerging
from the transgenic patch was varied from 0 to 1. As before,
to examine the resistance delay caused by the pRNAi, simu
lations that included pRNAi were compared to simulations
that did not include pRNAi, but were identical in every other
way (including nymph RNAi). FIG. 3.
0295) A clear resistance management benefit of pRNAi
was observed when the magnitude of the pRNAi effect on egg
viability for female adults emerging from the refuge patch
was reduced compared with magnitude of the effect for adults
emerging from the transgenic patch. The transgenic crops that
produced parental active dsRNA in addition to an insecticidal
protein were much more durable compared with transgenic
crops that produced only an insecticidal protein. Similarly,
transgenic crops that produced parental active dsRNA in
addition to both an insecticidal protein and a nymph active
dsRNA were much more durable compared with transgenic
crops that produced only an insecticidal protein and a nymph
active dsRNA. In the latter case, the durability benefit applied
to both the insecticidal protein and the insecticidal interfering
dsRNA.

Example 14
Transgenic Plants Comprising a Hemipteran Pest
Sequence and Additional RNAi Constructs
0296. A transgenic plant comprising a heterologous cod
ing sequence in its genome that is transcribed into an iRNA
molecule that targets an organism other than a hemipteran
pest is secondarily transformed via Agrobacterium or WHIS
KERSTM methodologies (See Petolino and Arnold (2009)

Methods Mol. Biol. 526:59-67) to produce one or more insec
ticidal dsRNA molecules (for example, at least one dsRNA
molecule including a dsRNA molecule targeting a gene com
prising SEQID NO:1). Plant transformation plasmid vectors
prepared essentially as described in EXAMPLE 3 are deliv
ered via Agrobacterium or WHISKERSTM-mediated trans
formation methods into Suspension cells or immature
embryos obtained from a transgenic plant comprising a het
erologous coding sequence in its genome that is transcribed
into an iRNA molecule that targets an organism other than a
hemipteran pest.
Example 15
Transgenic Plants Comprising an RNAi Construct
and Additional Hemipteran Pest Control Sequences
0297. A transgenic plant comprising a heterologous cod
ing sequence in its genome that is transcribed into an iRNA
molecule that targets a hemipteran pest organism (for
example, at least one dsRNA molecule including a dsRNA
molecule targeting a gene comprising SEQID NO: 1) is sec
ondarily transformed via Agrobacterium or WHISKERSTM
methodologies (see Petolino and Arnold (2009) Methods
Mol. Biol. 526:59-67) to produce one or more insecticidal
protein molecules, for example, Cry1A, Cry2A, Cry3A,
Cry 11A, or Cry51A insecticidal proteins. Plant transforma
tion plasmid vectors prepared essentially as described in
EXAMPLE 3 are delivered via Agrobacterium or WHIS
KERSTM-mediated transformation methods into suspension
cells or immature embryos obtained from a transgenic plant
comprising a heterologous coding sequence in its genome
that is transcribed into an iRNA molecule that targets a hemi
pteran pest organism. Doubly-transformed plants are
obtained that produce iRNA molecules and insecticidal pro
teins for control of hemipteran pests.

SEQUENCE LISTING
<16 Os NUMBER OF SEO ID NOS : 14
<21 Os SEQ ID NO 1
&211s LENGTH: 2237
&212s. TYPE: DNA

<213> ORGANISM: Euchistus heros

<4 OOs SEQUENCE: 1

gcc ctittggg tittagttctic tacgagctgc tictaccatcc act agg act a got citat citt

60

citct cittata ttagttctgg atatatat ct ct ct ct citct at citat atct acagctggga

12O

acaccgtagt cqtcttttgt tittatatata ttgcctgcat gttggaatga gatgattata

18O

act cotgata tatactittaa caatc.cgagg atgaacatcg gtgtgcaata coacccaagg

24 O

catt.ccgtct tcc.cgaattt ggagcac cat coatggatgg ct tcc.ccgac to cqgcacaa

3 OO

gtcgittaaag aggagcc.gcg agatgacgcg gagtacggit c agaacagcca ggaga.gc.cag

360

Ctgcc.gctga cqc.cgcc.ccc ctitcCagggc tacccc.ccgg ggaacacct a cc.gc.gaggcc

42O

acgc.ccc.cta aggatacgcc cc cc.gc.ctcc accc cct cqc ct caggagala gCagga aggc

48O

agctic caact Cogagggaga gtact acgag agcggagagt cc ctaaagag gCtgcagatg

54 O

gcc ct coat a ggaccgggat gataacggag gaga agctgc aatgtc.ctgt atgcgagttc

6 OO

tottgcagtg to aggtolaca gttcaatgaa caccitattgt cacacgagac taaatgttcc

660
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gccatggttc tta accctga cqgttct c ct aatcct ctac caatcgtag

469

<210s, SEQ ID NO 3
&211s LENGTH: 555
212. TYPE: PRT

<213> ORGANISM: Euchistus heros

<4 OOs, SEQUENCE: 3

Met Ile Ile Thr Pro Asp Ile Tyr Phe Asn Asn Pro Arg Met Asin Ile
1.

5

1O

15

Gly Val Glin Tyr Asp Pro Arg His Ser Val Phe Pro Asn Lieu. Glu. His
2O

25

3O

His Pro Trp Met Ala Ser Pro Thr Pro Ala Glin Val Val Lys Glu Glu
35

4O

45

Pro Arg Asp Asp Ala Glu Tyr Gly Glin Asn. Ser Glin Glu Ser Glin Lieu.
SO

55

6O

Pro Leu. Thr Pro Pro Pro Phe Glin Gly Tyr Pro Pro Gly Asn Thr Tyr
65

70

7s

8O

Arg Glu Ala Thr Pro Pro Lys Asp Thr Pro Pro Ala Ser Thr Pro Ser
85

90

95

Pro Glin Glu Lys Glin Glu Gly Ser Ser Asn Ser Glu Gly Glu Tyr Tyr
1OO

105

11 O

Glu Ser Gly Glu Ser Lieu Lys Arg Lieu Gln Met Ala Lieu. His Arg Thr
115

120

125

Gly Met Ile Thr Glu Glu Lys Lieu Gln Cys Pro Val Cys Glu Phe Ser
13 O

135

14 O

Cys Ser Val Arg Ser Glin Phe Asin Glu. His Leu Lleu Ser His Glu Thr
145

150

155

160

Lys Cys Ser Met Cys Asp Phe Ser Gly Glu Thir Ser Glu Lys Lieu. Arg
1.65

17O

17s

Glu. His Met Arg Asn. Wal His Asp Cys Asp Asp Asp Ser Ser Trp Gly
18O

185

19 O

Glu Glu Glu Lieu. Asn Thr Pro Llys Val Asn. Ser Glin Gly Llys Wall Lys
195

2OO

2O5

Thr Phe Arg Cys Lys Gln Cys Glu Phe Ser Ala Val Thr Lys Lieu. Glu
21 O

215

22O

Phe Trp Asp His Ser Arg Thr His Ile Lys Glin Glu Arg Lieu. Lieu. Thir
225

23 O

235

24 O

Cys Pro Llys Cys Pro Phe Val Thr Glu Tyr Lys His His Lieu. Glu Tyr
245

250

255

His Lieu. Arg Asn His Phe Gly Ser Llys Pro Phe Lys Cys Asp Llys Cys
26 O

265

27 O

Ser Tyr Ser Cys Val Asn Llys Ser Met Lieu. Asn. Ser His Lieu Lys Ser
27s

28O

285

His Ser Asn Ile Tyr Glin Phe Arg Cys Ala Asp Cys Thr Tyr Ala Thr
29 O

295

3 OO

Llys Tyr Cys His Ser Lieu Lys Lieu. His Lieu. Arg Llys Tyr Ala His Asn
3. OS

310

315

32O

Pro Ala Met Val Lieu. Asn Pro Asp Gly Ser Pro Asn Pro Leu Pro Ile
3.25

330

335

Val Asp Val Tyr Gly. Thir Arg Arg Gly Pro Lys Glin Llys Pro Lys Asn
34 O

345

35. O
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Glu Glin Gln Pro Glin Glin Pro Pro Glin Wall Pro Thir Ile Phe Asn. Pro
355

360

365

Tyr Ser Lieu. Leu Pro Thr Gln Met Pro Tyr Tyr Asn Ile Lieu. Asn Gly
37 O

375

38O

Phe Gly Gly Phe Pro Phe Pro Glin Asp Val Asn Met Glu Glu Lys Asn
385

390

395

4 OO

Asn Asn Val Glu Lys Glu Glu Ile Arg Glu Asp Lys Ala Pro Lieu. Asp
4 OS

41O

415

Lieu. Ser Cys Pro Glu Pro Met Val Glu Asp Ser Asn Glin Glu Ala Pro
42O

425

43 O

Val Lys Asn Arg Arg Lys Gly Lys Ala Phe Llys Lieu. Asp Arg Ile Ala
435

44 O

445

Lieu. Arg Lieu. Glin Glin Glin Val Glu Val Glu Glu Gln Pro Glu Pro Pro
450

45.5

460

Llys Pro Ile Pro Pro Pro Val Val Ser Glu Pro Ala Lys Ser Pro Glu
465

470

47s

48O

Ile Llys Ser Cys Glu Ala Asp Ser Glu Glin Gln Llys Val Glu Lys Thr
485

490

495

Glu Glin Glu Asn Val Tyr Ser Cys Thr Phe Cys Asp Ile Leu Phe Lys
SOO

505

51O

Asp Ile Val Met Tyr Thr Met His Met Gly Tyr His Gly Tyr Glu Asp
515

52O

525

Pro Phe Lys Cys Asn Met Cys Gly Glin Glin Thr Thr Asp Llys Val Ser
53 O

535

54 O

Phe Phe Lieu. His Ile Ala Arg Thr Ser His Ser
5.45

550

555

<210s, SEQ ID NO 4
&211s LENGTH: 2O
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: T7 phage promoter
<4 OOs, SEQUENCE: 4
taatacgact cactataggg

2O

<210s, SEQ ID NO 5
&211s LENGTH: 471
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: YFP v2 hpRNA encoding sequence
<4 OOs, SEQUENCE: 5

atgtcatctg gag cacttct Cttt catggg aagattic ctt acgttgttgga gatggaaggg

6O

aatgttgatg gcc acaccitt tag catacgt gggaaaggct acggagatgc ct cagtggga

12 O

aaggac tagt accoggttggg aaagg tatgt ttctgcttct acctittgata tatatataat

18O

aattat cact aattagtagt aatatagitat ttcaagtatt tttittcaaaa taaaagaatg

24 O

tagtatatag c tattgcttt totgtag titt ataagtgtgt at attittaat ttata actitt

3OO

tctaatatat gaccaaaa.ca toggtgatgtg caggttgatc cqcggittact titcc.cactga

360

ggcatctocq tag cctitt co cacg tatgct aaaggtgtgg ccatcaa.cat tcc ctitc cat

42O
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citccacaacg taaggaatct tcc catgaaa gagaagtgct c cagatgaca t

471

<210s, SEQ ID NO 6
&211s LENGTH: 222
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

223s OTHER INFORMATION: ST-LS1 intron

<4 OOs, SEQUENCE: 6

gact agtacc ggttgggaaa got atgtttic togcttct acc tittgatatat atataataat

6O

tat cactaat tagtag taat at agtatttic aag tatttitt ttcaaaataa aagaatgtag

12 O

tatatagota ttgcttittct gtag tittata agtgttgtata ttittaattta taacttittct

18O

aatatatgac Caaaac atgg tatgtgcag gttgatc.cgc gg

222

<210s, SEQ ID NO 7
&211s LENGTH: 45
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: Primer oligonucleotide BSB bh-1-F
<4 OO > SEQUENCE: 7

ttaatacgac toactatagg gagagtccac gactg.cgatg atgac
<210

45

SEQ ID NO 8

&211s LENGTH: 48
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: Primer oligonucleotide BSB hb-1-R
<4 OOs, SEQUENCE: 8

ttaatacgac toactatagg gagacitacga ttggtagagg attaggag

48

<210s, SEQ ID NO 9
&211s LENGTH: 301
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: Sense strand of YFP v2-targeted dsRNA
<4 OOs, SEQUENCE: 9

Catctggagc acttct Cttt catgggaaga titcct tacgt ttggagatg gaagggaatg

6O

ttgatggc.ca cacctittagc atacgtggga aaggctacgg agatgcctica gtgggaaagg

12 O

ttgatgcaca gttcatctgc acaactggtg atgttcc tigt gcc ttggagc acacttgtca

18O

c cactict cac ctatggagca cagtgctttg C caagtatgg to cagagttg aaggactitct

24 O

acaagt cctg. tatgccagat ggctatgtgc aagagcgcac aat cacctitt gaaggagatg

3OO

9

3O1

<210s, SEQ ID NO 10
&211s LENGTH: 47
&212s. TYPE: DNA

<213> ORGANISM: Artificial Sequence
22 Os. FEATURE:

<223> OTHER INFORMATION: Primer oligonucleotide YFPv2-F
<4 OOs, SEQUENCE: 10
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tatgtc.gc.cc tigactittga gcaggaaatg gcc accgc.cg Ctgcctic cac ctic cctggag

72 O

aagt cctatgaactt.ccc.ga C9gtcagg to atcac catcg gtaacgagag gttc.cgttgc

78O

ccagaggctic tict tccagcc titcCttcttg gg tatggaat cittgcggitat coatgag act

84 O

gtct acaact c catcatgaa gtgcgacgtt gaCat Cagga aggacttgta CC caac acc

9 OO

gtcCtctic.cg gaggtaccac catgt accca gg tattgctg acaggatgca gaaggaaatc

96.O

accocc ct cq ctic cittcaac catcaagat.c aagat cattg citcc.cccaga aaggaagitac

1 O2O

tccg tatgga t cqgtggttc catcttggct tcc ct gtc.ca cct tccago a gatgtggat.c

108 O

tccaag Cagg aatacgacga atc.cggcc.ca ggcatcgt.cc accgcaaatg Cttic

1134

What may be claimed is:
1. An isolated nucleic acid comprising at least one poly
nucleotide selected from the group consisting of:
SEQ ID NO:1; the complement of SEQID NO:1; a frag
ment of at least 15 contiguous nucleotides of SEQ ID
NO:1; the complement of a fragment of at least 15 con
tiguous nucleotides of SEQ ID NO:1; a native coding
sequence of a hemipteran organism comprising SEQID
NO:1; the complement of a native coding sequence of a
hemipteran organism comprising SEQ ID NO:1; a
native non-coding sequence of a hemipteran organism
that is transcribed into a native RNA molecule compris
ing SEQ ID NO:1; the complement of a native non
coding sequence of a hemipteran organism that is tran
scribed into a native RNA molecule comprising SEQID
NO:1; a fragment of at least 15 contiguous nucleotides
of a native coding sequence of a hemipteran organism
comprising SEQ ID NO:1; the complement of a frag
ment of at least 15 contiguous nucleotides of a native
coding sequence of a hemipteran organism comprising
SEQ ID NO:1; a fragment of at least 15 contiguous
nucleotides of a native non-coding sequence of a hemi
pteran organism that is transcribed into a native RNA
molecule comprising SEQ ID NO:1; and the comple
ment of a fragment of at least 15 contiguous nucleotides
of a native non-coding sequence of a hemipteran organ
ism that is transcribed into a native RNA molecule com

prising SEQID NO:1.
2. The polynucleotide of claim 1, wherein the polynucle
otide is selected from the group consisting of SEQID NO:1
and SEQID NO:2.
3. A plant transformation vector comprising the polynucle
otide of claim 1.

4. The polynucleotide of claim 1, wherein the organism is
selected from the group consisting of Euschistus heros (Fabr.)
(Neotropical Brown Stink Bug), Nezara viridula (L.) (South
ern Green Stink Bug), Piezodorus guildinii (Westwood)
(Red-banded Stink Bug), Halyomorpha halys (Stat) (Brown
Marmorated Stink Bug), Chinavia hilare (Say) (Green Stink
Bug), Euschistus serous (Stal) (Brown Stink Bug), Dichelops
melacanthus (Dallas), Dichelops fircatus (F), Edessa med
itabunda (F.), Thyanta perditor (F.) (Neotropical Red Shoul
dered Stink Bug), Chinavia marginatum (Palisot de Beau
vois), Horcias nobilellus (Berg) (Cotton Bug), Taedia
Stigmosa (Berg), Dysdercus peruvianus (Guérin-Méneville),
NeOmegalotomus parvus (Westwood), Leptoglossus Zonatus

(Dallas), Niesthrea Sidae (F), Lygus hesperus (Knight)
(Western Tarnished Plant Bug), and Lygus lineolaris (Palisot
de Beauvois).
5. A ribonucleic acid (RNA) molecule transcribed from the
polynucleotide of claim 1.
6. A double-stranded ribonucleic acid molecule produced
from the expression of the polynucleotide of claim 1.
7. The double-stranded ribonucleic acid molecule of claim

6, wherein contacting the polynucleotide sequence with a
hemipteran pest inhibits the expression of an endogenous
nucleotide sequence specifically complementary to the poly
nucleotide.
8. The double-stranded ribonucleic acid molecule of claim

7, wherein contacting said ribonucleotide molecule with a
hemipteran pest kills or inhibits the growth, reproduction,
and/or feeding of the pest.
9. The double stranded RNA of claim 6, comprising a first,
a second and a third RNA segment, wherein the first RNA
segment comprises the polynucleotide, wherein the third
RNA segment is linked to the first RNA segment by the
second polynucleotide sequence, and wherein the third RNA
segment is substantially the reverse complement of the first
RNA segment, such that the first and the third RNA segments
hybridize when transcribed into a ribonucleic acid to form the
double-stranded RNA.

10. The RNA of claim 5, selected from the group consisting
of a double-stranded ribonucleic acid molecule and a single
stranded ribonucleic acid molecule of between about 15 and

about 30 nucleotides in length.
11. A plant transformation vector comprising the poly
nucleotide of claim 1, wherein the heterologous promoter is
functional in a plant cell.
12. A cell transformed with the polynucleotide of claim 1.
13. The cell of claim 12, wherein the cell is a prokaryotic
cell.

14. The cell of claim 12, wherein the cell is a eukaryotic
cell.

15. The cell of claim 14, wherein the cell is a plant cell.
16. A plant transformed with the polynucleotide of claim 1.
17. A seed of the plant of claim 16, wherein the seed
comprises the polynucleotide.
18. A commodity product produced from the plant of claim
16, wherein the commodity product comprises a detectable
amount of the polynucleotide.
19. The plant of claim 16, wherein the at least one poly
nucleotide is expressed in the plant as a double-stranded
ribonucleic acid molecule.
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20. The cell of claim 15, wherein the cell is a Zea mays cell,
a Glycine max cell, or a cell from a Gossypium sp.
21. The plant of claim 16, wherein the plant is maize,
Soybean, or cotton.
22. The plant of claim 16, wherein the at least one poly
nucleotide is expressed in the plant as a ribonucleic acid
molecule, and the ribonucleic acid molecule inhibits the

expression of an endogenous polynucleotide that is specifi
cally complementary to the at least one polynucleotide when
a hemipteran pest ingests a part of the plant.
23. The polynucleotide of claim 1, further comprising at
least one additional polynucleotide that encodes an RNA
molecule that inhibits the expression of an endogenous pest
gene.

24. The polynucleotide of claim 23, wherein the additional
polynucleotide encodes an iRNA molecule that results in a
parental RNAi phenotype.
25. The polynucleotide of claim 24, wherein the additional
polynucleotide encodes an iRNA molecule that inhibits the
expression of a Brahma or kruppel gene.
26. The polynucleotide of claim 23, wherein the additional
polynucleotide encodes an iRNA molecule that results in
decreased growth and/or development and/or mortality in a
hemipteran pest that contacts the iRNA molecule (lethal
RNAi).
27. A plant transformation vector comprising the poly
nucleotide of claim 23, wherein the additional polynucleotide
(s) are each operably linked to a heterologous promoter func
tional in a plant cell.
28. The polynucleotide of claim 1, wherein the polynucle
otide is operably linked to a heterologous promoter.
29. A method for controlling a hemipteran pest population,
the method comprising providing an agent comprising a ribo
nucleic acid (RNA) molecule that functions upon contact
with the hemipteran pest to inhibit a biological function
within the hemipteran pest, wherein the RNA is specifically
hybridizable with a polynucleotide selected from the group
consisting of SEQ ID NOs: 12 and 13; the complement of
either of SEQ ID NOS:12 and 13; a fragment of at least 15
contiguous nucleotides of either of SEQID NOs: 12 and 13:
the complement of a fragment of at least 15 contiguous nucle
otides of either of SEQ ID NOS:12 and 13: a transcript of
either of SEQID NOS:1 and 2: the complement of a transcript
of either of SEQ ID NOS:1 and 2; a fragment of at least 15
contiguous nucleotides of a transcript of either of SEQ ID
NOs: 1 and 2; and the complement of a fragment of at least 15
contiguous nucleotides of a transcript of either of SEQ ID
NOS:1 and 2.

30. The method according to claim 29, wherein the agent is
a double-stranded RNA molecule.

31. A method for controlling a hemipteran pest population,
the method comprising:
introducing into a hemipteran pest, a ribonucleic acid
(RNA) molecule that functions upon contact with the
hemipteran pest to inhibit a biological function within
the hemipteran pest, wherein the RNA is specifically
hybridizable with a polynucleotide selected from the
group consisting of any of
SEQID NOs: 12 and 13,
the complement of either of SEQID NOS:12 and 13,
a fragment of at least 15 contiguous nucleotides of either
of SEQID NOs: 12 and 13,
the complement of a fragment of at least 15 contiguous
nucleotides of either of SEQID NOS:12 and 13,
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a transcript of either of SEQID NOs: 1 and 2.
the complement of a transcript of either of SEQ ID
NOS:1 and 2,

a fragment of at least 15 contiguous nucleotides of a tran
script of either of SEQID NOS:1 and 2, and
the complement of a fragment of at least 15 contiguous
nucleotides of a transcript of either of SEQID NOs: 1
and 2.

thereby producing a hemipteran pest having a pRNAi
phenotype.
32. The method according to claim 31, wherein the RNA is
introduced into a male hemipteran pest.
33. The method according to claim 31, wherein the RNA is
introduced into a female hemipteran pest, the method further
comprising releasing the female hemipteran pest having the
pRNAi phenotype into the pest population, wherein mating
between the female hemipteran pest having the pRNAi phe
notype and male pests of the population produces fewer
viable offspring than mating between other female pests and
male pests of the population.
34. A method for controlling a hemipteran pest population,
the method comprising:
providing an agent comprising a first and a second poly
nucleotide sequence that functions upon contact with the
hemipteran pest to inhibit a biological function within
the hemipteran pest, wherein the first polynucleotide
sequence comprises a region that exhibits from about
90% to about 100% sequence identity to from about 19
to about 30 contiguous nucleotides of SEQID NO:12,
and wherein the first polynucleotide sequence is specifi
cally hybridized to the second polynucleotide sequence.
35. The method according to claim 34, wherein the ribo
nucleic acid molecule is a double-stranded ribonucleic acid
molecule.

36. The method according to claim 34, wherein the hemi
pteran pest population is reduced relative to a population of
the same pest species infesting a host plant of the same host
plant species lacking the transformed plant cell.
37. A method for controlling a hemipteran pest population,
the method comprising:
providing in a host plant of a hemipteran pest a transformed
plant cell comprising the polynucleotide of claim 1,
wherein the polynucleotide is expressed to produce a
ribonucleic acid molecule that functions upon contact
with a hemipteran pest belonging to the population to
inhibit the expression of a target sequence within the
hemipteran pest and results in decreased reproduction of
the hemipteran pest or pest population, relative to repro
duction of the same pest species on a plant of the same
host plant species that does not comprise the polynucle
otide.

38. The method according to claim 37, wherein the ribo
nucleic acid molecule is a double-stranded ribonucleic acid
molecule.

39. The method according to claim 37, wherein the hemi
pteran pest population is reduced relative to a hemipteran pest
population infesting a host plant of the same species lacking
the transformed plant cell.
40. A method of controlling hemipteran pest infestation in
a plant, the method comprising providing in the diet of a
hemipteran pest a ribonucleic acid (RNA) that is specifically
hybridizable with a polynucleotide selected from the group
consisting of:
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SEQID NOs: 12 and 13;
the complement of either of SEQID NOS:12 and 13:
afragment of at least 15 contiguous nucleotides of either of
SEQID NOs: 12 and 13;
the complement of a fragment of at least 15 contiguous
nucleotides of either of SEQID NOS:12 and 13:
a transcript of any of either of SEQID NOS:1 and 2:
the complement of a transcript of either of SEQID NOs: 1
and 2:

a fragment of at least 15 contiguous nucleotides of a tran
script of either of SEQID NOS:1 and 2; and
the complement of a fragment of at least 15 contiguous
nucleotides of a transcript of either of SEQ ID NOs: 1
and 2.

41. The method according to claim 40, wherein the diet
comprises a plant cell transformed to express the polynucle
otide.

42. The method according to claim 40, wherein the specifi
cally hybridizable RNA is comprised in a double-stranded
RNA molecule.

43. A method for improving the yield of a corn crop, the
method comprising:
introducing the nucleic acid of claim 1 into a corn plant to
produce a transgenic corn plant; and
cultivating the corn plant to allow the expression of the at
least one polynucleotide; wherein expression of the at
least one polynucleotide inhibits hemipteran pest repro
duction or growth and loss of yield due to hemipteran
pest infection.
44. The method according to claim 43, wherein expression
of the at least one polynucleotide produces an RNA molecule
that Suppresses at least a first target gene in a hemipteran pest
that has contacted a portion of the plant.
45. A method for producing a transgenic plant cell, the
method comprising:
transforming a plant cell with a vector comprising the
nucleic acid of claim 1:

culturing the transformed plant cell under conditions Suf
ficient to allow for development of a plant cell culture
comprising a plurality of transformed plant cells;
Selecting for transformed plant cells that have integrated
the at least one polynucleotide into their genomes;
Screening the transformed plant cells for expression of a
ribonucleic acid (RNA) molecule encoded by the at least
one polynucleotide; and
selecting a plant cell that expresses the RNA.
46. The method according to claim 45, wherein the RNA
molecule is a double-stranded RNA molecule.

47. A method for producing a hemipteran pest-resistant
transgenic plant, the method comprising:
providing the transgenic plant cell produced by the method
of claim 44; and

regenerating a transgenic plant from the transgenic plant
cell, wherein expression of the ribonucleic acid mol
ecule encoded by the at least one polynucleotide is suf

ficient to modulate the expression of a target gene in a
hemipteran pest that contacts the transformed plant.
48. A method for producing a transgenic plant cell, the
method comprising:
transforming a plant cell with a vector comprising a means
for protecting a plant from a hemipteran pest;
culturing the transformed plant cell under conditions Suf
ficient to allow for development of a plant cell culture
comprising a plurality of transformed plant cells;
selecting for transformed plant cells that have integrated
the means for protecting a plant from a hemipteran pest
into their genomes;
screening the transformed plant cells for expression of a
means for inhibiting expression of an essential gene in a
hemipteran pest; and
selecting a plant cell that expresses the means for inhibiting
expression of an essential gene in a hemipteran pest.
49. A method for producing a hemipteran pest-resistant
transgenic plant, the method comprising:
providing the transgenic plant cell produced by the method
of claim 47; and

regenerating a transgenic plant from the transgenic plant
cell, wherein expression of the means for inhibiting
expression of an essential gene in a hemipteran pest is
Sufficient to modulate the expression of a target gene in
a hemipteran pest that contacts the transformed plant.
50. The nucleic acid of claim 1, further comprising a poly
nucleotide encoding a polypeptide from Bacillus thuringien
sis, Alcaligenes spp., or Pseudomonas spp.
51. The nucleic acid of claim 50, wherein the polypeptide
from B. thuringiensis is selected from a group comprising
Cry1A, Cry2A, Cry3A, Cry 11A, and Crys 1A.
52. The cell of claim 15, wherein the cell comprises a
polynucleotide encoding a polypeptide from Bacillus thur
ingiensis, Alcaligenes spp., or Pseudomonas spp.
53. The cell of claim 52, wherein the polypeptide from B.
thuringiensis is selected from a group comprising Cry1A,
Cry2A, Cry3A, Cry11A, and Cry51A.
54. The plant of claim 16, wherein the plant comprises a
polynucleotide encoding a polypeptide from Bacillus thur
ingiensis, Alcaligenes spp., or Pseudomonas spp.
55. The plant of claim 53, wherein the polypeptide from B.
thuringiensis is selected from a group comprising Cry1A,
Cry2A, Cry3A, Cry11A, and Cry51A.
56. The method according to claim 45, wherein the trans
formed plant cell comprises a nucleotide sequence encoding
a polypeptide from Bacillus thuringiensis, Alcaligenes spp.,
or Pseudomonas spp.
57. The method according to claim 56, wherein the
polypeptide from B. thuringiensis is selected from a group
comprising Cry1A, Cry2A, Cry3A, Cry11A, and Crys 1A.
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